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Abstract 
 
Enteroaggregative E. coli is known to cause diarrhoeal disease in developing and developed 
countries, but is also found in asymptomatic carriage and so the causal link between EAEC and 
disease is unknown. This study assessed bacterial load, the presence of co-infections and 
demographic data to assess if EAEC was independently associated with intestinal infectious disease 
in the United Kingdom. This study concluded that EAEC was independently capable of causing 
disease and accounts for ~1% of intestinal disease and therefore an important burden. 
 
A case control approach of analysis by multi locus sequence typing of 564 EAEC isolates from cases 
and controls in Bangladesh, Nigeria and the UK spanning the past 29 years, revealed multiple 
successful lineages of EAEC. The population structure of EAEC indicates some clusters are statistically 
associated with disease or carriage, further highlighting the heterogeneous nature of this group of 
organisms. Different clusters have evolved independently as a result of both mutational and 
recombination events; the EAEC phenotype is distributed throughout the population of E. coli.  
 
In vivo models looking at EAEC infection and virulence gene content of EAEC show that different 
complexes varied in their ability to cause disease further concluding that these complexes may have 
come from different ecological niches but that the EAEC phenotype enhanced survival and so these 
defined EAEC complexes have converged to stably retain the plasmid and phenotype. 
 
This study has identified several successful EAEC complexes associated with sporadic  disease (ST 10, 
38, 40, 295, 278, 394, 678 and 746  Cplx) with subset of complexes showing evidence of patho-
adaptation to cause extra-intestinal infections (ST38 Cplx) and outbreaks (ST40, 278 and 678 Cplx) or 
form hybrid strains with Shiga toxin producing E. coli causing severe disease (ST40 and 678 Cplx).  
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Statistical Analysis Used in this Study 
Chapter 2 Burden of EAEC in the UK 
Receiver-operating characteristic (ROC) analysis: Used to define a cut-off in the Ct values to 
estimate the number of true EAEC IID positive cases in the population. When a measurement is used 
to make a diagnosis , the choice of the ‘best cut-off’ is not simple and so a graphical approach is 
carried out to plot the sensitivity versus the specificity for each possible cut-off. The youden index is 
then used. 
Youden index (sensitivity + specificity-1): Used to calculate the maximum value of sensitivity and 
specificity to identify the optimum cut-off (Bewick et al. 2004;Fluss et al. 2005). This is a single 
statistic that captures the performance of a diagnostic test. In this case, could the presence of EAEC 
below a certain ct value be used to diagnostically. 
Students t –test: This test is used for comparing the actual difference between two means in 
relation to the variation in the data (expressed as the standard deviation of the difference between 
two means). This parametric test was used to compare the distribution of Ct values from cases and 
controls for EAEC positive individuals to ascertain if the bacterial load play a role in determining 
whether the presence of EAEC would be related to carriage or disease. 
Chi-square test: This was used to test if the distribution of the pathogen between cases and controls 
was as expected by chance (Figure 2.3). It was used to test the association of co-infections with EAEC 
in cases versus control (Figure 2.4). It was used to test the association of co-infection with EAEC in 
comparison to norovirus (Figure 2.5). If there is a variable which has a normal distribution then X2 
will have a chi squared distribution. This test was used to ascertain if the distributions of the 
presence of EAEC were normal or played a role in disease, the presence of co-infections were also 
taken into account. 
Odd Ratio (OR): A measure of association between an exposure and an outcome. For example what 
are the chances of someone having disease if EAEC is present in their stool? 
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Relative risk (RR): This is the ratio of the probability of an event occurring in an exposed group to 
the probability of the event occurring in a comparison non-exposed group. For example, the chances 
of case participants having EAEC present in their stool in comparison to control participants having 
EAEC present in their stool. 
Confidence Interval (CI): This is a type of interval estimate of a population parameter and is used to 
indicate the reliability of an estimate and is calculated from the observations different from sample 
to sample. It is a range of values which can be confident includes the true value. 
Logistic Regression: A logistic regression of univariate and multivariate analysis was carried out using 
case or control as outcome and infecting agent and age as independent variables. In this way the 
independent association between EAEC and disease  whilst controlling for other pathogens was 
assessed.  
Population attributable fraction (PAF): Model results from logistic regression were used to calculate 
the population attributable fraction (PAF): 
PAR = Pe (RRe -1) / RRe  
Where Pe is the proportion of cases with the exposure (EAEC) and RRe the relative risk of disease. 
This form allows for confounding of the exposure if an adjusted RR is used, as recommended in 
Rockhill et al (Rockhill et al. 1998). In this case, adjusted odds ratios are substituted into this 
equation to give an approximate, adjusted PAF. 
 
Chapter 3 – Definition of pathogenic EAEC groups by a case control approach 
Fisher’s exact test: This is a statistical significance test used in the analysis of contingency tables 
(displays the frequency of distribution of the variables). It is a class of exact tests because the 
significance of the deviation from a null hypothesis (e.g. probability (p) value) can be calculated 
exactly. It was used to look out the probability that EAEC complexes were associated with cases or 
controls and whether EAEC complexes were associated with being EAEC or other E. coli pathotypes. 
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Chapter 4 – Inference of Bacterial Microevolution 
ClonalFrame:  ClonalFrame is a software package and is a Bayesian method of constructing 
evolutionary histories that takes both mutation and recombination into account (Didelot and Falush 
2007). It segregates the sequences into frames and looks across sequences to ascertain if mutations 
are evenly distributed across the frames. 
Bayesian statistics style model: The inference of probability is updated as additional evidence is 
learned and in this analysis is based on the Markov chain Monte Carlo method. 
Markov Chain Monte Carlo: A class of algorithms for sampling from probability distributions (i.e. 
distributions of mutations or recombination) based on constructing a Markov chain (i.e. random 
process on which the next state depends only on the current state and not on the sequence of 
events that preceded it) that has the desired distribution as its equilibrium distribution (Note that 
there is no assumption on the starting distribution; the chain converges to the stationary distribution 
regardless of where it begins). For example, analysis is based on the data/evidence that is processed 
and no assumptions are made as to how this data occurred. It is used to estimate the distribution 
and compute a mean for example how often mutation and recombination occurs. 
Posterior probability: In Bayesian statistics, the posterior probability of a random event or an 
uncertain proposition is the conditional probability that is assigned after the relevant evidence is 
taken into account  
 
Inference of genetic events 
Visualisation of parameters and statistics were used to infer microevolution and the phylogeny of 
the EAEC data (Didelot and Falush 2006;Didelot and Falush 2007;Vos and Didelot 2009). Multiple 
analyses were carried out including: 
Mutation rate (theta) – rate at which change is due to mutation 
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rho over theta (ρ/θ) – a measure of the frequency at which recombination occurs relative to 
mutation. 
Recombination ratio (г/м) – ratio of rates at which nucleotides become substituted as a result of 
recombination and mutation. 
External to internal branch length ratio test – computes the distribution of the sum of the lengths of 
the external branches (i.e. ones that connect a leaf of the tree) divided by the sum of the lengths of 
the internal branches (i.e. the ones that connect two internal nodes of the tree) (shown as red). Also 
computes the expected distribution of the external to internal branch length ratio under the 
coalescent model (shown in blue). 
 
Chapter 5 – Genotypic and Phenotypic models to assess EAEC pathogenicity 
Kaplan-Meier method: Data from the assays were analysed using the Kaplan-Meier method (Bland 
and Altman 1998) which is an estimator for estimating the survival function from lifetime data for 
example the survival of a worm when fed EAEC. 
Log Rank test: This was carried out for equality of survivor functions (Bland and Altman 2004) in 
which a comparison of all complexes was tested against each other to ascertain if the survival 
function of the worm was reduced by ingesting EAEC from the different complexes.  
Cox regression : The groups were further analysed by cox regression analysis (Altman and Andersen 
1989), against the complex strains against the control strains. This study was limited by the small 
numbers so there would need to be extreme differences to show a significance determined by a 
hazard ratio of <0.5 or >2 and a probability <0.05. 
Hazard ratio: In survival analysis the hazard ratio is the ratio of hazard rates corresponding to the 
conditions described by two levels of an explanatory variable. For example in the EAEC study, the 
worms fed EAEC strains may die at twice the rate per unit time as the control non-pathogenic E. coli 
strain. The hazard ratio would be 2, indicating higher hazard of death 
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Pearson Chi-square test: This statistical hypothesis test was used to test the hypothesis of virulence 
genes being associated with cases or complexes. It is used when the sampling distribution of the test 
statistic is a chi-squared distribution when the null hypothesis is true resulting in a probability. The 
Pearson method is a chi-squared test for independence (mentioned without any modifiers) and is 
meant for an exact testing place of a Fishers exact test (which is appropriate for small sizes under 5). 
This test was appropriate as the sample size was over 5. 
Linear regression: Linear regression is an approach for modelling the relationship between scalar 
dependent variable y and one or more variables denoted x. This method was used to analyse if these 
complexes have a higher virulence than a reference group. ST38 complex was chosen as the 
reference groups as it contained the largest sample size and best representation of the data.  
Confidence Interval (CI): this is a type of interval estimate of a population parameter and is used to 
indicate the reliability of an estimate and is calculated from the observations different from sample 
to sample. It is a range of values which can be confident includes the true value. 
Coefficient: This was used to assess the virulence score of the complexes in comparison to a 
reference group. The coefficient is the change in outcome per unit increase - this just being one, as 
they are indicators for that complex vs. the reference group, and therefore can be interpreted as a 
differences in means compared to the control group.  
t-test: The model coefficients have a t distribution, so their significance is tested via a t-statistic, 
which is given, and its p-value - which is the probability that you would achieve results as extreme or 
more than that observed, given the null hypothesis of there being no difference between the 
complex and the reference group. 
Standard deviation: This shows how much variation or dispersion from the average exists, A low 
standard deviation indicates that the data points tend to be very close to the mean (or expected 
value) whereas a high standard deviation indicates that the data points are spread out over a large 
range of values. 
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Statistical analysis was carried out in STATA v 13.1 for Chapters 2, 3 and 5. ClonalFrame software was 
used for statistical analysis for Chapter 4. 
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Chapter 1 – Introduction 
1.0 What are Escherichia coli? 
1.1.1 The species E. coli 
 
Strains of Escherichia coli belong to a diverse bacterial species that reside in the human gut.  Some 
strains can be protective and form part of the commensal gut flora while others are pathogenic and 
cause us harm. E.  coli was first isolated during a study of faecal flora of neonates. It was originally 
described as Bacterium coli commune by Theodor Escherich in 1885 and renamed Escherichia coli in 
1919 (Castellani and Chalmers 2005). E. coli colonises our gastrointestinal (GI) tract shortly after 
birth (Escherich 1885;Robins-Browne 1987), competing with other organisms in a hostile 
environment, until our deaths. E.  coli is the type species of the Enterobacteriaceae family, are 
ubiquitous in nature and capable of adapting to environmental pressure, including exposure to 
antibiotics. (Bailey et al. 2010).  
1.1.2 Pathotypes of E. coli 
 
E. coli are the ‘Jekyll and Hyde’ of the bacterial community, and are both protective and pathogenic. 
Studies have revealed how E. coli has evolved into multiple lineages causing varied types of infection 
via multiple and diverse pathogenic mechanisms (Kaper et al. 2004;Wirth et al. 2006). Certain E. coli 
pathotypes are defined by the clinical presentation and site of infection. Extra-intestinal E. coli 
(ExPEC) are isolated from extra-intestinal sources such as blood cultures and wounds and also 
includes  Uropathogenic E. coli (UPEC) where infection is in the urethra or bladder.  Diarrhoeagenic 
E. coli (DEC) cause infection in the gut, are divided into additional pathotypes and are generally 
defined by the way they they adhere and/or interact with human epithelial cells (HEp-2 cells) or by 
the presence of certain pathogenicity factors as summarised in table 1.1. 
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1.1.3 Pathogenicity of E. coli 
 
There are multiple mechanisms of pathogenicity for different DEC including adherence mechanisms, 
production of toxins and iron acquisition mechanisms and the majority of strains can be placed in 
one or more of the groups described in detail below: 
 
1.1.3.1 - EPEC 
Enteropathogenic E. coli (EPEC) belong to a group of bacteria collectively known as attaching and 
effacing (A/E) pathogens with their ability to form distinctive lesions on the surfaces of intestinal 
epithelial cells. The A/E phenotype is related to the presence of a 35-kb cluster of virulence genes 
called the locus of enterocyte effacement (LEE) and encoded on a chromosomal pathogenicity island 
(PAI) (Croxen et al. 2013). Further classification of EPEC depends on the presence or absence of the 
E. coli adherence factor plasmid (pEAF) and is termed ‘typical’ or ‘atypical’ respectively (Trabulsi et 
al. 2002).The attaching and effacing (eae) gene (encoded on the LEE) produces an intimin 94-kDa 
protein which forms pedestal-like structures via cytoskeletal changes enabling the bacteria to 
intimately attach to the intestinal epithelial cells (McDaniel et al. 1995). Though EPEC are not known 
for producing toxins, they do produce a protein called lymphostatin which inhibits lymphocyte 
activation (Klapproth et al. 2000). Diarrhoea is likely to result from multiple mechanisms such as the 
loss of absorptive surfaces resulting from the microvillus effacement, increased intestinal 
permeability and intestinal inflammation (Kaper et al. 2004). EPEC symptoms include diarrhoea that 
is often accompanied by fever, vomiting, dehydration and onset of diarrhoea in human volunteers 
can be as early as 3 hours with wild-type bacteria (Shariff et al. 1993). EPEC infection is usually 
associated in children and occurrence of EPEC infections decreases with age, infection can be acute 
or persistent for more than 2 weeks and generally treated with rehydration therapy (Croxen et al. 
2013). EPEC is found across the globe and morbidity and mortality is higher in developing countries 
due to malnutrition and poor healthcare. Transmission is faecal oral and the reservoir for EPEC can 
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vary from a human source for typical EPEC (Levine 1978) to both humans and animals for atypical 
EPEC (Croxen et al. 2013). 
 
1.1.3.2 - STEC 
Shiga Toxin-producing E. coli (STEC) is classified by the presence of the Shiga toxin 1 or 2 gene (stx1 
or stx2) which is typically acquired by a lambdoid bacteriophage. STEC typical strains also have the 
eae gene enabling intimate adherence and A/E phenotype. STEC alternative nomenclature is vero-
cytotoxic producing E. coli (VTEC) where the stx genes are referred to as vtx genes. This thesis will 
refer to the nomenclature as STEC. The key virulence factor is the shiga-toxin encoded by the stx 
gene.  Stx is produced in the colon and travels to the kidneys via the bloodstream, where it damages 
renal endothelial cells and obstructs the microvasculature via direct toxicity and induction of local 
cytokine and chemokine production (Andreoli et al. 2002). This damage can lead to haemolytic-
uremic syndrome (HUS) which is characterised by haemolytic anaemia (anaemia caused by 
destruction of red blood cells), acute kidney failure (uraemia) and a low platelet count 
(thrombocytopenia). Enterohemorrhagic E. coli (EHEC) is a subset of STEC and described by its 
association with haemorrhagic colitis and HUS. STEC symptoms can range from mild watery 
diarrhoea to bloody diarrhoea and incubation period before onset of symptoms for STEC O157:H7 is 
about three days (Bell et al. 1994). STEC infections are found in all ages but the 
immunocompromised have a higher risk of developing severe symptoms. STEC tend to have higher 
rates of infection in developed countries with a variable incident rate across Europe, though the 
European Center for Disease Prevention and Control recommends not comparing incidences 
between countries due to the difference in detection methods (European Centre for Disease 
Prevention and Control and European Food Safety Authority 2011). Current treatment 
recommendations are to maintain hydration to prevent thrombotic complications (Serna and 
Boedeker 2008). Transmission is faecal oral and the reservoir for STEC is mainly associated with 
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animals, particularly ruminants such as cattle and exposure to petting farms (Chase-Topping et al. 
2007). 
1.1.3.3 - ETEC 
Enterotoxigenic E. coli (ETEC) is classified by the presence of enterotoxins (heat-labile , LT and/or 
heat stable, ST). The ST gene encodes for small ST peptides which cause watery diarrhoea by 
mimicking the hormone guanylin and ultimately resulting in the secretion of chloride into the 
intestinal lumen and preventing absorption (Weiglmeier et al. 2010).  The LT has multiple variants 
and is found encoded in the chromosome and may have been acquired by a phage (Jobling and 
Holmes 2012). The LT gene encodes for a large toxin which is assembled as an AB5 toxin and about 
80% identical to cholera toxin. The pentameric B subunits bind to GM1 gangliosides at lipid rafts to 
deliver the catalytic A subunit inside the cell. This ultimately results in increasing cAMP levels 
resulting in electrolytes and fluid loss into the intestinal lumen causing profuse watery diarrhoea 
(Kreisberg et al. 2011). Adherence to the small bowel mucosa is facilitated by over 20 antigenically 
diverse colonisation factors (Wolf 1997). ETEC is a major cause of travellers’ diarrhoea and highly 
prevalent in developing countries particularly in regions such as Latin America, Africa and certain 
regions of Asia in which ETEC has shown to be the aetiological agent in approximately 30% of cases 
(Shah et al. 2009). Oral rehydration fluid should be sufficient to treat this self-limiting disease but 
treatment is not always easily accessible in developing countries and can lead to mortality 
particularly in children (Nataro and Kaper 1998). Transmission is faecal oral and exposure to ETEC is 
usually from contaminated foods and water. ETEC  has been shown to survive in freshwater for three 
months (Lothigius et al. 2010). 
1.1.3.4 - EIEC 
Enteroinvasive E. coli (EIEC) are facultative intracellular pathogens, shares biochemical, genetic and 
pathogenic properties with Shigella and both are the etiological agents of bacillary dysentery or 
shigellosis (Nataro & Kaper 1998). This highly invasive pathogen has multiple virulence determinants 
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that are encoded by both chromosomal and plasmid loci and include a type 3 secretion system (Mxi-
Spa proteins), chaperones (Ipg sub-units and Spa15), transcriptional regulators (Vir F, VirB and MxiE) 
and translocators (ipAB, IpaC, and IpaD) (Schroeder and Hilbi 2008). EIEC are recognised as 
containing the Ipa invasive effector genes and other genetic elements present on a large invasive 
mosaic plasmid (Buchrieser et al. 2000). The detection of the ipaH gene by is used by the UK 
reference laboratories for characterisation of this pathotype. These virulence factors facilitate EIEC 
to invade the colonic epithelial cell, lyse the phagosome and move through the cell by nucleating 
actin microfilaments (Kaper et al. 2004).  EIEC can vary in its severity and symptoms will range from 
invasive inflammatory colitis and occasionally dysentery to watery diarrhoea that is indistinguishable 
from other E. coli pathogens (Nataro & Kaper 1998). The epidemiology of EIEC is not well known as 
the focus is to detect Shigella, which tends to have more severe clinical manifestations (Croxen et al. 
2013). EIEC hasn’t been found in surveillance studies in the UK over the past 15 years (Tam et al. 
2012a;Wilson et al. 2001) and is not thought to play a major role in diarrhoeal disease. EIEC is 
generally self-limiting and treatment would involve oral rehydration therapy. Transmission is faecal 
oral and exposure to EIEC is via contamination of food, it is likely that EIEC is host restricted like 
Shigella, as no particular reservoir has been described. 
 1.1.3.5 - DAEC 
Diffusely adherent E.coli (DAEC) has been classified by its diffuse adherence (DA) to cultured 
epithelial HEp-2 cells (Scaletsky et al. 1984). A well described pathogenicity factor is the presence of 
Afa genes that encode Afa/Dr adhesins. These adhesins bind to brush border-associated decay-
accelerating factor (DAF) which induces cytoskeleton rearrangement destroying the microvilli (Le 
and Servin 2006;Servin 2005). It is uncertain if this mechanism causes diarrhoea but destruction of 
the microvilli can result in increased permeability. DAEC is associated with watery diarrhoea which 
can become persistent and increase in severity of disease in young children (Servin 2005). Detection 
methods are still being developed for diarrhoeagenic strains of DAEC and there is no current 
universal method, thus the epidemiology of diarrhoeagenic DAEC remains unclear. Rehydration 
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therapy is currently the only treatment recommended for watery diarrhoea caused by DAEC.  
Transmission is faecal oral but is it unknown how DAEC is transmitted or its reservoir (Croxen et al. 
2013). 
1.1.3.6 - EAEC 
Enteroaggregative E. coli (EAEC) is classified by its aggregative adherence pattern on HEp-2 cells 
(Nataro et al. 1987) (1.10.1). Colonisation of the intestinal mucosa and colon is carried out by a 
combination of aggregative adherence fimbriae (Boisen et al. 2008;Czeczulin et al. 1997;Nataro et al. 
1993) and a dispersin protein (Baudry et al. 1990). This is encoded by the anti-aggregator 
transporter aat gene, which forms a loosely associated layer on the surface of EAEC strains, perhaps 
facilitating the spread across the mucosal layer as it counters the strong aggregating affects (Kaper 
et al. 2004). There are several toxins that EAEC can produce including a plasmid encoded toxin which 
has enterotoxic activity and can lead to changes in the epithelial-cell and cytoskeletal protein 
spectrin (Navarro-Garcia et al. 1999),  an enteroaggregative E. coli heat-stable toxin which could 
contribute to watery diarrhoea (Savarino et al. 1993) and a Shigella enterotoxin 1 thought to 
contribute to secretory diarrhoea (Noriega et al. 1995). However, not all EAEC strains produce all, if 
any of these toxins and the encoding genes for numerous adhesions and proteins associated with 
virulence are highly variable among strains (Croxen et al. 2013). Even the site of infection is not 
uniform, where some strains infect the small bowel while others infect the small bowel and colon 
(Okhuysen and DuPont 2010). EAEC can cause acute and persistent diarrhoea and EAEC strains 
associated with persistent diarrhoea in children were shown to have significant elevations in fecal 
lactoferrin, interleukin (IL)-8 and IL-1 beta. It is hypothesised that  stimulation of IL-8 from intestinal 
epithelial cells may be caused by EAEC flagellin (Steiner et al. 1998;Steiner et al. 2000). EAEC is a 
global pathogen (Okeke and Nataro 2001) but is particularly severe in developing countries where 
EAEC has been shown to impair growth while malnutrition worsens with persistent EAEC infection 
(Roche et al. 2010). Though EAEC pathogenicity factors are heterogeneous in nature, a general 
three-part model of EAEC pathogenesis has emerged: (i) adherence to the intestinal mucosa, (ii) 
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production of enterotoxins and cytotoxins, and (iii) mucosal inflammation (Estrada-Garcia and 
Navarro-Garcia 2012). EAEC is usually self-limiting and rehydration therapy is recommended but 
antibiotics will be considered particularly in persistent cases. Transmission is faecal oral and though 
atypical EAEC (strains lacking aggR) have been found in animals (Uber et al. 2006), the reservoir of 
clinically relevant EAEC is generally thought to be human. Recent screening of EAEC from 
environmental and animal sources confirmed that typical EAEC are not found in animals (Chattaway 
et al. 2014a). The characterisation of EAEC is further described in section 1.9.  
 
The genes associated with the different diarrhoeagenic pathotypes (Table 1.1) enable interactions 
with eukaryotic cells in very specific and individual ways (Figure 1.1). Though, different pathotypes 
have been defined, the question of what defines E. coli is still being investigated today. This 
introduction describes how the definition of this organism has evolved over the last century with the 
continued introduction of novel scientific techniques. 
 
 
 
 
  
Table 1 1  Description of the different pathotypes of Escherichia coli 
Abbreviation Meaning Description Disease 
DEC Diarrhoeagenic E. coli Any defined group of E. coli which has been associated with the ability to cause diarrhoea Intestinal/ Diarrheal 
DAEC Diffusely-adherent  E. coli A group of E. coli which been associated with the ability to cause diarrhoea defined by a specific pattern of 
diffuse adherence on HEp-2 cells. 
Intestinal/ Diarrheal 
EAEC Enteroaggregative E. coli A group of E. coli which been associated with the ability to cause diarrhoea defined by a specific pattern of 
aggregative aggregation on HEp-2 cells or the presence of the plasmid borne anti-aggregative transporter 
(aat) or EAEC regulatory (AggR) gene. 
Intestinal/ Diarrheal 
EIEC Enteroinvasive E. coli A group of E. coli which been associated with the ability to cause diarrhoea defined by the presence of the 
ipaH invasion gene also found in Shigella. 
Intestinal/ Diarrheal 
EPEC Enteropathogenic E. coli A group of E. coli which been associated with the ability to cause diarrhoea originally defined as specific 
serotypes and by localised  adherence on HEp-2 cells but now by the presence of certain virulence factors 
including the locus of enterocyte effacement (eae) gene. 
Intestinal/ Diarrheal 
ETEC Enterotoxigenic E. coli A group of E. coli which been associated with the ability to cause diarrhoea defined by the presence of heat 
stable or  heat labile toxins 
Intestinal/ Diarrheal 
VTEC Verocytotoxin-producing  
E. coli 
Also referred to as Shiga 
toxin-producing E. coli 
A group of E. coli which been associated with the ability to cause diarrhoea defined by the presence of a 
verocyto toxin gene, vtx, which has activity against cultured vero cells 
Intestinal/ Diarrheal 
EHEC Enterohemorrhagic E. coli VTEC/STEC causing bloody diarrhoea, haemorrhagic colitis and haemolytic uremic  syndrome (HUS) 
characterised by acute renal failure, haemolytic anaemia (anaemia due to haemolysis) and thrombocytopenia 
(low number of platelets) 
Intestinal/ Diarrheal 
ExPEC Extraintestinal Pathogenic 
E. coli 
Any defined group of E. coli which has been associated with the ability to cause extra-intestinal disease. Extra-intestinal/ 
Septecemia/ Menigitidis/ 
Urinary 
UPEC Uropathogenic E. coli Any defined group of E. coli which has been associated with the ability to cause urinary tract disease. Extra-intestinal/ Urinary 
CDEC Cell detaching E. coli A group of E. coli which has the capacity to detach tissue culture cells from solid supports in adherence assays 
or in a cell-detaching assay  
Intestinal/ Diarrheal/ Urinary 
CDTEC cytolethal distending 
toxin-producing E. coli 
A group of E. coli which been associated with the ability to cause diarrhoea defined by the presence of a toxin 
called cytolethal distending toxin. This causes morphological changes on HEp-2 cell lines including elongation 
of cells at 24 h; this is followed by progressive cellular distension and cytotoxicity  
Intestinal/ Diarrheal 
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Figure 1. 1 Attachment and interaction of E. coli pathotypes with Eukaryotic Cells 
 
Figure 1.1:Figure taken from (Kaper et al. 2004) describing the different interactions of the six recognised 
categories of diarrhoeagenic E. coli with eukaryotic cells. 
  
34 
 
1.2 In the Beginning – Microscopy 
 
The first practical microscope was built by Anton Van Leeuwenhoek in Holland and led to the first 
description of bacteria in 1676 (Gest 2004). As technology improved, microscopy was pivotal to the 
study of bacteria in the environment and their association with disease. Theodor Escherich was 
probably the first paediatric infectious diseases physician who studied the intestinal flora of 
neonates. Using basic culture techniques, Gram stain and development of anaerobic conditions, he 
was able to describe Bacterium coli commune as a facultative Gram negative coli form that produced 
gas during fermentation (Escherich 1885;Shulman et al. 2007). In 1919, Castellani and Chalmers 
proposed the designation Escherichia coli (Castellani A 1919). The family name Enterobacteriaceae, 
was first proposed in 1937 by Rahn compromising multiple taxa including E. coli (Rahn 1937) still 
within this family today. Although the proposal of the Enterobacteriaceae group had several 
nomenclature flaws and was made illegitimate by the International Journal of Systematic 
Bacteriology (Farmer, III et al. 1980), the name was widely used and the Judical Commission voted it 
to be conserved in 1958. The official name of E. coli was also sanctioned as the name of the common 
colon bacillus discovered by Escherich (Judicial Commission of the International committee on 
Bacteriological Nomenclature 1958).  
1.3 Definition of E. coli by biochemistry 
 
As biochemical properties of E. coli and other organisms were investigated, multiple taxa were 
described and classification systems proposed. The validity of the taxonomic groups within this 
family have been much debated, with the genus Shigella being labelled as a ‘dubious group’ and 
suggestions that any attempt to separate lactose fermenters as individual groups would be 
superficial (Borman et al. 1944). In 1944, E. coli was grouped simply as genus II colobactrum by its 
ability to ferment lactose and produce gas with other genus separated out by distinct properties 
(Borman et al. 1944), this was an attempt to simplify the growing numbers of species that are 
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currently called coliforms in clinical laboratories. These biochemical properties are the basis of many 
of the groups we see in the Enterobacteriaceae today (Edwards and Ewing 1962).  
 
Bergy’s Systematic Manual continually revises speciation of all bacteria and with each edition, new 
species are added or reassigned. Due to the complex and interconnected relationship of the 
biochemical properties of this family there is a great reluctance to re-define this group and reclassify 
mis-assigned subgroups. 
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1.4 Linking pathogenic E. coli via serology  
 
It is now well known that E. coli can be found in healthy and diseased individuals but the first 
indication that there could be harmful diarrhoeagenic and harmless commensal strains was 
described by Lesage in 1897 on serological grounds. The study showed that serum (the plasma from 
blood that contains antibodies) from a diarrhoeal patient agglutinated with E. coli from other 
patients during an epidemic but did not react with  E. coli obtained from healthy children or other 
enteric pathogens (Lesage 1897;Robins-Browne 1987). Between 1927-1953, a large number of 
outbreaks of infantile diarrhoea were recorded. Strains of E. coli associated with the earlier 
outbreaks were designated dyspepsiekoli, α, β or D433. By the 1950’s serogroups of E. coli O55 and 
O111 were being frequently isolated from cases (Robins-Browne 1987). These early studies led onto 
the serological typing schemes that we have today.  The E. coli serotyping scheme is currently 
organised according to  185 somatic (O) antigens, 49 flagellar (H) and  103 capsular (K) antigens 
(Kauffmann 1947;Parija 2009). 
 
The characterisation of E. coli in relation to serology is an organism that agglutinates against E. coli 
sera.  E. coli serum is made by using plasma from blood which has been exposed to a known 
serogroup of E. coli and therefore has specific antibodies in the sera.  Biochemically defined E. coli 
strains that do not react with the known sera are deemed O antigen unidentifiable. Interestingly, 
Kauffmann states that ‘In the coli group, cultural tests play but a minor role, so that the type 
division has to rest on a serological basis. The prevailing classification of the coli strains, based on 
cultural criteria (especially fermentation tests) should therefore be abandoned’. (Kauffmann 1947). 
However, in reference microbiology the biochemical confirmation of E. coli is vital due to cross 
reactions with other Enterobacteriaceae giving non-specific false positive agglutination, and both 
biochemistry and serology should be used for confirmation of identification. 
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1.5 How the study of genetics complicated the definition of E. coli 
1.5.1 DNA-DNA re-association 
E. coli are defined using a combination of biochemical and serological profiles. This approach clearly 
distinguishes E. coli from Shigella sp. Further studies attempted to define the species genetically.  
 
DNA-DNA re-association (where a labelled reference strain nucleotide sequence binds against a test 
strain) was used to assess genetic relatedness of E. coli O112 against different E. coli and Shigella sp. 
(Brenner et al. 1972). At the optimal re-association temperature of 60oC to form stable re-
associations, E. coli strains relatedness varied between 85-100%. Shigella sp. re-associated with E. 
coli K12 between 80-89%, it was suggested that Shigella sp. should be considered a different species 
within E. coli, rather than a separate genus, as no other strains from any other genus of enteric 
bacteria exhibit greater than 50% relatedness to E. coli at 60oC (Brenner et al. 1969). If E. coli was 
solely defined as a group of organisms that re-associate at 60oC at 85-100% this would include 
closely related Shigella sp (as defined by biochemistry and serology). However, even today Shigella 
sp. is still considered to be a separate genus. 
 
The Ad Hoc Committee on Reconciliation of Approaches to Bacterial Systematics acknowledges the 
importance of applying chemotaxonomic approaches, both structural (phenetic) and phylogenetic 
(evolutionary), when inferring or proposing hierarchical levels. They define a species containing 
strains of approximately 70% or greater DNA-DNA relatedness with phenotypic characteristics 
agreeing with the definition (Wayne et al. 1987). Even with the advancement of genetic analysis, 
phenotypic characteristics still play an underlying role in identification. 
 
1.5.2 16S rRNA Sequencing Analysis 
The search of an alternative to DNA-DNA re-association methods led to the sequencing of 16S 
ribosomal RNA, a component of the 30S small subunit of prokaryotic ribosomes. The gene encoding 
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this region is 16S rDNA and is found in all bacterial species and can be used to assess phylogenetic 
relationships (Woese and Fox 1977). The 16S rDNA gene has multiple helices and heterogeneous 
positions (Figure 1.2) enabling differentiation of bacterial species and is useful in other studies such 
as microbial ecology (Case et al. 2007). 
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Figure 1. 1 Structure of the 16S rDNA gene 
 
Figure 1.2: Helices (H) are numbered as described by Cannone et al.(Cannone et al. 2002). Positions indicated 
in blue are heterogeneous in one species, and those in red are heterogeneous in two or more species (Case et 
al. 2007). The black positions are homogenous in different species and are conserved regions, it is these 
regions that are used to design primers so that the gene can be amplified and sequenced. The differences can 
be used to speciate organisms but are not useful when different species are very similar such as E. coli and 
Shigella. 
 
Open access of a large bacterial database to search 16S rDNA gene sequences is a useful tool in 
genus identification but the inability to distinguish closely related groups suggest that 16S rRNA 
sequencing is not an appropriate method to replace DNA-DNA re-association for the delineation of 
species and measurement of intraspecies relationships (Stackebrandt and Goebel 1994). This is 
accurately reflected when comparing E. coli and Shigella sp. (Figure 1.3), which are not differentiated 
by this method and confirms that 16S rRNA sequencing is not suitable to analyse inter-strain 
relationships (Lukjancenko et al. 2010).  
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Figure 1 2 Phylogenetic tree based on 16S rRNA sequences 
 
Figure 1.3: (Lukjancenko et al. 2010). Tree of 61 sequenced E. coli (black) and related species (colored), based 
on the alignment of the 16S rRNA gene sequence. Apart from Shigella spp., the genes from E. albertii and E. 
fergusonii are also included (arrows). The 16S rRNA gene of S. enterica  Typhimurium LT2 was used as the root. 
Bootstrap values, indicated in red, show that most nodes are predicted with uncertainty; nevertheless, the 
genera Escherichia spp. and Shigella spp. are not separated in this tree, and the three Escherichia species are 
also mixed 
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1.6 Looking at the Population Structure of E. coli 
1.6.1 Multi-locus Enzyme Electrophoresis (MLEE) 
Multi-locus enzyme electrophoresis (MLEE) had long been a standard method in eukaryotic 
population genetics (Ayala 1976;Lewontin 1974;Nei 1975). The observation that there were high 
levels of electrophoretic variation in enzymes essential to the normal functions of metabolism in 
eurkaryotes, sparked numerous efforts to explain the existence of this variation in prokaryotes. 
Essentially MLEE is based on the different electrophoretic motilities (EM) of chosen multiple core 
metabolic enzymes. The enzyme is electrophoresed on an agar gel and the alleles at each locus will 
define the EM of their products for the different amino acid sequences between each enzyme. This 
can be shown by how far the band (product) travels in a gel, a difference in how far the band has 
travelled can show if a mutation has occurred and an amino acid has been substituted affecting the 
net charge of the enzyme (Figure 1.4) (Selander et al. 1986). 
Figure 1.3 The electric mobility of different enzymes in MLEE 
 
Figure 1.4: (Selander et al. 1986). Gel illustrating electrophoretic variation in the enzyme Mannitol 1-
phosphate dehydrogenase in E. coli in 18 isolates. The different alleles can be clearly seen in the begining and 
the middle of the gel, as the enzyme has travelled to different points on the gel and therefore has a different 
electrophoretic motility. 
 
 
A dendogram can then be generated from the matrix of pairwise differences between the 
electrophoretic types (ET) to show the relatedness between isolates. E. coli was the first bacterium 
for which population genetic techniques were introduced (Wirth et al. 2006). MLEE inferred 
evolutionary phylogenetic relationships and indicated that certain combinations of alleles occurred 
multiple times which was interpreted as indicating a clonal population structure with sporadic 
recombination amongst many bacteria including E. coli populations (Ochman and Selander 
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1984;Selander and Levin 1980). MLEE laid the foundation of population structure analysis for the 
bacterial kingdom but was not without its problems. The phenotype of the enzyme could be altered 
in response to environmental conditions such as phosphorylation, cofactor binding and cleavage of 
transport sequences, which could badly affect the reproducibility of MLEE results and limit the 
comparability between different laboratories. Also enzymes with different amino acid (AA) 
sequences may have a similar EM and any silent mutations where the DNA sequence varies but the 
AA code is unaltered will also give the same EM. E. coli definition via MLEE methodology is a group of 
organisms that fit within a defined set of EM profiles. The development of an equivalent method, 
multi-locus sequence typing (Wirth et al. 2006) enabled a portable and comparable DNA sequence 
database that could be easily compared to between different laboratories. 
1.6.2 Multi-locus Sequence Typing (MLST) 
Multi-locus sequence typing (MLST) is the sequencing of a defined set of multiple housekeeping 
genes. Each gene will have a defined set number of base pairs that is called an allele,  each variant of 
that allele (i.e. any difference in the sequence of nucleotides) has an allele number assigned. The 
combination of allele numbers for the seven different genes leads to a given sequence type (ST). For 
example, allelic profile 10-11-4-8-8-8-2 is ST10. If the allele number differs by one number then this 
is designated a single locus variant (SLV), if it differs by two numbers then it is a double locus variant 
(DLV) and if it differs by three it is a triple locus variant (TLV). A complex consists of any strains that 
are the same ST or a SLV of that group. For example for ST10, an allelic profile of 10-11-4-1-8-8-2 
would be ST34 and is an SLV (as the icd gene is different) and therefore part of the ST10 complex 
(Cplx). 
 
There are several MLST schemes available; in this study the University of College Cork 
(http://mlst.ucc.ie/mlst/) MLST scheme for E. coli was used.  
The seven housekeeping genes (Table 1.2) chosen are located throughout the chromosome with 
eight to 20% of the nucleotides being polymorphic (Figure 1.5), which represents the natural genetic 
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diversity of the genome (Wirth et al. 2006). Sequence typing enables us to take a snapshot of the 
core genetic relatedness of strains of E. coli and Shigella sp. Minimal spanning trees show how the 
two groups have clonally expanded into multiple complexes. In this analysis Shigella sp. does mainly 
form distinct clusters from E. coli indicating that although they may have a common ancestor, their 
core genetic content can be resolved (Figure 1.6). Population structure analysis indicates E. coli to be 
a distinct group of organisms forming multiple clonal complexes. 
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Table 1.2  Housekeeping genes used in MLST  
Name Gene Function 
Adk 
(536bp) 
Adenylate kinase  Catalyzes the reversible transfer of the terminal phosphate group between  adenosine triphosphate (ATP)and 
adenosine monophosphate (AMP). This small ubiquitous enzyme involved in the energy metabolism and nucleotide 
synthesis, is essential for maintenance and cell growth. 
 
fumC 
(469bp) 
fumarate hydratase The FH gene provides instructions for making an enzyme called fumarase (also known as fumarate hydratase). 
Fumarase participates in an important series of reactions known as the citric acid cycle or Krebs cycle, which allows cells 
to use oxygen and generate energy. Specifically, fumarase helps convert a molecule called fumarate to a molecule 
called malate. 
 
gyrB 
(460bp) 
DNA gyrase subunit B DNA gyrase is an essential enzyme that regulates the DNA topology in bacteria. It belongs to the type II DNA 
topoisomerase family and is responsible for the introduction of negative supercoils into DNA at the expense of 
hydrolysis of ATP molecules 
 
Icd 
(518bp) 
isocitrate/isopropylmalate 
dehydrogenase 
Isocitrate dehydrogenase  is an enzyme that participates in the citric acid cycle. It catalyzes the third step of the cycle: 
the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2 while converting 
NAD+ to NADH. In aerobic organisms, the citric acid cycle is part of a metabolic pathway involved in the chemical 
conversion of carbohydrates, fats and proteins into carbon dioxide and water to generate a form of usable energy. 
 
Mdh 
(452bp) 
malate dehydrogenase Malate dehydrogenase is an enzyme in the citric acid cycle that catalyzes the conversion of malate into oxaloacetate 
(using NAD+) and vice versa (this is a reversible reaction). Malate dehydrogenase is also involved in gluconeogenesis, 
the synthesis of glucose from smaller molecules. 
 
purA 
(478bp) 
adenylosuccinate 
dehydrogenase 
Adenylosuccinate synthase (or adenylosuccinate synthetase) is an enzyme that converts IMP to adenylosuccinate. It is 
involved in purine synthesis,.Purines are Biologically synthesized as nucleotides (bases attached to ribose 5-phosphate). 
 
 
recA 
(510bp) 
ATP/GTP binding motif RecA is a 38 kilodalton Escherichia coli protein essential for the repair and maintenance of DNA. RecA has a structural 
and functional homolog in every species in which it has been seriously sought and serves as an archetype for this class 
of homologous DNA repair proteins. Since it is a DNA-dependent ATPase, RecA contains an additional site for binding 
and hydrolyzing ATP.. It is also a binding motif for guanosine triphosphate (GTP) 
Table 1.2: Table listing the seven MLST housekeeping genes and their functions
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Figure 1.4 Genomic location and polymorphisms of MLST genes 
 
 
Figure 1.5: (A) Genomic locations and (B) genetic diversity of seven housekeeping genes. (B) 
Polymorphism levels for each gene are indicated in the histogram in which black bars reflect nucleotide 
polymorphisms and grey bars indicate amino-acid polymorphisms. Each gene symbol is followed by the 
length of the sequenced gene fragment (informative sites – polymorphic sites) (Wirth et al. 2006). 
 
Figure 1.5  Minimal spanning tree of E. coli and Shigella sp  
 
Figure 1.6: Pathogenic types within an MSTREE. Each ST is represented by a dot. Dots with uniform colours 
indicate that all isolates were of the same pathogen type (see legend) while the small pie charts indicate the 
fraction of isolates belonging to each pathogen type. Circled numbers indicate ST complexes, whereas arrows 
indicate STs 11 and 62. Black lines connecting pairs of STs indicate that they share six (thick lines), five (thin) or 
four alleles (dotted). Grey, dotted lines connecting pairs of STs of increasing line length indicate that they share 
three to one alleles respectively. In addition, the lines connecting the STs within an ST complex are shaded in 
grey (Wirth et al. 2006).   
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1.7 Evolving genetic analysis with high throughput sequencing 
 
Whole Genome Sequencing (WGS) involves the sequencing of the entire bacterial DNA content, 
including the core (essential housekeeping genes which relate to function vital to the survival of the 
organism and shared by all members of the group) and accessory (dispensable genes, not present in 
all members of the group, that enhance survival capabilities of the organism but not essential for 
survival) genomes. 
 
The first sequence of E. coli K12 consisting of 4,639,221 base pairs (bp) was published in 1997 
(Blattner et al. 1997) after six years of sequencing using multiple techniques including traditional 
Sanger sequencing methodology and long range PCR to sequence any gaps. This project resulted in a 
fully annotated genome and highlighted at the time that 38 % of genomic data had no attributed 
function.  
 
Having an accurate fully annotated genome laid an important foundation to our understanding of 
the genetic content of E. coli and the use of future reference platforms for comparative analysis of 
other strains. Studies comparing full genome sequencing of E. coli show that the genetic content of 
different stains does vary but that unrelated strains can share common mobile elements (Figure 1.7), 
suggesting that different lineages of E. coli are capable of adapting to different environments. E. coli 
are a group that has a complex ancestral history and its constituent strains are promiscuous, picking 
up genes from a variety of sources. WGS enabled the scientific community to recognise a core 
genetic content unique to E. coli.  
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Figure 1. 6  Circular representation of the E. coli 042 chromosome in comparison to other E. coli strains 
 
 
 
Figure 1.7: (Chaudhuri et al. 2010).  From the outside in, the outer circle 1 marks the position of regions of 
difference (including prophage (light pink) fimbrial operons (Dark green) as well as regions differentially 
present in other E. coli strains: blue (Present in 0157:H7 & absent/divergent in UPEC CFT073) Light Green 
(Present in 0157:H7 absent/divergent in UPEC CFT073). Circle 2 shows the size in bps. Circles 3 and 4 show the 
position of CDSs transcribed in a clockwise and anticlockwise direction, respectively (for colour codes see 
below); circle 4 to 13 show the position of E. coli 042 genes which have orthologues (by reciprocal FASTA 
analysis) in other E. coli strains (see methods): Sakai (0157:H7; red), UT189 (UPEC; dark blue), CFT073 (UPEC; 
light blue), 536 (UPEC; orange), APEC 01 (APEC; dark pink), E2348/69 (EPEC; black), H10407 (ETEC; salmon 
pink), E24377A (ETEC; pale pink), HS (grey), and K-12 MG1655 (green). Circle 14 sows the position of genes 
unique to E. coli 042 unique (red). Circle 15 shows a plot of G+C content (in a 10 Kb window). Circle 16 shows a 
plot of GC skew ([G−C]/[G+C]; in a 10 Kb window). Genes in circles 3 and 4 are colour coded according to the 
function of their gene products: dark green = membrane or surface structures, yellow = central or intermediary 
metabolism, cyan = degradation of macromolecules, red = information transfer/cell division, cerise = 
degradation of small molecules, pale blue = regulators, Salmon pink = pathogenicity or adaptation, black = 
energy metabolism, orange = conserved hypothetical, pale green = unknown, brown = pseudogenes 
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Next generation sequencing technology has reduced the practical limitations of how much 
comparative analyses we can do with genome sequencing, and reduced the cost substantially. 
enabling many institutions to carry out comparable genome research simultaneously. Core genome 
analysis shows E. coli strains and Shigella sp. have large core content similar to each other and that 
E. coli O157 has additional genes to both genera (Figure 1.8). Sequencing of multiple strains of E. coli 
enables us to consider all gene content across the strains and help build up a ‘pan-genome’ picture 
to determine the most accurate definition of the species E. coli. As the pan-genome of E. coli 
expands with addition of multiple strains, the core genetic content decreases and any E. coli strain 
will only have 20 % of its core found in all other E. coli (Lukjancenko et al. 2010). 
 
Accessory genome analysis (i.e. looking at mobile genetic elements or content that is not conserved 
in a genus or species) such as the pan-genome variable gene content (i.e. looking at the variable 
content of multiple strains within a genus or species) is also a useful typing tool (Figure 1.9). It is one 
of the few genetic methodologies that groups E. coli into separate clusters from Shigella sp. This 
indicates that perhaps it is the varied and mobile parts of the genome that differentiate between E. 
coli and Shigella sp. 
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Figure 1.7 BLAST atlas of Enterobacteriaceae against E. coli O157 
 
 
Figure 1.8:  (Lukjancenko et al. 2010).  BLAST atlas. In the middle, a genome atlas of E. coli O157:H7 strain 
EC4115 is shown, around which BLAST lanes are shown. Every lane corresponds to a genome, with the 
following colors (going outwards): green E. coli O157:H7 (15 lanes); light blue E. coli LANL strains (two lanes); 
dark blue Shigella spp. (eight lanes); red E. coli K12 and derivatives (six lanes); orange E. coli strain B 
phylogroup (four lanes); followed by all other E. coli genomes in different colors. The outermost three lanes 
represent E. fergusonii, E. albertii, and S. enterica Typhimurium LT2. Lack of color indicates that the genes at 
that position in strain EC4115 were not found in the genome of that lane. The position of replication origin and 
terminus is indicated 
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Figure 1.8 Pan-genome clustering of E. coli and related species. 
 
Figure 1.9: (Lukjancenko et al. 2010). Pan-genome clustering of E. coli (black) and related species (colored), based on the alignment of their variable gene content. The 
genomes now cluster according to species and a relatedness between E. coli K12 derivatives (green block) and group B isolates (orange block) is visible
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1.8 Definition of E. coli 
 
The conventional definition of E. coli is the expression of distinct biochemical profiles in which the 
species is defined as a sucrose, salicin and lactose fermentor and late maltose fermenter. These 
characteristics were used to define an outbreak on a neonatal ward and showed that this was a 
heterogeneous group (Bray 1945). Biochemical characterisation could not be used epidemiologically 
and serotyping schemes were developed to differentiate strains by their serological profiles 
(somatic, flagella and capsular antigens) (Gross and Rowe 1985;Kauffmann 1947). Eventually 
sequencing technology led to E. coli being defined by a core set of genes which has shown that the 
majority of different E. coli pathotypes can be discriminated from each other genetically. 
These technologies show that the more information we receive, the more complicated the picture of 
E. coli becomes and that a polyphasic approach should be used when trying to understand an E. coli 
strain, such as is the practice in the Gastrointestinal Bacteria Reference Unit (Figure 1.10) 
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Figure 1.9 Polyphasic approach to the detection and identification of E. coli in the reference laboratory, Colindale 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Identification and Typing of STEC 
Biochemistry, Serotyping and Real-Time PCR 
of stx 1 & 2, eae and O157 genes, Phage 
typing & VNTR analysis on outbreaks 
Reference Microbiology 
Containment level 3 E. coli 
Figure 1.10: Flowchart depicting the polyphasic approach of biochemical, serological and molecular techniques to detect, identify and characterise E. coli 
in the reference laboratory. Key: genes include stx (shiga-toxin), eae (effacement and attachment), O157 (somatic antigen), aggR (regulatory gene), LT/ST 
(heat liaible and heat stable toxin), ipaH (invasion). Pathotypes include VTEC (verocytoxic E. coli), EAEC (enteroaggreagative E. coli), EPEC 
(enteropathogenic E. coli), EIEC (enteroinvaisive E. coli) 
Identification and Typing of E. coli 
Biochemistry, Serotyping, Real-Time PCR of 
aggR (EAEC), eae (EPEC), LT/ST (ETEC) & ipaH 
(EIEC/Shigella) 
Reference Microbiology 
Containment level 2 E. coli 
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1.9 What are Enteroaggregative E. coli? 
1.10 Defining and Characterising Enteroaggregative E. coli 
 
EAEC was originally classified by its aggregative adherence pattern on HEp-2 cells (Nataro et al. 
1987). Different scientists in the field have defined enteroaggregative EAEC in various ways (Figure 
1.11), however, there is no one genotypic characteristic that can be used to define all EAEC. 
Figure 1. 10 What are Enteroaggregative E. coli ? 
 
 
  
 
Stacked bricked formation is the ‘gold 
standard’ of EAEC. This does not 
differentiate between disease and 
carriage.  
 
EAEC has multiple genes associated with 
EAEC aggregative adherence (AA). 
However, the plasmid is not always 
detected with the AA phenotype. Whether 
this is due to the variability of the target, 
the loss of the plasmid during subculture 
or the absence of the plasmid altogether is 
unknown. 
 
Limited work has been carried out and 
shows that there are successful EAEC 
clones found in disease and carriage stools. 
Population structure of EAEC has not been 
put into context of DEC pathotypes 
specificity and pathogenic association. 
 
Some genes which were originally 
associated with EAEC have since been 
found in other genus. Also the virulence 
gene content of EAEC is incredibly 
heterogeneous and found in disease and 
carriage. Most are plasmid borne and 
those that are chromosomal are either 
found in other genus or not present in all 
EAEC. 
Figure 1.11: Figure descripting the complexity of defining enteroaggregative E. coli by previous 
studies 
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1.10.1  Identifying Enteroaggregative E. coli by adherence on human cells 
In 1987, whilst looking at aggregation of E. coli  on human epithelial (HEp-2) cells, it was observed 
that a sub-set of strains associated with persistent diarrhoeagenic children in Peru had a unique 
stacked bricked aggregative adherence (AA) pattern (Nataro et al. 1987). This was different to the 
traditional localised adherence patterns found in EPEC and more characteristic than the pattern 
associated with diffusely adherent E. coli (DAEC) (Figure 1.12).  
 
1.10.2  EAEC characterisation by virulence gene detection and profiling 
Studies have focused on attempting to characterise EAEC genetically with varied results. The design 
of a CVD432 probe (Baudry et al. 1990) that bound specifically to a subset of AA phenotype strains 
was later found to be specific for the anti-aggregative transporter (aat) gene (responsible for 
transporting a protein called dispersin across the membrane) (Nishi et al. 2003). The aat gene was 
encoded on a plasmid, designated pAA. Initially, the aat PCR was used as a PCR target for EAEC 
plasmid detection but current PCR assays for EAEC, target a gene responsible for regulating many of 
the EAEC genes (aggR) (Nataro et al. 1994). The alternative target aggR is a better target than aat as 
there are more conserved regions of the gene and the aat gene is not always found in the plasmid. 
However, a small minority of  EAEC plasmids do not carry the aggR regulatory gene (Huang et al. 
2007;Jenkins et al. 2006a;Jenkins et al. 2006b), indicating that the regulatory mechanisms encoding 
the EAEC phenotype are complicated. 
 
.  
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Figure 1.11  Different adherence phenotypes of E. coli pathotypes on HEp-2 cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enteroaggregative E. coli (EAEC) 
Classic stacked-bricked adherence along the 
side of the HEp-2 cells 
Enteropathogenic E. coli (EPEC) 
Localised adherence along the side of the 
HEp-2 cells 
Diffusely adherent E. coli (DAEC) 
Diffuse adherence throughout the HEp-2 
cells 
Cell Detachment E. coli (CDEC) 
Cytotoxicity and destruction to HEp-2 cells. 
Adherence is lost when the HEp-2 cells are 
destroyed though some strains of EAEC are 
also known to bind to the glass slide and can 
be seen. 
Figure 1.12: Adherence characteristics of EAEC, EPEC and DAEC on HEp-2 cell.  
Photos taken by Marie Anne Chattaway, 2011, University of Haverford, USA. 
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Detection of multiple EAEC plasmid and chromosomal virulence genes also termed as genotypical 
profiling has been extensively studied (Huang et al. 2007;Jenkins et al. 2006a;Jenkins et al. 
2006b;Okeke et al. 2000a;Pereira et al. 2007;Regua-Mangia et al. 2009) and the presence of a 
combination of key virulence genes is the current favoured method of characterising EAEC (Table 
1.3). Studies attempting to characterise the EAEC plasmid have found multiple compatibility types 
harbouring a variable combination of genes putatively linked to background (Okeke et al. 2010). 
Therefore, characterising a pathogenic EAEC group by detection of plasmid borne genes is not ideal 
due to the mobility of this genetic element.  The key set of characterising EAEC genes has yet to be 
agreed by experts in the field.  To date there is no single gene, or combination of genes, that are 
EAEC specific and found in all EAEC strains. 
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Table 1.3  Common EAEC virulence genes 
Target gene Function Reference  Target gene Function Reference  
aat 
Anti-aggregation protein transporter 
gene, Part of protein transporter 
system 
(Jenkins et al. 2006b) Set1A 
Shigella enterotoxin, anti-
sense strand of pic 
(Huang et al. 2007) 
aaiC aaiC from 042 pheU island (Jenkins et al. 2006b) Irp2 
Yersiniabactin 
biosynthetic gene 
(Schubert et al. 1998) 
astA 
Enteroaggregative heat stable toxin 1 
(EAST-1) 
(Jenkins et al. 2006b) tia 
putative invasion 
determinant 
(Jenkins et al. 2006a) 
aggR Transcriptional activator of AAFs (Czeczulin et al. 1999) aap Dispersin gene (Piva et al. 2003) 
aggA AAF/1 fimbrial type I (Piva et al. 2003) pet Plasmid encoded toxin (Sheikh et al. 2002) 
aafA AAF/II fimbrial type II (Piva et al. 2003) aaiC 
Part of the aai gene 
cluster encoding a type Vi 
secretion system 
(EU Reference Laboratory 
for E.coli Department of 
Veterinary Public Health 
and Food Safety 2013) 
agg3A AAF/III fimbrial type III (Bernier et al. 2002) pic 
Secreted protease 
(146kDA), 116kDa after 
cleavage, multifunctional 
protein involved in enteric 
pathogenesis. 
(Piva et al. 2003) 
Agg4A AAF/IV fimbrial type IV (Boisen et al. 2009)   
 
 
 
Table 1.3 lists the most commonly targeted virulence targets found in EAEC. 
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1.10.3  Characterisation of EAEC by population structure 
An alternative method to characterising EAEC would be to look at the core background of EAEC to 
understand the population structure and clonality of this complex pathotype. The MLST E. coli  
scheme devised for population structure analysis focused initially on the well-established pathotypes 
such as STEC, EIEC, EPEC and Shigella spp. (Figure 1.6) (Wirth et al. 2006). Although small numbers of 
EAEC sequence types have been deposited in the public MLST database 
(http://mlst.ucc.ie/mlst/dbs/Ecoli), the only comprehensive study to date is by Okeke et al who 
investigated association of EAEC with ST groups and disease in children under five in Nigeria, and 
highlighted links to virulence genes, resistance and plasmid groups. Results indicated that ST10 was 
linked to cases but there was no other association between other STs and disease or association 
with certain virulence and resistance profiles or the plasmid compatibility groups (Okeke et al. 2010).  
Until a more precise definition of a pathogenic EAEC is determined, using PCR or MLST in isolation 
will not define this pathotype or improve the diagnosis of clinically relevant strains. 
1.11  Understanding the Burden and Importance of EAEC 
 
It is difficult to determine the clinical and public health significance of EAEC because we are unable 
to define the pathogenic types or be clear whether EAEC are capable of independently causing 
disease. 
1.11.1  Burden of EAEC 
Measuring the burden of infectious disease is essential for the rational design of public health 
intervention strategies and for the allocation of resources. For intestinal infectious diseases (IID) 
there is a massive global burden; WHO estimates around two billion cases every year (WHO Media 
Centre 2009). In England and Wales, detailed surveillance studies have shown that there are up to 
17 million sporadic, community cases of IID and one million GP consultations annually in the UK 
(Tam et al. 2012b). Despite routine investigations of IID in the UK for salmonellosis, shigellosis, 
campylobacteriosis, Cholera, infection by Escherichia coli O157, rotavirus, norovirus and parasitic 
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infections, well over half of the laboratory investigated diarrhoeal episodes are not diagnosed (Tam 
et al. 2012a). One, often under diagnosed but potential aetiological agent is EAEC; this pathotype of 
E. coli, has been associated with cases of gastrointestinal infection (Nataro et al. 2006;Tam et al. 
2012b;Tompkins et al. 1999) at a level comparable to Salmonella in England and Wales (Amar et al. 
2007;Tompkins et al. 1999). 
 
1.11.2  Co-infections in intestinal infectious disease 
Traditionally, gastrointestinal disease has been associated with single pathogens but recent studies 
using a pan-pathogen PCR approach have shown that cases reporting symptoms of GI disease often 
have multiple pathogens present in their faecal specimens. Multiple studies have specifically 
detected and characterised EAEC from faeces, but this is usually limited to research studies (Huang 
et al. 2007;Jenkins et al. 2006a;Jenkins et al. 2006b;Okeke et al. 2000a;Pereira et al. 2007;Regua-
Mangia et al. 2009) where detection of co-infections have not been undertaken.  Alternatively, 
cohorts studies have detected multiple pathogens but further analysis into the true aetiology among 
co-infections or even analysing the amount of co-infection has not been considered (Amar et al. 
2007;Tam et al. 2012a;Tompkins et al. 1999). As diagnostic tools improve, more studies are 
recognising gut infections of mixed aetiology (Lindsay et al. 2011), but when multiple pathogens are 
present in a diarrhoeic stool, determining the causative agent can be problematic. This is especially 
true in studies investigating EAEC infection, for example, in Peru multiple pathogens were found in 
40% of infants with diarrhoea and with EAEC in their stool (Ochoa et al. 2009).  
1.11.3  EAEC and outbreaks 
Enteroaggregative E. coli has been associated with disease globally (Antikainen et al. 2009;Cennimo 
et al. 2009;Jenkins et al. 2006b;Okeke & Nataro 2001;Okhuysen & DuPont 2010;Toma et al. 
2003;Usein et al. 2009). A number of EAEC outbreaks have been described in the literature, most 
notably a large outbreak in Japan involving 2697 children (Itoh et al. 1997). The EAEC group has 
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gained notoriety during a recent outbreak in Germany and France (Rubino et al. 2011). The outbreak 
strain E. coli ST678 (O104:H4) had both phage encoding stx genes and the EAEC plasmid. The 
acquisition of the EAEC plasmid may have played a role in adherence to the hosts gut mucosa, as the 
strain lacked the attachment and effacement (eae) gene known for intimate adherence in classical 
STEC strains (Jenkins et al. 2003). The emergence of this hybrid pathogen was described previously 
in 1996 when an O111:H2 strain had caused an outbreak of HUS in France (Mellmann et al. 2011), in 
1999 when a strains of E. coli O86:H- associated with HUS was isolated in Japan (Iyoda et al. 2000) 
and most recently in 2011 when a strain of E. coli O111:H21 strain was associated with a family 
outbreak in Ireland (Dallman et al. 2012). All of these cases were associated with severe disease.  
The reason EAEC is not widely accepted as a pathogen, like Salmonella for example, is that a 
significant portion of healthy controls also harbour this pathotype (Huang et al. 2007;Okeke et al. 
2000a;Regua-Mangia et al. 2009). Furthermore, research data describing the association of genetic 
factors with virulence are contradictory (Boisen et al. 2012;Huang et al. 2007;Jenkins et al. 2005).  
The reliability of virulence factors to identify EAEC for diagnostic purposes is unclear (Okeke & 
Nataro 2001). Studies have shown EAEC to be a potentially important pathogen in diarrhoeal disease 
but a causal link between disease and the presence of EAEC in the stool has not been defined. 
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1.12 How has enteroaggregative E. coli evolved? 
 
Population structure analysis of E. coli has facilitated the understanding of how the different 
pathotypes have evolved and the emergence of successful clonal populations such as  STEC O26 and 
O157. The number of strains of EAEC in the MLST public database is relatively low compared to 
other pathogenic E. coli groups.  As of 17th January 2013 there were 5425 entries, with the exclusion 
of the Nigeria dataset which is used in this study, only 2.4% (132 entries) were designated EAEC.  
Despite the low numbers, analysing the publically available MLST database including the Nigerian 
dataset (251, 4.6%) to get an understanding of how EAEC are distributed shows that EAEC are 
dispersed throughout the population of E. coli (Figure 1.14).  
 
Overlaying EAEC in the context of both intestinal and extra-intestinal pathotypes is difficult to 
interpret. Comparing EAEC with the sub-population structure of other diarrhoeagenic E. coli 
pathotypes (1143 entries), shows a clearer picture of potential EAEC clonal populations (mainly 
based on the Okeke study (Okeke et al. 2010)) (Figure 1.15).  
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Figure 1.12  Distribution of EAEC in the population structure of E. coli 
 
  
 
 
 
  
Key of Pathotypes 
 EAEC - 280 
 EHEC, VTEC, STEC - 350 
 EPEC - 235 
 ETEC - 180 
 EIEC - 50 
 Commensal - 56 
 DAEC - 13 
 Antibiotic Resistant - 498 
 UPEC - 463 
 ExPEC - 219 
 APEC - 205 
 Unknown - 2594 
Figure 1.14: Minimal spanning tree of MLST public data (17.01.2013) including all E. coli (N=5143). 
Different pathotypes are coloured as indicated on the key. The orange arrows indicate how EAEC is 
dispersed throughout the population structure. 
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Figure 1.13  EAEC groups in the diarrhoeagenic pathotypes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ST 40 Cplx 
ST 10 Cplx 
ST 29 Cplx 
O26 & O111 
ST 38 Cplx 
ST 31, 394 & 349 
Cplx 
ST 11 Cplx 
O157 & O55 
Figure 1.15: Minimal spanning tree of MLST public data (17.01.2013) including diarrhoeagenic E. coli 
 
ST Groups relate to a complex including all related groups with a single locus variant. Red Circles indicate main 
locations of EAEC, Green Circles indicate well known VTEC/EPEC groups. 
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This snap shot of EAEC background raises questions regarding the complexity of evolution of these 
groups. Whereas some groups appear to be EAEC specific, such as the ST38, 31, 394 and 349 
complex, others share a background with other pathotypes including the ST40 complex with EPEC 
and the ST10 complex with EPEC, ETEC and to a small number of STEC. This indicates that all EAEC 
have not evolved from the same ancestral lineage and that perhaps different groups of EAEC have 
acquired the EAEC phenotype as an advantage to their survival. Okeke et al showed that the ST10 
complex had a higher mutation rate than the ST31, 38 & 394 complexes, which had a higher 
recombination rate (Okeke et al. 2010). However, the focus was on understanding the EAEC groups 
from a single geographical location (diarrhoeagenic and asymptomatic children in Nigeria) and 
association with other important genetic markers. An understanding if there are specific successful 
EAEC groups that are expanding globally and associated with disease warrants further investigation. 
 
1.13  How is EAEC phenotype linked to genotype and disease? 
 
Understanding the presence of genetic markers and background is an important step in the 
characterisation of EAEC. Relating this with phenotype and disease may help scientifically validate 
the definitions of pathogenic EAEC. This may facilitate the design of clinically meaningful diagnostics 
tests. There are several phenotypic factors to be considered with EAEC, which if linked with 
successful pathogenic groups, may help us understand the key factors involved in virulence. 
1.13.1  Intensity of adherence 
First, there is the ability of an organism to adhere to the hosts’ mucosa; although we know that EAEC 
adhere to HEp-2 cells, it is not known whether the intensity of adherence plays a role in the severity 
of symptoms. The survival and success of all pathogens require that they colonise the host and 
adhere to cells ,which enables the organism to utilise  nutrients and activate metabolic pathways, all 
of which are used for survival.  
65 
 
1.13.2  Metabolic Utilisation  
Characterisation of biochemical reactions required for survival in the gut is a useful tool 
diagnostically. Studies have shown that metabolic profiles can be linked to a group being more 
pathogenic (Hwang et al. 2010). The traditional view of an evolutionary route towards increased 
pathogenicity is the acquisition of virulence genes. The loss of genetic material however, can result 
in a biochemical deficiency linked to pathoadaption and may also be associated with increasing 
virulence (Sokurenko et al. 1999). This has been shown in Shigella sp. and enteroinvasive E. coli 
where ‘Black holes’, i.e. large genomic deletions, have enhanced virulence (Maurelli et al. 1998). 
Shigella sp. were shown to contain pathoadaptive mutations via re-organisation of the cadA regions 
that were associated with enhanced virulence, this results in the inability to utilise lysine. The EAEC 
101-1 Japan outbreak strain was the largest EAEC outbreak to date affecting over 2,600 children 
(Itoh et al. 1997). The cadAB genes were deleted in the outbreak strain and it was suggested that 
deletion of cad genes may produce hypervirulent EAEC lineages (Hwang et al. 2010). The question 
remains, If pathogenic lineages of EAEC do exist, could metabolism of these groups be slightly 
different to non-pathogenic EAEC? Looking at end points of utilisation may not answer this question 
as typical E. coli  utilise similar substrates, However, assessing real-time values of the utilisation of 
multiple substrates using a phenotypic array such as the Ominlog (Biolog), and using dendograms to 
assess the metabolic relationships of strains may identify subtle differences between pathogenic and 
non-pathogenic groups.  
1.13.3  In vivo models for pathogenicity assessment 
The EAEC group are potential gut pathogens, but how can we assess if lineages of EAEC are 
responsible for causing disease? Studies have shown the presence of EAEC can result in the 
production of interleukin as a response of the mucosal immune system (Goyal et al. 2010;Khan et al. 
2010;Steiner et al. 2000) indicating an interaction with the gut. However, the gut is a complex 
microbiotic environment and symptoms vary between patients, even the ability of EAEC to cause 
disease varies depending on immune markers in healthy volunteers (Nataro et al. 1995). Seeing if 
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there is a direct link between an EAEC strain from a successful pathogenic group or from a case 
without confounders (i.e. the complexity of the gut mucosal immune system and co-infections) will 
enable us understand if the presence of defined diarrhogenic EAEC alone is enough to cause disease. 
The impractical healthy volunteer challenge model is therefore not suitable for this as it will be 
unknown if the response is specifically to the presence of EAEC and is ethically challenging. 
Alternative models for EAEC have been investigated such as T84 cells and human intestinal explants. 
These have been used to model cytocoxic effect and adhesion of EAEC and showed marked toxic 
effects most prominently in areas where bacteria were adhering (Nataro et al. 1996). Virulence gene 
expression and diarrhoeagenic effects have been modelled with an abiotic intestinal simulator (in 
vitro anaerobic continuous culture system) ,a gnotobiotic piglet model and mouse models  (Hicks et 
al. 1996;Nataro et al. 1996;Tzipori et al. 1992).  These models show that EAEC produce distinctive 
intestinal lesions and in some cases were able to differentiate the lesions from those caused by 
other major categories of diarrhoeagenic E. coli. All of these systems are highly specialised, and are 
only available in one or two laboratories 
 
A simple, economical, practicable and high through-put alternative model which provides an innate 
response using invertebrates has been investigated.  The well-studied Caenorhabditis elegans model 
(Aballay and Ausubel 2002) has been used with multiple bacterial pathogens (Aballay et al. 
2000;Fuhrman et al. 2008;Mellies et al. 2006;Mylonakis and Aballay 2005;Tan and Ausubel 
2000;Tenor et al. 2004) where worms fed bacteria grown on standard nematode growth media 
(NGM) die over a short period of time (2-3 days). This is the ‘slow killing’ method and is a 
consequence of the worms intestinal lumen being colonised by the bacterial pathogen (Mahajan-
Miklos et al. 1999;Tan et al. 1999), that has escaped the mouth grinding action of the worm that 
should kill the bacteria . Hwang et al showed that some EAEC strains killed C. elegans when used as a 
food source, most likely by means of an infection like process via the colonisation of the distal C. 
elegans intestine. This was in comparison to non-pathogenic E. coli which did not colonise and kill 
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the worm. This study was carried out on a few strains focusing on mutation of the pCADA plasmid 
(Hwang et al. 2010). This model could be used to look at strains from different lineages and assess 
the host-pathogen interactions. 
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1.14 Definition of enteroaggregative E. coli 
 
The original definition of EAEC of stack bricked formation of the bacteria on HEp-2 cells (Nataro et al. 
1987) has not been successfully replaced by any one alternative test. Due to the specialised and 
laborious nature of this method, the most popular method for detecting EAEC is by the detection of 
the aggR gene (Chattaway et al. 2014a) and currently used in multiple diagnostic laboratories in the 
UK and the Gastrointestinal Bacteria Reference Unit, UK.  
 
Due to the fact that there is no specific method to define EAEC and to ensure that there is no bias in 
the data output in this thesis towards a subset of EAEC. All EAEC that had been characterised using 
multiple methods were included such as the HEp-2 cell assay, the CVD432 probe (Baudry et al. 
1990), the aat gene (Nishi et al. 2003) and the aggR gene (Nataro et al. 1994). 
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Aims and Objectives 
 
Chapter-1 Introduction. 
The introduction is split into two parts. The first part explains the different pathotypes and 
pathogenicity of E. coli and tells the story of how E. coli as a species has changed in its definition over 
the past century with evolving technology and microbiological practices. The second part focuses on 
the definition and characterisation of EAEC, burden, evolution and phenotype of EAEC in relation to 
the context of the theories exploited in this thesis. 
 
Chapter 2-Is the burden and aetiology of enteroaggregative E. coli in intestinal infectious disease 
in the UK important? 
Chapter 2 gives an insight to how the burden of EAEC in the United Kingdom compares to other 
important pathogens. It is hypothesized that EAEC is independently capable of causing disease 
irrespective of co-infections and has played an important and current role in IID over the past 15 
years. This has been assessed by statistically analyzing both infectious intestinal disease (IID) 
databases with emphasis on the pathogenicity of EAEC. Methods were developed to assess disease 
burden using results of a semi-quantitative real-time PCR assay to diagnose enteroaggregative E. coli 
aetiology in episodes of IID in the UK (Chapter 2). 
 
Chapter 3-Can you differentiate pathogenic EAEC via population structure analysis and use this 
approach in public health studies? 
The aim of this part of the study was to use a case control approach using strains from Bangladesh, 
Nigeria and the UK based on the hypothesis that certain E. coli lineages by Multi-locus sequence 
typing (MLST) are exclusively EAEC and that these lineages vary in their ability to cause disease. It is 
hypothesized that the case control isolates will identify pathogenic lineages not currently 
represented in the public database. This will be proven by analysis of the population structure of 
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EAEC to place the case control isolates into natural groupings and evaluating the lineages by disease 
causing EAEC cases and carriage EAEC controls. The EAEC population structure will then be used in 
two public health studies to ascertain if this approach can be used in other  clinical situations. 
 
Chapter 4-What is the Evolutionary history of EAEC? 
Here, the study hypothesis that EAEC have a complex and diverse evolutionary history, that has led 
to the heterogeneous and complex nature of this pathogen is investigated. This will be shown by 
phylogenetic analysis of the strains of the concatenated sequence of MLST via ClonalFrame analysis. 
 
Chapter 5-Can the Phenotype of EAEC be linked to EAEC Genotype? 
The hypothesis that there are pathogenic lineages of EAEC and that these lineages will be 
phenotypically or genotypically distinct from the carriage EAEC groups is examined in this part of the 
study. This will be investigated by selecting representative groups and looking at the metabolic 
profile using the Biolog and their pathogenic potential, using the HEp-2 cell assay and the 
Caenorhabditis elegans worm model. Additional analysis of looking at EAEC strains and linking ST 
background to serotype and virulence gene profiling was carried out. An assessment of using 
serotyping to detect pathogenic lineages was also carried out. 
 
Chapter 6-Discussion 
Each of the results chapters (chapters 2-5) include a brief background to the work and the methods 
used for that part of the study.  There is no separate methods chapter.  The discussion summarises 
the findings from this thesis.   
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Chapter 2 - Burden of EAEC in the United Kingdom 
 
2.1 Background  
 
The aetiological agent is not identified in over half of laboratory investigated diarrhoeal episodes in 
the UK (Tam et al. 2012a). It is possible that a significant number of these cases of gastroenteritis 
can be attributed to diarrhoeagenic E. coli (DEC), including enteroaggregative Escherichia coli (EAEC) 
(1.1.3). Several authors have described high levels of EAEC cases in gastrointestinal disease infection 
(Nataro et al. 2006;Tompkins et al. 1999). However, in these studies, EAEC were also found in 
asymptomatic cases leading to doubt surrounding the role of EAEC in the disease process.  
 
The aim of this chapter was to reanalyse data from two intestinal infection disease (IID) burden 
studies carried out in the UK over the past 15 years (Tam et al. 2012b;Tompkins et al. 1999). The first 
IID study included cases and controls whereas the second IID study included cases only. Real-time 
PCR methodology, used in both studies for detection of target genes for potential GI pathogens, was 
semi-quantitative (Barletta et al. 2011;Nadkarni et al. 2002). It was used to determine bacterial load 
of pathogens, including the aat gene for EAEC in faecal specimens from symptomatic,  and 
asymptomatic patients, to look in detail for a causal link between disease and the presence of EAEC 
in the stool and whether this methodology could be used to assess causative burden in the second 
IID study. 
Bacterial load and evidence of co-infection (i.e. the presence of other pathogens that may be 
attributable to disease) were assessed to determine whether or not these factors were associated 
with increased likelihood of disease.  
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2.2. Methods  
2.2.1 Subjects and datasets used 
The first intestinal infectious disease study (IID1) was originally undertaken to identify the 
microorganisms and toxins in the UK population associated with disease and carriage. Stool samples 
were collected between August 1993 and January 1996. The study included both cases and controls 
among the community (based on a population based cohort) and cases presented to their GPs (with 
age/sex matched controls - from GP centres). During this time, 6743 were tested, 3654 of which 
were cases. The case definition included people of all ages with loose stools or vomiting (more than 
once in 24 hours) lasting less than two weeks. Any people that had a known non-infectious cause 
were excluded. A control definition included people free of loose stools or vomiting for three weeks 
before the matched case became ill. Controls were matched by age and those over 5 years of age 
were also matched by sex (Sethi et al. 1999;Tompkins et al. 1999).  
Samples were later re-tested using real-time PCR for detection of the aat gene found in EAEC 
(aatTMF GGGCAGTATATAAACAACAATCAATGG, aatTMR GTAGTTGTTCCTCTCACTAAGCATTTCAAT, 
AATP VIC-TCTCATCTATTACAGACAGCC-MGB) (Amar et al. 2005;Amar et al. 2007). The data 
generated included qPCR cycle threshold (Ct) values inversely proportional to the number of copies 
of the aat gene in 4664 stool specimens (2443 cases, 2221 controls) including 113 cases and 38 
controls specimens that were culture positive for EAEC. Real time cycle threshold (Ct) values were 
obtained for 102 EAEC positive cases and 31 EAEC positive controls and this data was used to assess 
bacterial load in this study. 
 
Laboratory data from the second IID study (IID2 case study where stool samples were collected from 
cases only with the same case definition as IID1) (O'Brien et al. 2010) ,  in which a prospective Cohort 
Study and GP presentation study was carried out during the period 24th April 2008 – 29th March 
2009, were also analysed as part of this study.  The dataset contained 83 EAEC positive stool 
specimens (from a total of 3966 stools) with real time PCR Ct Values.   
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2.2.2 Burden Assessment - Defining diagnostic cut off values for Ct value in EAEC 
infection 
Real- time PCR has been shown to be an accurate tool for detection of infectious disease in faeces 
(Phillips et al. 2009;Phillips et al. 2010) and as previously described, the Ct can be used as a measure 
of aetiological agent in the faeces and is inversely proportional to the amount of organism present in 
the specimen (Barletta et al. 2011;Nadkarni et al. 2002). Therefore the lower the Ct value the higher 
the bacterial load. The number of cycles of PCR replication required to raise the number of copies of 
the target sequence in the reaction mixture above a pre-determined threshold is represented by the 
Ct value (Grove 1999). The real-time-PCR assay for the aat gene was run for 40 cycles and a 
specimen was considered positive if the Ct value was <40. 
 
Assessment of the burden of EAEC disease using the most recent (IID2 case only) study was not 
possible directly. The lack of controls in IID2 and the lack of an absolute association of EAEC 
presence with diarrhoeal infection meant that the data from the case control study in IID1 was used 
to redefine the Ct cut-off value of the aat gene. 
 
A receiver-operating characteristic (ROC) analysis was used to define a cut-off in the Ct values to 
estimate the number of true EAEC IID positive cases in the population. This cut-off was used for the 
estimation of burden of disease caused by EAEC. The ROC analysis Ct value cut-off was not used for 
the other analyses in this study as a ‘case’ value, an example being investigating linkage with other 
pathogens, where a ‘case’ is the definition used by the original IID studies. 
 
For the ROC analysis, reference groups were selected from the IID1 study using microbiological and 
clinical characteristics. The positive reference group was defined as in the IID1 study case (people 
with loose stools or clinically significant vomiting lasting  less than 2 weeks in the absence of a 
known non-infectious cause and preceded by a symptom free period of 3 weeks), detection of EAEC 
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by real-time PCR for the aat gene and culture positive EAEC in the patients’ faeces. The negative 
reference group was also defined as in the IID study control (no IID symptoms in the past 3 weeks), 
detection of EAEC by real-time PCR for the aat gene and culture positive EAEC from faeces. In the 
ROC analysis, the sensitivity and specificity were calculated for each potential cut-off Ct value and an 
empirical ROC plot created using StataSE 12.0 (a statistical programme for analysing data) (StataCorp 
2011). The Youden index (sensitivity + specificity-1) was calculated and the maximum value used to 
identify the optimum cut-off (Bewick et al. 2004;Fluss et al. 2005). This value was then used to 
predict the number of true positive cases of those with a Ct value in the case only study, IID2. We 
compared the distribution of Ct values from cases and controls for EAEC positive individuals using 
the Student’s t-test.  
 
2.2.3 Causal link between EAEC and disease - statistical methods 
It became clear following the initial analysis, that the relationship between EAEC presence and 
disease was not absolute and so several methods were used to further investigate the association of 
EAEC with disease:  
2.2.3.1 Carriage rates of EAEC in healthy controls, compared to other pathogens 
For each infection the chi squared test was used to test if the distribution of the pathogen 
between cases and controls was as expected by chance. 
2.2.3.2 Association of disease with individual pathogens where multiple pathogens were 
detected in stool 
All EAEC positive individuals with multiple pathogens (both cases and controls) were tested 
to determine whether individual pathogens were equally distributed between cases and 
controls using Chi squared tests for independence. Because norovirus was the most common 
pathogen, a comparison using the Chi squared test for co-infection in all individuals positive 
for EAEC and all individuals positive for norovirus was carried out to determine if the 
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presence of other individual pathogens were dependent on infection with EAEC or 
norovirus. 
2.2.3.3 Independent association of EAEC presence with disease 
A logistic regression of univariate and multivariate analysis was carried out using case or 
control as outcome and infecting agent and age as independent variables. In this way the 
independent association between EAEC and disease whilst controlling for other pathogens 
was assessed. Model results were then used to calculate the population attributable fraction 
(PAF): 
PAR = Pe (RRe -1) / RRe  
Where Pe is the proportion of cases with the exposure (EAEC) and RRe the relative risk of 
disease. This form allows for confounding of the exposure if an adjusted RR is used, as 
recommended in Rockhill et al (Rockhill et al. 1998). In this case, adjusted odds ratios are 
substituted into this equation to give an approximate, adjusted PAF. 
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2.3 Results  
2.3.1 Descriptive statistics  
To test if the analysis of data from the IID1 case control study remained relevant in 2009, we 
compared the demographic data from the two periods. There was no significant difference between 
the rate of EAEC in the IID1 case–control study (1993–96) and IID2 case-only study (2008–09), 
with 1.4% and 1.9%, respectively; individuals with EAEC present in their stool were distributed 
evenly across all age groups in both IID1 and IID2 (chi-squared p value for non-independence:0.253). 
For EAEC-positive individuals, there was no significant difference in age between cases and controls 
(p=0.237). We therefore believe that the epidemiology did not change significantly for EAEC 
infection between the two periods. Cases tended to be slightly older than controls in IID1 (mean age 
of cases: 30.1 years, standard deviation (SD): 24.7 years; mean age of controls 28.7 years, SD: 23.9 
years; p value for difference:0.051). 
2.3.2 Defining diagnostic cut off values for Ct value in EAEC infection 
 
In order to investigate the link between Ct value and disease, the sensitivity and specificity of the Ct 
value was assessed in EAEC-positive specimens from the case control study (dataset IID1); Ct values 
were obtained and included 102 cases and 31 controls. Figure 2.1 shows the resulting ROC curve, 
and Figure 2.2 the distribution of Ct values in cases and controls. The cut-off was chosen to balance 
sensitivity and specificity and was set at a Ct value of 31 (Figure 2.1). The ratio of false positives 
versus false negatives with this cut-off point was 1.09 (95% confidence interval (CI): 0.79–1.53) 
(Figure 2.2). The total number of test-positives, although not a good diagnostic for the individual 
(due to poor sensitivity and specificity), was a reasonable estimate of the total number of cases. 
Importantly however, in the population studied, there was a significant association between 
bacterial load and disease state (p=0.039), and further investigations were carried out using the 
point of <40 to indicate presence of EAEC. 
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Figure 2.1 Receiver-operating characteristic (ROC) Analysis of Ct values for enteroaggregative E. coli from 
gastrointestinal disease cases (n=102) and controls (n=31). August 1993-January 1996 
 
 
 
Figure 2.1: The red circle at Ct value 31 indicated the cut-off value which was chosen at the point where 
sensitivity and specific were equivalent. Figure used in Eurosurveillance publication (Chattaway et al. 2013). 
  
79 
 
Figure 2.2 Distribution of Ct values for curve analysis of enteroaggregative E. coli in gastrointestinal disease 
cases (n=102) and controls (n=31). August 1993-January 1996 
 
 
 
Figure 2.2: Fitted curve distribution of Ct values. The red line indicates the cut-off point where the ratio of 
false positives versus negatives with this cut-off point was closest to equivalent 1.09; 95% confidence interval: 
0.79-1.53. Figure used in Eurosurveillance publication (Chattaway et al. 2013). 
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2.3.3 Investigation of the association of EAEC presence with disease.  
2.3.3.1 Carriage rates of EAEC, compared to other pathogens, in healthy controls: 
Submitting a stool specimen that was positive for EAEC was positively associated with having disease 
(Figure 2.3). However, one quarter of all EAEC positive individuals were asymptomatic (38/151). 
 
Figure 2.3 Organisms present in stool samples from gastrointestinal disease cases (n=2,221) and controls 
(n=2,213) in the IID1 study, August 1993- January 1996 
 
 
 
Figure 2.3: Submitting a stool specimen that was positive for enteroaggregative E. coli (EAEC) was positively 
associated with having disease. EAEC was found in <2% of controls, indicating that EAEC is not a ubiquitous 
commensal organisms. The p values are indicated on the right (chi-square). Figure used in Eurosurveillance 
publication (Chattaway et al. 2013). 
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2.3.3.2 Association of disease with individual pathogens in persons with multiple 
pathogens in their stool 
The presence of co-infection was almost three times higher in EAEC-positive cases (74/113, 66%) 
than in EAEC-positive asymptomatic controls (9/38, 24% Figure 2.4) with more multiple co-infections 
in cases (38/113, 34%) than controls (1/38, 3%) (chi-square test, P<0.001). Norovirus and C. jejuni 
were statistically associated with being present in EAEC cases (Figure 2.4). Concomitant presence of 
other micro-organisms has decreased over the years; in the IID1 EAEC cases data subset came to a 
total of 42 (41.2%) whereas in the IID2 study, the EAEC cases co-infection total was 30 (35.7%) 
specimens. This analysis is not statistically relevant (chi-square test, P=>0.05) but the IID1 data 
showed that there was only one EAEC control that had a co-infection (3%) and so there is a higher 
association with co-infection and cases then with controls. 
2.3.3.3 Investigation of the independent association of EAEC presence with disease. 
The logistic regression of EAEC status (but not Ct value) in univariate analysis gave an OR of 2.55, 
95% CI: 1.91 - 3.39, P<=0.001; and in multivaritate analysis the OR was 2.41, 95% CI: 1.78 - 3.26, 
P<=0.001. This means that among IID cases, the odds of EAEC infection were 2.5 times higher 
compared with asymptomatic controls. The resulting adjusted PAF was 0.033% (95% CI 0.024-
0.039%), suggesting that around 3.3% of cases of IID in the UK are attributable to EAEC. This 
confirms that EAEC is an independent cause of IID. 
A comparison of co-infections with norovirus, the most common cause of IID, is presented in Figure 
2.5. and shows enterotoxigenic E. coli and Shigella sp.to be statistically associated with EAEC as a co-
infection (Figure 2.5). 
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Figure 2.4 Co-infection of Enteroaggregative E. coli (EAEC) cases and controls 
 
Figure 2.4: There were a higher variety of co-infection types, a higher percentage of co-infections and more 
multiple co-infections in EAEC positive cases than in EAEC positive controls. 
Note: organisms designated sp. Include all species of that genus (except Campylobacter sp. C. jejuni and C. coli 
are listed separately). The p values are indicated on the right (chi-square). Figure used in Eurosurveillance 
publication (Chattaway et al. 2013).  
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Figure 2.5 Comparison of co-infections with Enteroaggregative E .coli (EAEC) and Norovirus 
 
Figure 2.5: Co-infection with EAEC was more common than with norovirus (66% versus 43% respectively). 
Staphylococcus aureus refers to all S. aureus >106/g. The p values for individual agents are indicated on the 
right (chi-square). Figure used in Eurosurveillance publication (Chattaway et al. 2013).   
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2.4.  Discussion  
2.4.1 Burden of EAEC disease 
Although described as a pathogenic group of E. coli it is well documented that EAEC may be 
associated with asymptomatic infection (Huang et al. 2007;Okeke et al. 2000a;Regua-Mangia et al. 
2009). In this chapter the question was asked – how much gastrointestinal disease is caused by 
EAEC? In an attempt to remove healthy carriers from the case definition (a lower bacterial load 
might be expected in carriers than in cases) data was analysed from a PCR based case control study 
(IID1). Using data from the IID1  (1993-1996) case control study and the Ct value as an indicator of 
bacterial load, a defined diagnostic cut-off with 60% sensitivity and specificity (Ct <31) was 
established. Consideration of the bacterial load has enabled us to design a Ct cut-off values that 
attributes positive EAEC cases in the population. The cut-off value of Ct 31 represents a value where 
the number of false positives is closely equal to the number of false negatives (Figure 2.1) and 
therefore can be used as a value representative to EAEC burden within the population. It is not a cut-
off value for diagnosing EAEC infection. 
 
The application of this Ct value indicated that 47% (39/83 EAEC positive faeces below Ct 31) of EAEC 
positive cases in IID2 (2008-2009) were associated with disease which would represent about 1% of 
IID cases; this is equivalent to the burden of GI disease called by Salmonella (Tam et al. 2012b). 
However, the low sensitivity and specificity values would suggest that estimation of bacterial load by 
the Ct value of a quantitative PCR for virulence factors is not a useful diagnostic test for EAEC 
infection in an individual. 
 
There was a strong association between a higher load of EAEC (low Ct) and being a case and so an 
attempt was made to define more accurately the EAEC positive individuals where EAEC was the 
causal agent of diarrhoea. The bacterial load data revealed the presence of two overlapping 
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normally distributed data sets for EAEC: one representing the load in the asymptomatic group 
(controls) and one in the symptomatic group (cases) (Figure 2.2).  
 
The consideration of any possible confounding effects of age (and so acquired immunity) and co-
infection was addressed using logistic regression confirmed by univariate analysis; the results 
showed that an individual was 2.5 times more likely to be a case then a control if they had EAEC. 
Therefore it was concluded that EAEC was independently associated with disease and an important 
burden in intestinal disease. 
 
The results from both IID studies and consideration of factors such as co-infections and patients not 
reporting mild GI disease for investigation, show a possible under-representation of EAEC infection 
rate such as 1% of the population (Chattaway et al. 2013). This highlights EAEC and as an important 
aetiological agent of GI disease. EAEC should be regarded as a significant burden of enteric disease in 
the UK. 
 
2.4.2 Causal link between EAEC presence in stool and disease 
2.4.2.1 Carriage rates of EAEC in healthy controls, compared to other pathogens 
Studies show that EAEC is detected in the stools of asymptomatic individuals (Figure 2.3). A similar 
situation is gastrointestinal viral infection where the most likely explanation is that post-infection 
levels of virus particles, although reduced, persist up to 56 days after symptoms have cleared (Atmar 
et al. 2008;Partridge et al. 2012). It is likely that the adherence mechanisms associated with EAEC 
also enables persistent carriage post-infection. 
 
Another explanation of the presence of a pathogen in the absence of disease is pre-existing 
immunity to the infection at the time of exposure, which could result in reduced viral or bacterial 
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replication and a failure to develop symptoms. If pre-existing immunity was the cause of 
symptomless EAEC carriage we would expect to find an age distribution where adults are less 
frequently infected (older individuals have a higher chance of exposure and therefore a higher 
chance of immunity). However, the age distribution was even across the age groups.  Having ruled 
out the significance of bacterial load and pre-existing immunity as explanations of asymptomatic  
infection, .the role co-infecting pathogens with the association of EAEC with GI disease was 
explored. 
 
2.4.2.2 Association of disease with individual pathogens in persons with multiple 
pathogens in their stool 
Previous studies have shown that organism load was related to disease in norovirus infection 
(Phillips et al. 2010). This study has shown that this concept cannot be applied to the presence of 
EAEC. A high EAEC bacterial load does not always directly link to disease and so it was suggested that 
distribution of co-infections warranted investigation.  
 
The presence of increased co-infection in cases raises two possibilities: (i) - that the co-infecting 
pathogen rather than the EAEC is the aetiological agent and (ii) the interaction between the two 
organisms, is causing disease. To test this hypothesis we used norovirus, an infectious agent known 
to be present in both symptomatic and asymptomatic infection, as a comparator. As norovirus was a 
very common infection, we removed cases infected simultaneously with both norovirus and EAEC 
from the calculation: there were more co-infections in EAEC-positive cases than in norovirus positive 
cases (66% versus 43%). For EAEC co-infection, 12.6% were explained by enterotoxigenic E. coli 
(ETEC) and Shigella co-infections (Figure 2.5). This suggests that a proportion of EAEC cases can be 
explained by the presence or interaction of other pathogens (ETEC and Shigella are associated 
almost exclusively with symptomatic infection).  
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This high proportion of co-infection with EAEC cases compared to controls from the IID1 study (66% 
compared with 24%), may be an indicator that infection of the gut, such as with EAEC, may change 
bowel surfaces (for example the gut mucosa may become inflamed) and lead to favourable 
conditions for multiple types of pathogen colonisation (Strauman et al. 2010). Alternatively, it may 
be the co-infecting pathogen that enables EAEC to colonise the host more effectively, possibly by 
removing competition and exposing attachment sites. 
 
Another consideration is that in certain cases the co-infection is causing disease and EAEC is a gut 
commensal. This hypothesis is supported by statistical analysis showing that an individual is highly 
likely to be an EAEC case if they have a co-infection (Chi-square, P=0.000). However, the logistic 
regression univariate data, and also the multivariate analysis, that accounts for co-infections, show 
that there is an association with EAEC and disease and you are 2.5 times more likely to be a case if 
you have EAEC. Therefore EAEC is capable of causing disease in certain people. It is clear that there is 
a relationship between EAEC and co-infecting microbiological agents but direct association with a 
specific organism in relation to disease could not be elucidated from this analysis.  Non-specific 
changes or damage to the gut by either co-infections or EAEC carriage could be the disease 
mechanism for EAEC cases rather than interaction with specific co-infection organisms. 
 
2.4.2.3 Independent association of EAEC presence with disease 
The logistic regression of co-infection univariate and multivaritate was statistically significant and 
again confirmed that EAEC was independently associated with disease; the odds of disease were 2.4 
times higher if EAEC was present than if not and were still highly significant after controlling for co-
infections. The PAF adjustments indicated that EAEC would be responsible for disease in 3.3% of 
cases, a significant proportion in gastrointestinal disease and higher than for Salmonella (Tam et al. 
2012b). Although age was an independent predictor for disease overall, controlling for age did not 
change the association of disease with EAEC, and there was no interaction between EAEC and age. 
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Therefore EAEC was independently associated with disease and it was concluded that most EAEC 
strains are capable of causing infection but not all. 
 
The work in this chapter does not directly address causality over association but suggests that 
bacterial strain variation best explains the results for the following reasons. 
There are two common arguments for EAEC being found in high levels in healthy individuals: 
1) Low levels of EAEC are present in a commensal relationship in the human gut and only increase to 
detectable levels after infection with a true pathogen but an independent association of EAEC with 
disease argues against this for at least half of the infections in this study.  
2) Post infection immunity leading to carriage in apparently healthy individuals; a lack of any 
detectable trends in age distribution and no clear distinction between pathogen load and disease, as 
seen in norovirus infection (Phillips et al. 2009), suggests that acquired immunity is not occurring in 
the UK population.  Transient passage, is also unlikely as there is no known long term reservoir for 
exposure to EAEC from outside the human gut.  
 
It is suggested that some, but not all, EAEC cause infection. The explanation for this may lie within 
defining EAEC by in vitro phenotype and a more detailed analysis of the phylogeny and putative 
pathogenicity genes is required. It is suggested that non-pathogenic EAEC that are able to adhere in 
an aggregative pattern to HEp-2 cells in the laboratory but unable to cause disease in the human 
host, are found in controls and in co-infections with true pathogens but pathogenic variants are 
found as the sole pathogen detected in diarrhoeic stools.   
 
The alternative definition of EAEC by genetic markers to relate to in vitro phenotype has been 
attempted using alternative probes but this has also failed to define those EAEC capable of causing 
disease. For example, neither the presence of the target genes most commonly used in diagnostic 
assays, aat (anti-aggregative transporter) (Denno et al. 2012) and/or aggR (a transcriptional 
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activator) (Antikainen et al. 2009;Denno et al. 2012;Gomez-Duarte et al. 2010;Toma et al. 2003) 
correlate precisely with disease. 
 
It may be that the diagnostic genetic factors used for EAEC are not true virulence factors – rather 
they encode the ability to adhere to human intestinal cells and facilitate colonisation (especially 
during infection with a true pathogen). It is likely that a combination of the EAEC associated 
adherence factors, other virulence factors and genetic background enables EAEC to cause primary 
infection. This was demonstrated with the strain of ST678 (serotype O104:H4) associated with the 
outbreak in Germany in 2011 (Chattaway et al. 2011) where the EAEC adherence genes were 
present in the same bacterial host as the shiga-like toxin gene (stx) in a stable genetic background. A 
robust and reliable diagnostic test for pathogenic EAEC is required to elucidate the true burden of GI 
disease caused by EAEC.  Ideally, a suitable diagnostic assay would detect a combination of the EAEC 
plasmid genes in addition to chromosomally encoded virulence factors. The work carried out during 
this thesis explores “other” genomic factors associated with diarrhoeagenic EAEC. 
 
The main limitation of this study is the absence of controls in the IID2 study. Although there were 15 
years between the IID1 and IID2 studies, the demographic data for cases suggest that the 
epidemiology has not changed during that period (Chattaway et al. 2013). Although there was a 
slight decrease in co-infection rates, it was not statistically different. It is believed the burden data is 
still relevant in 2014. Another interesting observation of the study is the range of co-infectious 
agents identified. Small numbers of cases with co-infections (six cases or less for EAEC co-infections 
with C. difficile, Yersinia, Giardia, Cryptosporidium, rotavirus, VTEC and Staphylococcus) meant that 
the ability to detect statistical differences between cases and controls was limited. However, the 
study did allow, for the first time, the explanation of the association between EAEC and all potential 
co-infecting agents as well as the more common pathogens norovirus (n=29) and Campylobacter 
(n=12). 
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2.4.3 Application of the aat gene Ct value as a mean of diagnosing EAEC infection 
The assessment of Ct value in this study has shown a potential method of assessing burden in the 
population studied, although the EAEC Ct values does not equate to an idealistic ROC curve (Figure 
2.1) or a typical normal distribution curve (Figure 2.2) like you would find in norovirus (Phillips et al. 
2010) and so it is not suitable method to use a cut-off value for diagnosing EAEC infection.  
Intestinal infection is multi-factorial (infectious dose, immunity status, underlying physiological 
conditions) and though the burden of EAEC is generally higher in cases, other factors have not been 
taken in to account such as co-infection.  Microbiological protocol to diagnose infection is to look for 
a dominant (i.e. most easily isolated and present in high numbers) or recognised known pathogen ( 
i.e. Salmonella, Shigella e.t.c.) and EAEC is not currently part of these protocols.  
If microbiological protocols were to change to include EAEC, the method still needs to be agreed as 
cell adhesion assays are not practical at the frontline laboratories.  Although the aat (anti-
aggregative transporter encoding gene) probe has become an alternative method for EAEC detection 
over the gold standard of the HEp-2 assay (Vial et al. 1988), and was the probe of choice in both IID 
studies, studies have shown that not all EAEC carry the plasmid and targeting the aat gene doesn’t 
always detect the organism (Jenkins et al. 2006a). There are other EAEC specific genes being 
investigated  for detection methods such as the aggR gene (a transcriptional activator gene which 
regulates multiple chromosomal and plasmid virulence factors) (Antikainen et al. 2009;Gomez-
Duarte et al. 2010;Toma et al. 2003), but with EAEC being such a heterogeneous organism, until a 
properly defined sub-set of diarrhoeagenic EAEC is described an improved detection system will be 
difficult to develop 
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2.5.  Summary  
 
This chapter has provided a unique insight into the burden of IID attributed to EAEC, which was 
estimated at 1% of the UK population in 2008-2009. The presence of EAEC was not always associated 
with disease, and the use of a Ct value cut-off to accurately diagnose EAEC as a cause of infection 
was not robust. This methodology alone cannot be used to diagnose EAEC infection and alternative 
approaches are needed. It is hypothesised that EAEC is a mixture of pathotypes of which only some 
groups are capable of causing disease (Chattaway et al. 2013). The following chapter describes the 
population structure of EAEC and analysis of the data in order to define sub-groups within the EAEC 
population and find associations with disease or carriage.   
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Chapter 3 - Definition of pathogenic EAEC groups by a case control 
approach 
3.1 Background  
 
Chapter 2 showed that EAEC plays an important role in gastrointestinal infection and hypothesised 
that certain sub-set populations of EAEC are pathogenic and capable of causing symptoms of GI 
disease, while other are not pathogenic. The work described in this chapter investigates this 
hypothesis further. 
 
Attempts to define enteroaggregative E. coli (EAEC) have been based on traditional methods, for 
characterising and typing E. coli developed over the past century. Serotyping has been a useful 
method for identifying the pathotype Shiga toxin producing E. coli (STEC) serotype O157:H7, as the 
serotype is a robust marker for this successful and stable clonal group.  In this context, a successful 
clonal group is defined as a group of closely related strains that have continued to proliferate over 
time and are still present in the population. STEC O157:H7 has a recognisable genetic background 
(ST11), and a defined set of virulence factors (stx toxin and eae intimin gene).  However, serotyping 
doesn’t help define the pathogenic profile of all E. coli . A more useful method is to detect the 
presence of specific pathogenicity  genes.  The approach of genotyping and virulence gene profiling 
over serotyping has been used to identify E. coli pathotypes where the genetic background is stable 
and key genes are found (Table 1.1). 
 
However, this methodology and approach has been unsuccessful in determining groups or profiles 
for EAEC. Serotyping has revealed hundreds of combinations of somatic ‘O’ antigens and flagella ‘H’ 
antigens found in both EAEC cases and controls, and so  few serotypes have been linked specifically 
to the EAEC pathotype (Jenkins et al. 2006a;Okeke & Nataro 2001). The most common group 
defining genes used to detect EAEC are plasmid borne (aat transporter gene and aggR regulator 
gene). Virulence gene profiling in various case control studies has resulted in the growing number of 
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putative pathogenicity factors emphasising the heterogeneity of this complex group (Huang et al. 
2007;Jenkins et al. 2006a;Jenkins et al. 2006b;Okeke et al. 2000a;Pereira et al. 2007;Regua-Mangia 
et al. 2009) . Essentially, the traditional methods of characterising EAEC by HEp-2 adherence and 
EAEC virulence gene content have not shown a direct link to the pathogenicity of EAEC and these are 
not suitable methods to determine detection of pathogenic EAEC. While most studies focus on the 
plasmid encoded genes,  this study adopted a novel approach based on the use of MLST to 
determine the population structure of EAEC to investigate and understand the background of 
isolates from multiple case control studies around the globe, including the UK, Bangladesh and 
Nigeria. It is hypothesised that this approach can elucidate a clear definition of pathogenic EAEC by 
assessing the association with disease against the core genetic background which is more stable in 
comparison to mobile genetic elements. 
 
The applications of novel approaches in research are not always tested in public health situations (to 
ascertain the validity and impact of new methodologies) in order to facilitate public health 
investigation. The data obtained from this study were tested in two different public health settings 
to assess the utility of the methods described in this chapter. 
 
1) The European SAFEFOODERA-ESBL project was initiated to assess the prevalence of 
Extended spectrum beta-lactamase (ESBL) producing E. coli in humans (n=274), food producing 
animals (n=295) and animal food products (n=59) across Europe to ascertain if there are any 
zoonotic groups of ESBL in the food chain and characterise the strains. Isolates that were ESBL 
positive underwent further characterisation and are the isolates used in this study (Wu et al. 2013).  
The population structure of this dataset was assessed using the methods described in this thesis to 
determine whether there were any ESBL complexes prevailing across Europe. Isolates were 
investigated from Germany (n=84), The Netherlands (n=254) and the UK (n=291) (Wu et al. 2013).  
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2) The second study was to use MLST in the investigation of EAEC outbreaks to ascertain if 
there were certain complexes responsible for outbreaks. Known EAEC outbreaks over the past two 
decades investigated at the Gastrointestinal Bacteria Reference Unit were mapped onto the EAEC 
population structure developed as part of the work described in this chapter and analysed. 
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3.2. Methods  
3.2.1  Strains Used in the study 
Three case control studies, sporadic and outbreak cases of 564 EAEC spanning over 29 years (1985 – 
2013) were used in this study (Table 3.1). All of these strains were included to encompass a 
representation of EAEC in the global community (including UK travellers) over the past three 
decades. EAEC were defined as having the aat gene/CVD432 probe reaction (Baudry et al. 1990;Nishi 
et al. 2003), and/or the aggR regulatory gene (Jenkins et al. 2006a) and/or the aggregative 
adherence (AA) phenotype (Nataro et al. 1987)  where the phenotypic test was available (Table 3.1).  
 
The three case control studies included both IID studies from the UK  described in Chapter 2 and a 
Bangladesh and Nigerian study. The Nigerian study defined a case as a child aged 5 years or younger 
attending one of four primary health care centres in Osun State (Southwest Nigeria) who had 
frequent stools (usually more than 3 daily), lasting less than 2 weeks. Control subjects were healthy 
children of the same age range. This resulted in obtaining specimens from 187 cases and 144 
controls for testing (Okeke et al. 2000a) from which 66 cases and 55 controls EAEC isolates were 
available for analysis as part of this thesis . The Bangladesh study were strains taken from the Global 
Enteric Multicenter Study (GEMS) and cases were defined as children of 0-59 months  who fulfilled 
the WHO definition of diarrhoea (3 or more loose stools in 24 hours), controls were matched from 
the community by age, sex and near by by village who had no diarrhoea for seven days (Kotloff et al. 
2012). This study resulted in 550 cases and 878 control specimens being tested (Kotloff et al. 2013) 
from which 97 cases and 61 EAEC isolates were available for this study. 
 
In summary, Isolates included strains from multiple case control studies including the UK (273), 
Bangladesh (169), Nigeria (121) and the prototypical 042 EAEC reference strain from Peru (1) (Table 
3.1). In addition to the case control study, EAEC identified at the Gastrointestinal Bacteria Reference 
Unit over the past 3 decades from clinical specimens or outbreaks were included. Due to the varying 
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definition of EAEC, all strains were included irrespective of phenotypic and genotypic definition to 
prevent any bias that may affect the analysis. Where an EAEC outbreak was related to one ST and 
serotype, only one representative strain was included. 
 
All EAEC strains described above were held in the archive at GBRU, except the strains from the 
Nigerian study where only the MLST data was made available.  All strains, except for the strains from 
Nigeria, were plated onto Columbia blood agar plates (5% sheep blood) [PHE, Media] to test for 
purity and archived onto Dorset Egg slopes (egg white and yolk) [PHE, Media] and stored at room 
temperature and also archived on cryobeads  [Prolab] and stored at -80oC.  
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Table 3.1 List of 564 strains used in this study 
Country Source Year Range Case Control Reference 
Peru ∞042 prototypical strain 1985 1 0 (Nataro et al. 1985) 
 
UK #GBRU Archive Clinical strains 1985-1995 17 0 This Study∞ 
 
UK ∞IID1 Case/Control Study 1993-1996 121 36 (Wilson et al. 2001) 
 
UK ∞GBRU Outbreak A 1994 2 0 (Spencer et al. 1999) 
UK ∞GBRU Outbreak B 1994 8 0 (Spencer et al. 1999) 
 
UK ∞GBRU Outbreak C 1994 1 0 (Spencer et al. 1999) 
 
UK ∞GBRU Outbreak D 1995 3 0 (Spencer et al. 1999) 
Bangladesh ∞GBRU Outbreak E 1998 12 0 This Study∞ 
 
Nigeria ∞Nigeria Case/Control Study 1999 66 55 (Okeke et al. 2010)  
 
UK #IID2 case study 2008-2009 25 0 (Chattaway et al. 2013) 
 
Bangladesh ∞GEMS Case/Control Study 2007-2011 97 61 (Kotloff et al. 
2012;Panchalingam et 
al. 2012) 
 
Germany #O104:H4 VTEC Outbreak 2011 1 0 (Chattaway et al. 2011) 
 
UK #O111:H2 Household 
Outbreak 
2012 1 0 (Dallman et al. 2012) 
 
 
UK #GBRU Clinical Strains 2009-2013 38 0 This Study∞ 
 
UK #GBRU Spice Outbreak 2013 19 0 (Dallman et al. 2014) 
 
Table 3.1  ∞Strains from this study not previously described include archived clinical strains received by GBRU 
for typing between 1985-1995, Outbreak E of enteroaggregative E. coli that occurred in Bangladesh in 1998, 
recent clinical strains received by GBRU for typing between 2009-2013. #EAEC were defined as having the aat 
and/or aggR gene. ∞Other EAEC strains were defined as having the aat gene /CVD432 probe reaction and/or 
the aggregative adherence (AA) phenotype. 
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3.2.2  Identification and serotyping of isolates from Bangladesh and UK 
Biochemical confirmation of the identification of 443 Bangladesh, UK and Peru isolates as Escherichia 
coli was performed (Castellani and Chalmers 2005). Typical metabolic profiles of E. coli included gas 
production following growth in glucose, positive reactions for glucose, lactose, mannitol, lysine, 
ornithine, mucate, sodium acetate and indole. Serotyping of the somatic and flagella antigen (Gross 
and Rowe 1985) was carried out on the heat stable lipopolysaccharide (somatic or O) antigens and 
the flagellar (H) antigens. Strains which agglutinated with all antigens failed to express the O antigen 
were termed “rough” and those that did not agglutinate with any of the established serogroups or 
flagella antigens were termed ‘O’ or ‘H’ unidentifiable (O? or H?). Nigerian strains had previously 
been identified and published (Okeke et al. 2000b), strains were not available for serological 
identification. 
3.2.3  Multi-locus Sequence Typing (MLST) 
3.2.3.1 DNA Extraction 
DNA extraction of the strains was undertaken using the Wizard kit [Promega, UK]. Pure cells were 
grown overnight in 1.2ml nutrient broth [PHE Media] in a shaking incubator [New Brunswick 
Scientific] at 37oC in oxygen. The broth was centrifuged [International Equipment Company] at 
13,000rpm for 4 min and the supernatant was discarded.  
Cells were lysed by gently adding and mixing 630 µl of nucleic lysis solution, incubating for 10 min at 
80oC, cooling at room temperature and adding 3 µl of RNase solution. This was then mixed by 
inverting and incubated at 37oC for 15 min and cooled at room temperature.  
Proteins were then precipitated by adding 230 µl of protein precipitation solution and inverting 
immediately to mixed and then vortexed. They were then incubated on ice for 10 min, inverted and 
centrifuged at 13,000 rpm. 
DNA was precipitated by transferring the clear supernatant to a clean tube containing 650 µl of 
isopropanol and mixed. The mixture was centrifuged at 13,000rpm for 15 min, the supernatant was 
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then discarded. One ml of 70% ethanol was added and mixed and the DNA was precipitated as white 
string. The tube was then centrifuged at 13,000 rpm for 1 min. The supernatant was carefully 
aspirated and the tube was left to air dry. 
DNA was rehydrated in 50 µl of nuclease free water and left to solubilise overnight at 4oC. 
DNA was measured using a spectrophotometer [Qubit, Invitrogen] to ensure at least 50 ng was 
present for the PCR reaction. 
3.2.3.2 Polymerase Chain Reaction 
Gene fragments from housekeeping E. coli genes were amplified as described by Wirth et al (Wirth 
et al. 2006) to obtain allele data including adk (536 bp), fumC (469 bp), gyrB (460 bp), icd (518 bp), 
mdh (452 bp), purA (478 bp) and recA (510 bp). Each 25 µl reactions contained 1 µl DNA, 1 µl of each 
primer (10 pmol/µl) [MWG Eurofins] , 12.5 µl PCR master mix [Sigma] and 9.5 µl nuclease free water 
[Sigma]. Amplification was carried out on a PCR ABI 3700 thermocycler [Applied Biosystems] and 
included an initial denaturation step at 95oC for 2 min followed by 30 cycles of the following 
conditions: denaturation at 95oC for 1 min, annealing temperature for each primer set at 56oC for 1 
min and extension at 72oC for 2 min, with a final extension step at 72oC for 5 min. 
Amplified DNA was prepared for sequencing using the ‘‘ExoSAP’’ method (Amersham Biosciences UK 
Ltd). Essentially, 1 µl of ExoSAP was added to 10 µl of amplified DNA, the two hydrolytic enzymes 
(Exonuclease I and Shrimp Alkaline Phosphatase) were activated and unwanted deoxynucleotides 
and primers were removed by heating the mixture in a thermocycler at 37oC for 30 min and then 
80oC for 10 min. 
3.2.3.3 Amplification of Sequencing Reaction 
Cleaned fragments were sequenced from both ends using the di-deoxy chain terminator method 
(Sanger et al. 1992), with V3.1 Bigdye terminator chemistry (West et al. 2005) [Applied Biosystems]. 
Briefly, a dye PCR mastermix was made consisting of 1 µl of 5 pmol/µl forward primer, 4 µl of 
terminator ready reaction, 4 µl of nuclease free water and 1 µl of cleaned amplified DNA template 
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(5-20ng). This was also repeated for the reverse primer as both strands of each fragment were 
sequenced at least once. The reaction conditions carried out on a PCR ABI 3700 thermocycler 
[Applied Biosystems] and included an initial denaturation step at 96oC for 1 min followed by 25 
cycles of the following conditions: denaturation at 96oC for 10 seconds, annealing temperature for at 
50oC for 5 seconds and extension at 60oC for 4 min. The final reaction was stored at -20oC. 
3.2.3.4 Cleaning of Amplified Sequencing Reaction 
Sequencing reaction was cleaned by adding 15 µl of nuclease free water into each well of amplified 
sequencing reaction, 52 µl of EtOH/ NaOAc (from stock of 7 ml ethanol and 280 µl sodium acetate 
pH 5.2 3M [Sigma]) was added, vortexed and incubated at room temperature for 45 min. The plate 
was then centrifuged for 1 hour at 2800 x g at 4oC.  
After spinning, the plate was inverted to decant the supernatant and then placed inverted onto 
whatman filter paper and spun at 500 x g for 1 min.  
Fragments were then washed by adding 150 µl of 70% EtOH and centrifuged at 2800 x g at 4oC for 10 
min. After spinning, the plate was inverted to decant the supernatant and then placed inverted onto 
whatman filter paper and spun at 500 x g for 1 min. The plate was stored at -20oC until sequenced. 
3.2.3.5 Sequencing of Cleaned Sequencing Reaction 
Both ends were sequenced at least once using the di-deoxy chain terminator method with v 302 
Bigdye terminator chemistry The resulting sequencing reactions were analyzed on 3700 ABI 
sequencing machines [Applied Biosystems, USA].  
3.2.3.6 Analysis of Sequenced Data 
Sequence data was imported into BioNumerics V 6.5 and fragments were aligned and assessed for 
quality. Consensus trimming was carried out for each allele and fasta files were exported. Allele and 
sequence type (ST) assignments were made at the publicly accessible E. coli MLST database at 
http://mlst.ucc.ie/mlst/dbs/Ecoli/.  
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3.2.4  Population structure analysis 
To assess the population structure of the EAEC isolates in this study, Minimal Spanning Trees 
(MSTree) (where the two STs with the greatest number of single locus and then double locus 
variants are linked first, preferably using intermediate STs) were constructed using BioNumerics V 
6.5 software. 
3.2.4.1 Assessment of EAEC Disease and Carriage Groups  
As of 18th December 2013, the data available in public database indicated there were 155 EAEC 
(excluding the 121 Nigerian strains described by Okeke et al. 2010, out of 6110 E. coli entries 
representing 2.4% of the database. There were 1164 entries of defined diarrhoeagenic pathotypes of 
E. coli of which EAEC accounts for 13 % (155/1164). Diarrhoeagenic pathotypes included ETEC, STEC, 
EPEC, EIEC and DAEC (Table 1.2)  
From the 564 strains used in this study, a complex (defined by a ST and any single locus variants 
related to that ST) was considered successful if it contained 4 or more strains accounting for a 
minimum of 2.5% (4/155) of the known EAEC deposited in the public database.  
From the EAEC MSTree dataset used in this study, there were 17 complexes (Cplxs) containing four 
or more EAEC that were  deemed representative of successful strains  (i.e. strains which have 
continued to proliferate over time in the population) . The assigned Cplxs were then tested using a 
fishers exact test (Fisher 1922)  for the significance of the groups being associated with disease or 
carriage in relation to the entire dataset (564 strains).  Statistical tests of significance were 
conducted using the Fisher’s exact test on Epi-Info version 2.3.1 (http://www.openepi.com) 
(Appendix 7.5). 
In order to understand if these successful groups were exclusive to EAEC or had evolved with other 
E. coli pathotypes, the public database was compared against each of the 17 Cplxs to rule out groups 
with a high association with other pathotypes. Extra-intestinal sites of infection for ExPEC  (1.1.2) 
included wounds, meningitis, external sources (ExPEC_Vag) and urinary pathogenic E. coli (UPEC). 
Antibiotic resistance E. coli including extended beta-lactamase producing E. coli  (e.g. presence of 
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CTX-M-15, AmpC CYM-2, c CMY-2, NDM-1, CTX-M-32 & OXA-48 genes). Other pathotypes included 
avian pathogenic E. coli (APEC) ,non-pathogenic commensal strains and E. coli with no defined 
pathotype. 
The 17 Cplxs described in this study were compared against all E.coli complexes on the public 
database and data from this study was tested using a fisher exact test (Fisher 1922) on Epi-Info 
version 2.3.1 (http://www.openepi.com) (Appendix 7.5), for significance of the 17 Cplxs being 
associated with EAEC over other pathotypes of E.coli. 
3.2.5  Statistics 
Fishers Exact test (Fisher 1922) was used to test the significance of the groups being associated with 
cases and controls. Fisher's exact test is a statistical significance test used in the analysis of 
contingency tables. Although in practice it is employed when sample sizes are small (<5 samples), it 
is valid for all sample sizes. The test is useful for categorical data and was used in this study to 
investigate disease versus carriage groups; it is used to examine the significance of the association 
(contingency) between the two kinds of classification (Altman 1991). In this case, the aim was to 
determine whether a named disease group is associated with cases or whether a carriage group was 
associated with control.  
 
3.2.6 Impact of novel approach on public health 
Application of MLST to investigate EAEC population structure in a public health setting was assessed 
in two ways: 
1. MLST was performed on  the ESBL-producing strains from the SAFEFOODERA study to 
determine if EAEC is associated with an animal reservoir and if there are any lineages of 
EAEC that are particularly resistant to antibiotics. 
2. Using MLST in EAEC outbreak investigations as a typing method and to determine if there 
are certain lineages associated with outbreaks. (Wirth et al. 2006) (Methods 3.2.3).  
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3.2.6.1 Detection of EAEC in other E. coli populations 
The 359 ESBL-producing E. coli isolates used in this study were from the SAFEFOODERA collection 
(Wu et al. 2013) (www.safefoodera.net) and isolated in Germany (73), The Netherlands (158) and 
the UK (128). Isolates were obtained from multiple sources, including cases of humans infections 
(140), poultry (137), cattle (63), pigs (16) and dog/cats (3). Isolation sites included urine (97), faeces 
(92), cattle and poultry meat (64), caecum (51), organs (19), blood (8) and other multiple single 
sources (28). Isolates had been stored in Luria Bertoli broth and stored at -20oC, having been 
collected between 2005 and 2009. MLST was carried out as described in method section 3.2.3 and 
3.2.4. Isolates were grown aerobically overnight on Columbia blood agar plates (5% sheep blood) 
[PHE,Media] aerobically at 37oC. DNA was extracted using the Wizard kit [Promega, Mannheim, 
Germany] (3.2.3.1), stored at 4oC, and used as template for real-time PCR assays. DNA was screened 
for the presence of the EAEC transport regulator gene (aggR), located on the EAEC plasmid (Nataro 
et al. 1994). AggR primers and probes were designed for this study (AggR_F 5’-
CCATTTATCGCAATCAGATTAA-3’ AggR_R 5’-CAAGCATCTACTTTTGATATTCC-3’, AggR_P Cy5-
CAGCGATACATTAAGACGCCTAAAGGA-BHQ) (Chattaway et al. 2014a). Positive control strain used 
included E60725 (O92:H33).The amplification conditions included an initial denaturation of 95 oC for 
5 min, then 94 oC for 1 min, 55 oC for 1 min and 72 oC for 1 min for 30 cycles, and a final extension of 
72 oC for 10 min on a Rotagene [Qiagen, Manchester, UK].  
3.2.6.2 MLST in the investigation of outbreaks 
Outbreak strains included (Table 3.1) were colour coded in the population structure from this study 
to ascertain if there were particular lineages associated with outbreaks or if EAEC outbreaks are 
easily resolved via MLST.    
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3.3.  Results  
3.3.1 Population Structure Results and EAEC Group Assignments 
3.3.1.1 Sequence Type distribution and complex structure 
Of the 564 EAEC strains studied, there were 126 different sequence types , with additional new 
sequence types including 57 single locus variants (SLV), 20 double locus variants (DLV) and two triple 
locus variants (TLV) (Table 3.2). There were 17 main complexes containing 4 or more strains of EAEC 
totalling 358 strains with the top five complexes including ST10 Cplx (39%, 141/358), ST31 Cplx and 
ST40 Cplx (12%, 42/358), ST394 Cplx (7%, 26/358) and ST295 Cplx and ST38 Cplx (6%,21/358) (Figure 
3.1). There were 35 isolates (6.2%, 35/564) that contained one or more new alleles (40 new alleles in 
total) not previously found. All new alleles were deposited to the public database 
(http://mlst.ucc.ie/mlst/dbs/Ecoli) for a new allele and/or ST assignment. 
The population of EAEC strains from this study showed a complex clonal structure where multiple 
lineages have arisen. Some of these lineages have been successful and expanded into large groups 
and adapted with multiple mutations. Examples include the clonal complex ST10, 200,130, 394 & 38. 
Other lineages have expanded, apparently in isolation, and are not linked to other groups (ST678, 
720 and 1891) and many singletons (i.e. a ST that is not linked to any SLV) exist  and are unlinked to 
any complexes. Generally, the diversity of these strains was observed on a global scale, however, 
some STs were associated with a specific geographical location such as Bangladesh (ST1891 & 720) 
and UK (ST40, 1380 and 165). There were no representative groups (i.e.four or more strains) that 
were only found in the Nigeria collection but there were multiple exclusive ST consisting of a 
maximum of two strains (Figure 3.2). Some STs were found in two countries, such as Bangladesh and 
the UK (ST200, 295 and 678), Bangladesh and Nigeria (ST 484 and 155), and others were dispersed 
throughout all three countries (ST10, 130, 31, 34, 38, 278 and 394) (Figure 3.2, Appendix 7.1).   
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Table 3.2  Summary of Sequence Types found in EAEC dataset 
Sequence Type Complex No. % 
10 10 91 16.1 
34 10 38 6.7 
200 40 31 5.5 
31 31 25 4.4 
38 38 21 3.7 
394 394 18 3.2 
295 295 16 2.8 
40 40 12 2.1 
130 31 12 2.1 
278 278 10 1.8 
678 None 10 1.8 
484 168 8 1.4 
1380 394 8 1.4 
3748 295 6 1.1 
48 10 6 1.1 
43 10 6 1.1 
449 31 5 0.9 
720 None 5 0.9 
1891 None 5 0.9 
155 155 5 0.9 
159 746 4 0.7 
30 30 4 0.7 
349 349 4 0.7 
165 165 4 0.7 
226 226 4 0.7 
SLV Various 57 10.1 
DLV Various 10 1.8 
TLV Various 2 0.4 
414,746,841,501,206,167,315 Various 3 0.5 
433,362,455,499,480,1114,2186, 
1295,435,495,456,3570,467,481, 157,459,474,1326,218,58 
Various 2 0.4 
2166,219,448,223,3107,3051,504,120,520,436,475,510, 
488,556,460,483,461,23,466,423,513,489,511,473,940, 
424,438,476,512,426,471, 557,464,52,477,515,468,437, 
507,506,454,450,434,485,478,46,500,502,469,453,444, 
144,728,496,491,425,422,486,2517,73,937,117,1657, 
111,152,329,227,164,1136, 2067,101,3670,1490 
Various 1 0.2 
 
Table 3.2 Sequence types found in EAEC dataset (N=564), shared complexes are colour coded, 
ST10 Cplx (red), ST40 Cplx (green), ST394 Cplx (blue), ST295 Cplx (purple), ST31 Cplx (orange)   
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Figure 3.1 Distribution of Complexes in EAEC dataset (N=358) 
 
 
 
Figure 3.1: Pie Chart showing the main complexes containing 4 or more EAEC strains comprising of 63.5% 
(358/564) of the dataset. 
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Figure 3.2 Minimal spanning Tree of EAEC pathogenic disease groups in relation to geographical location 
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  Nigeria (121) 
  UK (254) 
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             Triple Locus Variant 
10 
34 
484 
295 
200 
40 
278 
678 
38 
394 
31 
130 
720 
1891 
349 
746 
30 
501 
155 
Figure 3.2: Minimal spanning tree of the 564 EAEC used in this study colour coded by isolates from Bangladesh (red), Nigeria (purple) and UK (green) 
and the prototypical 042 strain from Peru (yellow). Complexes shaded in grey consist of single locus variants (SLV). MSTree shows that complexes are 
mainly distrusted in at least two countries with only a few small groups geographically specific. 
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3.3.1.2 EAEC groups associated with disease and carriage  
The population structure of EAEC is heterogeneous (Figure 3.1, 3.2 and 3.3) comprising of 17 
successful Cplxs of four or more EAEC isolates (Table 3.3). EAEC isolates from cases and controls are 
dispersed throughout the population structure, ST720 is the only successful group that solely 
contains isolates from cases (Figure 3.3). 
 
There was a 2.7:1 ratio of case isolates to controls in this study, groups with a higher ratio in cases 
were deemed associated with cases and groups with a higher ratio in controls were deemed 
associated with controls. Groups that were below this ratio were deemed to not be associated with 
cases or controls. This resulted in eleven groups being associated with disease (ST10, 40, 746, 155, 
678, 278, 30, 165, 1891, 720 & 501 Cplx), two groups associated with carriage (ST31 & 349 Cplx) and 
four groups not associated with disease or carriage (ST295, 38, 394 & 168 Cplx).  
 
The disease complexes and carriage complexes were combined and statistical analysis showed both 
of the disease and carriage complexes were statistically significant (P = <0.001 and P = 0.001 
respectively). 
 
Individual complexes were then tested for statistical association with disease or carriage which 
showed ST10 Cplx and ST40 Cplx were independently statistically significantly (P = 0.01 & 0.03 
respectively) associated with disease. ST31 Cplx was independently statistically significantly (Fishers 
chi-square, p=0.005) associated with carriage (Table 3.3).  
 
Situating the 17 successful EAEC complexes identified in this study within the global E. coli phylogeny 
as represented in the public database (Table 3.4) showed that with the exception of ST155 Cplx, all 
complexes were significantly associated with being EAEC pathotype (P≤0.01). 
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Figure 3.3 Minimal spanning Tree of EAEC pathogenic disease groups in relation to case or control 
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  Controls (152) 
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Figure 3.3: Minimal spanning tree of the 564 EAEC used in this study colour coded by isolates from cases (red) and controls (yellow). Complexes shaded 
in grey consist of single locus variants (SLV). Trees shows that complexes usually contain a mixture of cases and controls with few STs being exclusively 
associated with cases (ST720, ST30). 
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Table 3.3  Assessment of EAEC groups associated with cases or controls 
 
EAEC Group ST 
complex 
UK Nigeria Bangladesh Case Control Total Total % of 
EAEC 
CASE: 
CONTROL 
% 
P Value 
Group 1 10 128 24 21 138 35 173 30.7 80:20 0.01 
Group 2 40 39 1 12 44 8 52 9.2 85:15 0.03 
Group 3 31 27 11 12 28 22 50 8.9 56:44 0.005 
Group 4 295 13 2 21 24 12 36 6.4 67:33 0.24 
Group 5 38 3 4 21 19 9 28 5.0 68:32 0.33 
Group 6 394 9 10 8 20 7 27 4.8 74:26 0.56 
Group 7 746 9 1 1 10 1 11 2.0 90:10 0.16 
Group 8 155 0 1 9 9 1 10 1.8 90:10 0.2 
Group 9 678 
(ST484) 
8 0 2 9 1 10 1.8 90:10 0.2 
Group 10 278 7 1 2 9 1 10 1.8 90:10 0.2 
Group 11 168 0 4 5 5 4 9 1.6 56:44 0.2 
Group 12 30 7 0 0 8 0 8 1.4 100:0 0.08 
Group 13 165 3 0 5 7 1 8 1.4 83:17 0.32 
Group 14 1891 0 0 5 4 1 5 0.9 80:20 0.59 
Group 15 720 0 0 5 5 0 5 0.9 100:0 0.21 
Group 16 501 2 2 0 3 1 4 0.7 75:25 0.71 
Group 17 349 0 1 3 1 3 4 0.7 25:75:25 0.06 
Totals  - 248 62 132 343 107 442  -  -  - 
Whole Data Set   - 273 121 169 412 152 564  -  -  - 
  
Table 3.3: Table showing the data of EAEC numbers according to complex, country and association with case or control. Groups are in order of complex size 
from the largest to smallest. Probability (Fishers exact test) of the group being significantly associated with case or control is tabulated at the end. There are 
two groups statistically associated with cases (ST10 Cplx and ST40 Cplx) and one group statistically associated with controls (ST31 Cplx). 
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Table 3.4  Assessment of EAEC associated with other pathotypes 
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Group 1 10 149 42 17 22 4 0 0 5 141 83 234 463 272 81.6 41.3 191 <0.001 
Group 2 40 51 8 4 0 3 0 0 0 2 0 66 68 9 89.4 86.8 59 <0.001 
Group 3 31 39 19 0 0 0 0 0 0 6 8 58 72 14 100.0 80.6 58 <0.001 
Group 4 295 34 1 3 0 0 0 0 1 0 2 38 41 6 92.1 85.4 35 <0.001 
Group 5 38 24 4 0 0 1 0 0 0 10 27 29 66 38 96.6 42.4 28 <0.001 
Group 6 394 17 11 0 0 0 0 0 0 3 2 28 33 5 100.0 84.8 28 <0.001 
Group 7 746 10 0 0 4 0 0 0 0 0 1 14 15 5 71.4 66.7 10 <0.001 
Group 8 155 9 2 1 3 1 1 0 2 27 22 17 68 57 64.7 16.2 11 0.11 
Group 9 678 10 0 0 0 0 0 0 0 1 0 10 11 1 100.0 90.9 10 <0.001 
Group 10 278 9 0 0 0 0 1 0 0 0 0 10 10 1 90.0 90.0 9 <0.001 
Group 11 168 5 4 0 0 0 1 2 0 10 8 12 30 21 75.0 30.0 9 0.003 
Group 12 30 8 2 1 0 0 0 0 0 0 0 11 11 1 90.9 90.9 10 <0.001 
Group 13 165 8 0 1 7 3 0 0 0 6 1 19 26 18 42.1 30.8 8 0.005 
Group 14 1891 5 0 0 0 1 0 0 0 0 0 6 6 1 83.3 83.3 5 <0.001 
Group 15 720 5 0 0 0 1 0 0 0 0 1 6 7 2 83.3 71.4 5 <0.001 
Group 16 501 2 1 0 0 0 0 0 0 0 0 3 3 0 100.0 100.0 3 <0.001 
Group 17 349 3 1 2 0 0 0 0 1 0 2 6 9 5 66.7 44.4 4 0.01 
 
 
Table 3.4: Table showing EAEC groups in association with other E. coli pathotypes in the public database (all data from 18.12.2013). Nigerian dataset is 
included under the public database, UK and Bangladesh dataset is included under EAEC PhD. See section 3.2.4 for description of pathotypes included. Total 
EAEC included is 719 strains (564 from PhD plus 155 EAEC from public database strains), other E. coli total is 5955 strains (6674 minus 719 EAEC and minus 
141 Shigella isolates included in the public database). Probability (Fishers exact test) of the group being significantly associated with EAEC or other 
pathotypes is tabulated 
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3.3.2 Impact of novel approach on public health 
3.3.2.1 Detection of EAEC in other E. coli populations 
From the 359 ESBL-producing E. coli isolates screened, eleven isolates contained the aggR gene, ten 
of which were isolated from extra-intestinal sources from human cases. There were no EAEC isolated 
from animals (Table 3.5, Figure 3.4). Six isolates were ST38 and were statistically associated with 
causing extra-intestinal infections (P=<0.001, Fisher exact test). 
Table 3.5  Characteristics of EAEC isolated from ESBL producing E. coli 
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ESBL-723 EAEC OR:H30 38 38  UK Human Urine 
ESBL-746 EAEC 
O125ac:H
30 38 38  UK Human Urine 
ESBL-884 EAEC O19a:H30 38 38  UK Human Urine 
ESBL-831 EAEC O19a:H30 38 38  UK Human Urine 
ESBL-815 EAEC O19a:H30 38 38 UK Human Blood 
ESBL-26 EAEC O153:H30 38 38  Netherlands Human Urine 
ESBL-221 EAEC O92:H33 34 10  Germany Human Faeces 
ESBL-45 EAEC O?:H26 58 155  Netherlands Human Urine 
ESBL-46 EAEC O?:HH- 694 None Netherlands Human Urine 
ESBL-48 EAEC O15:H1 545 None Netherlands Human Urine 
ESBL-64 EAEC O?:H23 224 None Netherlands Human Urine 
 
Table 3.5: Characteristics of EAEC isolated from the 359 ESBL-producing E. coli isolates screened for aggR. Out 
of eleven EAEC, six were from ST38 taken from urine and blood samples and were statistically with causing 
extra-intestinal infections. 
 
Key: Pathotypes: EAEC – Enteroaggregative E. coli Serotyping: R – rough reaction, O? – O unidentifiable, H- not 
motile, Genotyping: ST – Sequence type, Complex – ST complex comprising of single locus variants (SLVs). 
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Figure 3.4 Venn diagram of diarrhoeagenic E. coli Source Attribution of 359 ESBL screened 
 
 
 
 
 
Figure 3.4: Venn diagram showing on overview of where EAEC was isolated in comparison to other 
diarrhoeagenic E. coli including EPEC and STEC. ESBL producing EAEC was predominately isolated from extra-
intestinal sources rather than diarrhoeagenic sources indicated that some EAEC such as ST38 have 
pathoadapted to extra-intestinal niches. 
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3.3.2.2 MLST in the investigation of outbreaks 
Overlaying outbreaks investigated at the Gastrointestinal Bacteria Reference Unit indicates that 
strains of EAEC within a single outbreak are rarely resolved into one background including serotype 
or ST and are distributed across multiple complexes. The exception being the O111 and O104 
outbreaks associated with ST40 and ST678 Cplx respectively which was shown to be a point source 
outbreak (Chattaway et al. 2011;Dallman et al. 2012). ST278 was associated with three outbreaks 
from 1994-2013 (Figure 3.5, Table 3.6).  
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Table 3.6  Serotype and ST outbreak strains 
Isolate Source Somatic Flagella ST ST Complex Year Country 
E98527 Outbreak A 19 H- 1114 ST165 Cplx 1994 UK 
E98529 Outbreak A O? 18 31 ST31 Cplx 1994 UK 
E96386 Outbreak B 73 18 1380 ST394 Cplx 1994 UK 
E96390 Outbreak B O? H- SLV ST10 Cplx 1994 UK 
E96483 Outbreak B O? 33 34 ST10 Cplx 1994 UK 
E96485 Outbreak B 134 27 31 ST31 Cplx 1994 UK 
E96487 Outbreak B O? H- 34 ST10 Cplx 1994 UK 
E97590 Outbreak B 73 13 48 ST10 Cplx 1994 UK 
E97820 Outbreak B 62 30 34 ST10 Cplx 1994 UK 
E97900 Outbreak B O? H- 34 ST10 Cplx 1994 UK 
E97470 Outbreak C 86 34 10 ST10 Cplx 1994 UK 
E101396 Outbreak D 98 H- 278 ST278 Cplx 1995 UK 
E101406 Outbreak D 98 H- 278 ST278 Cplx 1995 UK 
E101621 Outbreak D 98 H- 278 ST278 Cplx 1995 UK 
E89095 Outbreak  E 80 27 SLV ST155 Cplx 1998 Bangladesh 
E89096 Outbreak  E 113 H- 159 ST746 Cplx 1998 Bangladesh 
E89099 Outbreak  E 28ab 18 1657 None 1998 Bangladesh 
E89102 Outbreak  E 44 18 394 ST394 Cplx 1998 Bangladesh 
E89104 Outbreak  E 141 49 111 None 1998 Bangladesh 
E89105 Outbreak  E 80 27 58 ST155 Cplx 1998 Bangladesh 
E89106 Outbreak  E R 7 1891 None 1998 Bangladesh 
E89107 Outbreak  E O? 27 278 ST278 Cplx 1998 Bangladesh 
E89111 Outbreak  E 89 18 10 ST10 Cplx 1998 Bangladesh 
E89112 Outbreak  E 69 11 SLV ST295 Cplx 1998 Bangladesh 
E89114 Outbreak  E 44 18 449 ST31 Cplx 1998 Bangladesh 
E89115 Outbreak  E 162 H- 278 ST278 Cplx 1998 Bangladesh 
H125280572/573* STEC Outbreak O104 4 678 ST678 Cplx 2011 Germany 
H120680226 
H120720504* 
Household Outbreak O111 2 40 ST40 Cplx 2012 Ireland 
H131920214 Spice Outbreak O? 19 746 ST746 Cplx 2013 UK 
H131920215 Spice Outbreak 20   278 ST278 Cplx 2013 UK 
H131920216 Spice Outbreak 104 4 678 None 2013 UK 
H131920217 Spice Outbreak 33 16 295 ST295 Cplx 2013 UK 
H131920218 Spice Outbreak 104 4 678 None 2013 UK 
H131920219 Spice Outbreak 131 27 10 ST10 Cplx 2013 UK 
H131920220 Spice Outbreak 131 27 10 ST10 Cplx 2013 UK 
H131920221 Spice Outbreak 20 19 278 ST278 Cplx 2013 UK 
H131920222* Spice Outbreak 19a 30 38  ST38 Cplx 2013 UK 
H131941060 Spice Outbreak 111ac 4 226 ST226 Cplx 2013 UK 
H131941061 Spice Outbreak 55 19 10 ST10 Cplx 2013 UK 
H131941062 Spice Outbreak 104 4 678 None 2013 UK 
H131941063 Spice Outbreak 104 4 678 None 2013 UK 
H131941064 Spice Outbreak O? 21 227 ST10 Cplx 2013 UK 
H131941065 Spice Outbreak 63 12 1664 ST295 Cplx 2013 UK 
H131941070 Spice Outbreak 104 4 678 None 2013 UK 
H131941071 Spice Outbreak 131 27 10 ST10 Cplx 2013 UK 
H131941072 Spice Outbreak 131 27 10 ST10 Cplx 2013 UK 
H131941073 Spice Outbreak 131 27 10 ST10 Cplx 2013 UK 
H131941074 Spice Outbreak 131 27 10 ST10 Cplx 2013 UK 
 
 
Table 3.6: Serotype and ST results of strain in outbreaks. 
 * denotes additional outbreak strains not included in the original dataset 
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Figure 3.5  EAEC outbreaks in the EAEC population structure 
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Figure 3.5: Minimal spanning tree of the 564 EAEC used in this study colour coded by outbreaks investigated by GBRU. Complexes shaded in grey consist 
of single locus variants (SLV). Outbreaks O104 and O111 were shown to be from one ST whereas the other outbreaks are distributed among multiple 
complexes. ST38 was the only complex not associated with any outbreaks whereas ST278 was associated with three separate outbreaks. 
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3.4.  Discussion  
3.4.1 There are successful multiple lineages of EAEC groups that are globally 
distributed 
This study has shown there are successful, statistically significant EAEC clusters associated with 
disease or carriage. These groups included the EAEC published groups in the public database and 
comprised ST10, 40, 38, 394 and 349 (Okeke et al. 2010). This study also identified MLST complexes 
that were not, represented as successful (i.e. more than four strains as defined in this thesis) in the 
public database including ST130, 295, 720, 484 and 678. This indicated that this data, represents a 
snapshot of the population structure of EAEC from three different countries. The addition of strains 
across the globe would expand the number of successful established EAEC groupings. It should be 
noted that the public database is biased towards E. coli of interest to the scientific community, such 
as pathogens and antibiotic resistant strains, with less representation of commensal strains and it 
seems likely that not all isolates were tested for the aggregative phenotype. A larger, better defined 
population may show “non-EAEC” (i.e. other E. coli pathotypes) present in more of the MLST 
complexes.  
 
Population structure analysis of EAEC in this study using MLST showed the presence of independent 
multiple lineages of E. coli (i.e. groups that did not have common ancestor within the population). 
Although there are some STs restricted to one country, the majority of complexes contain isolates 
from at least two countries indicating global distribution of clusters (Figure 3.2). The explanation for 
the small exclusive geographical groups could be adaptation to a specific, local ecological niche, 
sampling bias or small sample size. The global distribution of the MLST complexes is most likely due 
to human travel and migration. The independent appearance of the EAEC phenotype in discrete 
complexes across the E. coli phylogeny would appear to represent homoplasy - or convergent 
evolution - suggesting that having the EAEC phenotype represents a biological advantage in certain 
bacterial genetic backgrounds.  
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3.4.2 The definition of ‘case’ or ‘control’ is ambiguous 
There were 17 successful or prevailing EAEC Cplxs defined in this study (i.e. more than four strains 
and representing 2.5% of the known EAEC population) but there were only two Cplxs statistically 
associated with disease (ST10 Cplx and ST40 Cplx) and one group associated with carriage (ST31 
Cplx), with the majority of groups having a mixture of ‘cases’ or ‘controls’. EAEC belonging to the 
same ST complex may have been isolated form a case or a control and therefore the presence of the 
pathogen is not always associated with GI symptoms and the presence of EAEC in the stool may be 
associated with asymptomatic presentation.  There are multiple possible reasons for this including 
general host susceptibility (often associated with age or physiological conditions), host acquired 
immunity, virulence gene content, co-infections, post infection carriage and, as shown in this 
chapter, genetic background. Another consideration is due to sample size, for example complexes 
containing less than 50 strains were not statistically significant. This does not mean that they are not 
clinically relevant as the sample size in these groups maybe too small for significance and this may 
change as the Cplxs increase in size. 
 
The ability for EAEC to retain the plasmid may also play a role in establishing a successful Cplx and 
the population structure indicates that certain plasmids are stable in certain backgrounds while 
others (such as singletons) are not and therefore do not expand into a successful EAEC Cplx. The 
multiple plasmid compatibility types (Okeke et al. 2010) harboured by different strains of  EAEC 
indicate that the plasmids of EAEC also have a complex ancestry, possibly suggesting independent 
but convergent co-evolution of these plasmids with the EAEC strains, that has resulted in a mosaic 
profile of similar gene sets on different plasmids (Dallman et al. 2014), this could explain why the 
plasmids and gene content are so heterogeneous. It is suggested that strains with different 
phylogenetic backgrounds (determined by ST)  may have an affinity for these plasmids with specific 
compatibility types. 
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Any analysis based on the concept of an EAEC case or control being defined as isolating EAEC from 
symptomatic or asymptomatic subjects will produce a complicated picture as shown in the 
case/control population structure (Figure 3.3). With the complex nature of EAEC, it is likely, that 
some of the ‘case’ or ‘control’ definitions are misleading and that a strain from a  ‘control’ subject 
may be a “disease” strain but was misidentified in the original study, due to  host acquired immunity 
(Nataro et al. 1995). An EAEC strain from a ‘case’ may have characteristics of a “carriage” strain (in 
terms of the combination of virulence factors or the lineages it belongs to) but is classed as a “case” 
strain because the individuals has diarrhoea caused by a co-infection (Chattaway et al. 2013).  During 
the IID study, over 25% of EAEC cases were co-infected with norovirus and over 5 % with Shigella 
(Figure 2.4).   
 
The discovery of the multiple compatibility EAEC plasmids containing the genes responsible for the 
EAEC phenotype introduces another layer of heterogeneous complexity with this pathotypes. The 
plasmid can be acquired by any E. coli strain irrespective of whether it is pathogenic or commensal. 
Despite the issues associated with the definition of ‘case’ or ‘control’, the analysis in this study 
describes the population structure that can be used to explore EAEC causing clinical disease and to 
build an understanding on EAEC Cplxs that are public health threats. 
 
3.4.3 Application of EAEC MLST population structure analysis has had an important 
impact on public health 
3.4.3.1 EAEC have pathoadapted to extra-intestinal niches 
Using the applications from this study, an ESBL producing E. coli population structure was created 
(Wu et al. 2013) and screening for aggR, highlighted that ST38 ESBL producing EAEC were associated 
with extra-intestinal infections (Table 3.5, Figure 3.4) (Chattaway et al. 2014a). ST38 is a successful 
EAEC diarrhoeagenic group as shown in this study and others (Okeke et al. 2010). According the 
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public database, the only other diarrhoeagenic pathotype in this ST is one STEC (O1:H15) (from a 
pigeon in Germany, the method of testing for pathotype assignment is unknown). The other 
pathotypes are urinary tract infections (UTI) and antibiotic resistance E. coli including the ESBLs 
producers (ESBL producers in the MLST database are usually isolated from the urinary tract or other 
extra-intestinal sites). It seems likely that EAEC strains within ST38 Cplx have adapted to cause 
disease in both the gut and the urethra/bladder. These strains in the ST38 complex were further 
investigated and contained multiple EAEC and ExPEC virulence factors: AAFI – EAEC fimbriae type, 
aggR - EAEC regulatory gene, - aap, EAEC dispersin gene, traT, -serum resistance, fimH, - fimbriae in 
E. coli , fyuA and irp2 –iron acquisition receptors (Chattaway et al. 2014a). Thus the ST38 strain 
described here is likely to have acquired the two phenotypes (UPEC and EAEC) independently 
suggesting the emergence of a UPEC/EAEC hybrid strain. It is possible that the genetic background of 
E. coli ST38 was stable enough to host the EAEC plasmid. The presence of the plasmid facilitated 
survival in the gut through increased adherence and has acquired UPEC virulence factors facilitating 
the exploitation of an extra-intestinal niche, the urinary tract.  
 
Despite the historical characterisation of numerous virulence factors, there is no single genetic 
feature that currently defines EAEC or UPEC isolates (Wiles et al. 2008). As the EAEC ST38 strain had 
between four and seven ExPEC-associated virulence factors, it is suggested that by epidemiological, 
microbiological and molecular content, these EAEC ST38 strains should be considered an ExPEC 
associated with uropathogenic infections (Chattaway et al. 2014a;Wiles et al. 2008). 
 
ExPEC EAEC is an important emerging group for several reasons, (i) the multiple drug resistance 
associated with this group can impact on patient care, (ii) the potential of this pathogen to cause 
multiple infections, such as gastrointestinal disease and UTIs, and (iii) the potential of this group to 
evolve into a hypervirulent strain causing outbreaks. EAEC has already been shown to acquire 
additional virulence genes evolve into hypervirulent strains, for example the EAEC/STEC  hybrid 
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which has led to multiple outbreaks of HUS (Buchholz et al. 2011;Dallman et al. 2012). Although 
STEC strains have not been associated with extra-intestinal infections, there is the potential for EAEC 
ST38, which can cause disease in both the gastrointestinal tract and the urinary tract, to acquire stx1 
and/or stx2 genes and thus cause severe disease. 
3.4.3.2 There are successful complexes associated with EAEC outbreaks 
Unlike Salmonella, in which the presence of this organisms in a faecal specimen is almost always 
associated with GI symptoms, EAEC is frequently isolated from both cases and controls.  EAEC 
cannot be definitively defined as a pathogen. The increased understanding of the EAEC npopulation 
structure gained during this study, has facilitated population structure approach being used in 
outbreak investigations of EAEC. For example, seeing where adaptation and integration of EAEC with 
other E. coli pathotypes (such as STEC) and causing severe disease fits within the structure . This has 
been shown in recent outbreaks including a household outbreak of STEC/EAEC hybrid ST40 
(O111:H21) (Dallman et al. 2012) and the infamous ST678 STEC/EAEC hybrid (O104:H4) outbreak in 
Germany (Chattaway et al. 2011). 
 
In these outbreaks, an EAEC strain acquired the stx phage and increased the pathogenic potential 
and disease severity of the strain. The outbreaks were clonal and caused by one strain. In the cases 
of investigating other EAEC outbreaks, tracing the source and causative EAEC strains is more 
complicated. Several outbreaks of EAEC have been investigated in the UK over the last 20 years: 
Outbreaks A-E (Table 3.1) (small EAEC outbreaks that occurred between 1994-1998) and a recent 
EAEC outbreak from 2013 with an epidemiological link to contaminated curry leaves, known as the 
street spice outbreak (Dallman et al. 2014). Serological typing and MLST showed the strains were 
variable (Table 3.6).  
 
Characterisation of EAEC by MLST in isolation is not a useful technique, for example knowing the ST 
of an EAEC without understanding the heterogeneous nature of EAEC could lead to false 
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assumptions. In the case of STEC O157 in which the genetic background is consistently ST11, the 
detection of this ST Cplx via MLST give a good indication that that strains was STEC O157. In the case 
of EAEC, there can be multiple complexes and they may relate to a different pathotypes and so a 
polyphasic approach of using MLST and EAEC virulence genes, such as the aggR gene would be 
required. Understanding the population structure of EAEC can help ascertain which strains may have 
caused disease. What the population structure shows, is that you get dominant ST complexes 
associated with outbreaks and other sporadic STs. Considering the complex nature of EAEC as 
described in this study, it is likely that the dominant STs may have particular traits associated with 
causing outbreak situations and are likely to be more pathogenic. Strains associated with sporadic 
cases and those that do not prevail in the population could be “carriage” or low pathogenicity EAEC 
strains or those that have transiently acquired  the EAEC plasmid. Alternatively, they may have 
caused the diarrhoea due to factors such as low immunity, such as HIV cases (Mayer and Wanke 
1995;Medina et al. 2010) but are not truly pathogenic (like in the volunteer studies (Nataro et al. 
1995)). 
  
Analysis of these outbreaks and symptomatic cases indicated there were three main complexes 
successful in outbreaks and likely to be important EAEC ST complexes (Figure 6.2): ST10 complex 
(Outbreak B, street spice outbreak), shown to be statistically associated with disease in under 5 
years old (Okeke et al. 2010), and statistically associated with disease in this study (Table 3.3). ST678 
(street spice outbreak, German outbreak) notoriously associated with the German outbreak 
(Chattaway et al. 2011) and a dominant ST in the street spice outbreak (Dallman et al. 2014). ST278 
(outbreak D, E and street spice outbreak) has recently been associated with the street spice 
outbreak (Dallman et al. 2014) and is a dominant ST associated with three outbreaks. Isolating ST278 
EAEC strains from the IID1 and Nigerian studies indicate that these strains continue to circulate in 
the background but also may have specific characteristics that increase its potential to cause 
outbreaks. 
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The EAEC street spice outbreak had a similar source (dried curry leaves) to the ST678 outbreak which 
was linked to fenagreek sprouting seeds in that they were both associated with contaminated seeds 
and spices (Dallman et al. 2014). Studies have shown that EAEC adhere to vegetables, such as salad 
leaves (Berger et al. 2009) and this might explain why they cause outbreaks associated with this type 
of foodstuff.  
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3.5 Summary 
 
The novel approach described in this chapter of using a case control approach to assess the 
population structure of potentially pathogenic EAEC in multiple countries, has shown EAEC to have a 
complex population structure and diverse phylogeny. Statistical analysis of the complexes indicated 
certain complexes to be statistically associated with GI symptoms such as ST 10 and ST40 Cplx. 
Understanding the EAEC population from this study has had a positive impact on public health in 
terms of understanding EAEC Cplxs associated with outbreaks (Chattaway et al. 2011;Dallman et al. 
2012;Dallman et al. 2014) and discovering a pathoadaptive EAEC ST38 group that causes extra-
intestinal infections (Chattaway et al. 2014a). It is likely that further studies may reveal more 
regarding EAEC high pathogenic complexes. MLST as an analytical tool alone may not define 
pathogenic strains of EAEC and a more robust and polyphasic approach is recommended. A 
suggestion would be to combine the presence of putative EAEC virulence factors with ST complex to 
get best indicator of pathogenic potential as explored in Chapter 5. 
 
The complex ancestry of EAEC indicates that there is not one ancestral complex that has expanded, 
but multiple ancestral complexes indicating possible convergent evolution of this successful 
phenotype (Chattaway et al. 2014b). However, the assessment of MLST alleles described in this 
chapter cannot indicate how these have occurred or whether this is predominantly due to mutation 
or recombination. To understand the evolutionary events that have driven the success of EAEC, a 
look into the exact sequence mutations of the different genes are required. Chapter 4 uses an 
evidence based Bayesian model, the genetic evolution of the dataset was assessed to look at the 
mutation types within the genes, understand how the EAEC groups have evolved and attempt to 
explain phylogenetic diversity observed during this study. 
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Chapter 4 - Inference of Bacterial Microevolution 
4.1 Background  
 
Chapter 3 laid a foundation for understanding the population structure of EAEC demonstrating the 
diversity of the group but also highlighting certain prevailing or successful lineages and suggesting 
that certain ST complexes were more likely to be associated with cases with GI symptoms than 
others. The evolution of these successful groups warrant further investigation.  
 
Defining the sequence variation within the sequenced housekeeping genes is a well-established and 
simple method which requires input of sequence data into the E. coli MLST database 
(http://mlst.ucc.ie/mlst/dbs/Ecoli/). Interpreting that variation in terms of genetic evolution requires 
sophisticated mathematical models. ClonalFrame is a computer package for the inference of 
bacterial microevolution using multilocus sequence data and looks at the sequence data from each 
gene as opposed to allele analysis. It is a Bayesian statistics style model in which the inference of 
probability is updated as additional evidence is learned. The model constructs evolutionary histories 
by taking both mutation and recombination into account (Didelot & Falush 2007). The programme 
identifies clonal relationships between the members of a sample, and homologous recombination 
events that may have disrupted the clonal inheritance; it takes both point mutation and 
recombination into account. (Didelot & Falush 2007). It enables us to see close relationships 
between strains that may be obscured by recombination. This approach was used to understand 
how the genetic events in core genomic background, (represented by MLST) of the strains analysed, 
have influenced the evolution of the defined EAEC disease and carriage groups. 
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4.2. Methods  
4.2.1 Clonal Frame Analysis 
The same dataset described in Chapter 3 was used (Table 3.1). Clonal Frame analysis was carried out 
(http://www.xavierdidelot.xtreemhost.com/clonalframe.htm ) to investigate the relationships of the 
different sequence type complexes. The Graphic User Interface in the ClonalFrame programme was 
used to construct 75% majority-rule consensus trees, mutational (theta) and recombination rates. 
Other analysis included the measure of the frequency at which recombination occurs relative to 
mutation (ρ/θ). The relative effect of recombination on the genetic diversification of populations, 
ratio r/m in which the ratio of rates at which nucleotides become substituted as a result of 
recombination and mutation (Vos & Didelot 2009) was also used. Finally, the external to internal 
branch length ratio was computed which gave the inferred expected values against the coalescent 
and actual ratios. Analysis was split into assessing the Bangladesh and Nigeria case control studies 
and UK clinical data set for comparison against the entire dataset. 
 
4.2.2 Placing EAEC in the E. coli phylogeny 
Multi-locus sequence analysis (MLSA) was performed by concatenating MLST sequence alleles of the 
EAEC from this dataset and all sequence types representative of the E. coli phylogeny. These were 
aligned and clustered (MEGA V 5.1) and the genetic relationship of isolates designated as assessed  
in the context of all E. coli using a neighbour joining tree phylogeny (MEGA V 5.1 and FigTree V 1.4). 
Phylogrouping PCR was carried out on the 17 main groups of EAEC (Doumith et al. 2012) and 
labelled on the phylogeny. 
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4.3.  Results  
4.3.1 Evolutionary Events leading to successful EAEC disease groups  
ClonalFrame analysis showed that EAEC mutation and recombination rates varied between countries 
(Table 4.1) and complexes (Table 4.2). ST10 Cplx (statistically associated with cases, Table 3.3) had 
the highest mutation rate (4.05) and recombination rate (1.2) whereas ST295 Cplx (predominantly 
associated with cases, Table 3.3) the lowest mutation rate (0.02) and lowest recombination rate 
(0.002). However, both of these groups had a similar mutation to recombination ratio. 
Recombination had the greatest impact on the evolution of ST40 Cplx (statistically associated with 
cases, Table 3.3) (12) and ST394 Cplx (predominantly associated with cases, Table 3.3)  (10). 
Recombination occurred 1.7 times more often than the mutation rate in the strains from Bangladesh 
and Nigeria whereas in EAEC strains from the UK, recombination and mutation rate was almost 
equal. In the entire dataset recombination events occurred 1.3 times more often than mutation. The 
geographical location of where an EAEC strain was isolated does not influence phylogeny (with the 
exception of small geographical specific STs possibly due to sampling bias) and successful EAEC STs 
were distributed globally (Figure 3.2). The impact of recombination in the diversification of the 
sample set relative to mutation showed the greatest impact in the Bangladesh strain set, and the 
least impact in the strains from the UK. These data suggest that recombination may play an 
important role in the evolution of EAEC (Table 4.1). 
 
External to Internal Branch Length Ratio gave coalescent expectations indicating that all EAEC 
irrespective of location and including the entire dataset were significantly different (P= <0.001) from 
the inferred value (Figure 4.1). Coalescent expectation is the expectation of values or output ofa 
dataset inputted into ClonalFrame of mutation over time, the inferred values is the actual values 
produced from the analysis or output of the same dataset. The difference between the two is 
significantly different (P=<0.001) suggesting that a particular event or series of events  (such as 
recombination events) have occurred leading to the extant population of a dataset inputted into 
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ClonalFrame  rather than natural events (such as sporadic mutation) over time. This data suggests 
that the overall population structure of EAEC has not occurred naturally over time such as would be 
expected from sporadic mutation. This data indicates that a particular event  or more likely a series 
of events such as acquiring chunks of foreign DNA (recombination) has been pivotal in the evolution 
of EAEC lineages. 
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Table 4 1  Mutation and Recombination rates of dataset by geographical source and all Sequence types found in dataset 
Parameters 
Bangladesh N=169 (108 
Cases, 61 Controls) 
Nigeria N= 121  (66 cases, 55 
controls) 
UK N= 254 (228 cases, 36 
controls) 
All ST N=199 (138 cases, 61 
controls) 
 
Mutation Rate (theta 0) 
Mutational rate & assumed 
to be constant on the 
branches of topology 
mean:15.033101,   
credibility_region: 6.951621-
26.141660 
mean:120.794748,   
credibility_region: 
69.290083-33.005260 
mean:70.132709  
credibility_region: 49.35070 - 
94.014220 
mean:16.019035   
credibility_region: 8.644529-
23.717401 
Recombination rate (R) 
recombination rate  & 
assumed constant on 
branches of topology 
mean:22.5888284,   
credibility_region: 
14.055470-33.461680 
mean:31.381483,   
credibility_region: 
19.687600-43.376330 
mean:15.664218,   
credibility_region: 9.840895-
22.310770 
mean:89.532805  
credibility_region: 
64.216890-121.960200 
view rho over theta (p/0) 
How often recombination 
occurs relative to mutations 
mean:1.650017,   
credibility_region: 0.775438-
3.148886 
mean:1.689762,   
credibility_region: 0.785667-
3.808293 
mean:1.048907,   
credibility_region: 0.505756-
1.982207 
 
mean:1.317856,   
credibility_region: 0.767609-
2.072695 
view r over m (r/m) The 
impact of how important the 
effect of recombination was 
in the diversification of the 
sample relative to mutation 
mean:4.384019,   
credibility_region: 2.382602-
8.059029 
mean:4.103293,   
credibility_region: 2.138517-
8.091730 
mean:2.605728,   
credibility_region: 1.444657-
4.395547 
mean:2.876673,   
credibility_region: 1.946228-
4.241088 
External to Internal Branch 
Length Ratio Gives the 
inferred expected values 
against the coalescent and 
actual rations. It they are 
significantly apart then it 
shows there was a genetic 
event such as recombination 
that led to these values. 
mean:0.732716,   
interval:0.545600-0.942675 
Significance:0.00070 
mean:0.569694,   
interval:0.408030-0.760060 
Significance:0.01583 
mean:0.672798,   
interval:0.507496-0.885945 
Significance:0.00049 
mean:0.902324,   
interval:0.722079-1.068309 
Significance:0.00001 
 
Table 4.1: ClonalFrame mutation and recombination rates as well the impact of recombination over mutation in the diversification of the data and the significance of the 
expected over the inferred value as to whether the data evolved over a period of time (not significant) or due to a large genetic event (significant). This analysis was applied 
to the different geographical locations and all STs found in the 564 EAEC dataset. 
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Table 4.2  Mutation and Recombination rates of dataset by ST complex. 
Parameters ST10 Cplx & DLV ST38 Cplx & DLV ST40 Cplx & DLV ST295Cplx & DLV ST394Cplx & DLV 
ST31 & ST 130Cplx & 
DLV 
Mutation Rate  
(theta 0)  
mean:4.047662  
credibility_region: 
2.096737-6.310707 
mean:0.281472 
credibility_region: 
0.023902-1003483 
 
mean:0.948535 
credibility_region: 
0.029708-2.621763 
mean:0.0277171 
credibility_region: 
0.000899-1.872790 
mean:0.231795 
credibility_region: 
0.008852-1.006419 
mean:0.657076 
credibility_region:0.1
34456-1.484436 
Recombination rate 
(R)  
mean:1.248849  
credibility_region: 
0.419549-2.841862 
mean:0.083915  
credibility_region: 
0.000868-0.388625 
 
mean:0.612102 
credibility_region: 
0.001200-1.909099 
mean:0.002833 
credibility_region: 
0.000732-0.011280 
mean:0.107088  
credibility_region: 
0.000807-0.464062 
mean:0.378763 
credibility_region: 
0.035706-0.977376 
view rho over theta 
(p/0)  
mean:0.334218,   
credibility_region: 
0.092813-0.825982 
mean:0.683871,   
credibility_region: 
0.003663-3.603088 
 
mean:5.557545,   
credibility_region: 
0.000534-46.863189 
mean:0.572612,   
credibility_region: 
0.000759-4.492473 
mean:4.075097,   
credibility_region: 
0.001951-33.129625 
mean:1.074699,   
credibility_region: 
0.044360-5.632848 
view r over m (r/m)  mean:1.200017,   
credibility_region: 
0.394262-2.665440 
mean:3.558562,   
credibility_region: 
0.019087-19.63949 
mean:12.004059,   
credibility_region: 
0.002926-
102.352654 
 
mean:0.914214,   
credibility_region: 
0.002019-7.049239 
mean:10.392526,   
credibility_region: 
0.007888-74.564922 
mean:4.274411,   
credibility_region: 
0.245787-20.061001 
External to Internal 
 Branch Length 
 Ratio. 
mean:0.481798,   
interval:0.283358-
0.728356 
Significance:0.02534 
mean:0.778292,   
interval:0.302418-
1.510262 
Significance:0.15335 
mean:0.641577,   
interval:0.300055-
1.20614 
Significance:0.09755 
 
mean:0.646918,   
interval:0.299785-
1.250929 
Significance:0.15941 
mean:0.644643   
interval:0.237609-
1.323429 
Significance:0.24016 
mean:0.567944 
interval:0.276826-
1.143014 
Significance:0.12012 
 
Table 4.2: ClonalFrame mutation and recombination rates as well the impact of recombination over mutation in the diversification of the data and the significance of the 
expected over the inferred value as to whether the data evolved over a period of time (not significant) or due to a large genetic event (significant). This analysis was applied 
to the different complexes including single locus variants (SLV) and double locus variants (DLV) 
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Figure 4.1 External to internal branch length ratio of enteroaggregative E. coli dataset 
 
 
Figure 4.1: ClonalFrame external to internal branch length ratio of EAEC STs found in this study. The difference 
between the two is significantly different (P=<0.001) indicating that this extant population is not due to natural 
mutation alone. 
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4.3.2 Evolution of EAEC in the context of the E. coli population 
EAEC in the background of the four main branches of E. coli phylogeny show a dominant evolution in 
branch 1 and 2 (Figure 4.2) consisting of phylogroups D, A and B1 respectively. ST30, 38, 394 and 31 
Cplx which are grouped together by MLST population structure (Figure 3.3) and cluster tightly on 
branch 1 (phylogroup D) of the E. coli phylogeny. Possibly indicating they evolved during a similar 
timeframe and share a similar ancestral source. The other large successful groups are dispersed 
throughout branch 2 and more diverse (larger distance on the tree), so a similar ancestral source and 
timeframe are more unlikely. 
 
ST10 Cplx shows that some SLVs on the MLST structure are dispersed in the context of the E. coli 
phylogeny (Figure 4.2). This highlights the limitation of using MLST as the EAEC lineages in the 
context of all E. coli are not as closely related as they seem. Using ClonalFrame, some strains that 
appear to be closely related (ie different by a SLV) are shown to have a larger genetic difference and 
that recombination is the likely cause. 
 
ST295 Cplx which is linked to ST10 Cplx by ST48 with a triple locus variant via MLST population 
structure analysis (Figure 3.3) is on the opposite end of branch 2, and therefore evolutionary distant. 
MLST would show these groups to differ by 3 loci and would be assumed to be different. This is 
confirmed by ClonalFrame  supporting the hypothesis that strains associated with ST 95 and ST10 
are evolutionary distinct. 
 
The smaller successful groups with only 4 EAEC strains were found at the end of branch 4 which 
contained a mixture of phylogroups A and D, indicating that these backgrounds have not enabled 
EAEC to expand into prevailing lineages. None of the main EAEC complexes (Table 3.3) were found in 
branch 5 of the E coli phylogeny which is generally associated with extra-intestinal infections such as 
ST131 belonging to phylogroup B2. 
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Figure 4.2 Neighbour joining tree of all E. coli sequence types and EAEC in this study 
 
 
 
Figure 4.2: Neighbour joining tree of concatenated MLVA of the 564 EAEC used in this and all ST across the E. 
coli population structure. Phylogeny is separated into four main branches. EAEC is distributed throughout the E. 
coli phylogeny as shown in branches 1-4 containing phylogroups, A, B1 and D. The main EAEC complexes were  
not found in branch 5, phylogroup B2 associated with extra-intestinal infections. 
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4.4 Discussion 
4.4.1 Multiple genetic events have led to the independent evolution of EAEC 
In order to understand the genetic events which led to the formation of different EAEC associated 
MLST complexes, Clonal Frame analysis of the branching events for each node was carried out. 
Variation in the frequency of recombination or mutation which occurred in all of the seven loci at 
different time points was seen (data not shown) indicating continuous multiple genetic events. The 
relative frequency of recombination as compared to mutation (ρ/θ) for the entire data set was 1.31 
and is comparable to the rates for E. coli proposed by Wirth et al (Wirth et al. 2006) and Touchon et 
al (Touchon et al. 2009) but higher than computed rates for the E. coli species via MLST who 
estimated recombination at essentially zero (Perez-Losada et al. 2006).  
 
The parameters of rates and impact are based on the Markov model (Didelot & Falush 2006) which 
assumes such that horizontal gene transfer events are equally probable between any pair of 
lineages, irrespective of phylogenetic and ecological proximity (Galtier 2007). The analysis clearly 
shows that this is not the case and that recombination rates vary within the EAEC pathotype 
between different lineages, the most ancestral being ST10 Cplx with the least impact of 
recombination in comparison to the other lineages (Table 4.2). 
 
Multiple successful complexes vary in mutation and recombination rates (Table 4.2) and are 
distributed throughout the E. coli population (Figure 4.2). These complexes have clearly evolved 
independently through multiple genetic events that have led to the phenotypic congruency of this 
pathotype. These EAEC strains in the population structure show different, apparent, mutation/ 
recombination rates and suggests that certain bacterial backgrounds allow the biological advantage 
(such as strong adherence to the gut with the AA plasmid) to be expressed - possibly influenced by 
the ability to retain the EAEC plasmid. Fast radiation (expansion of successful strains) of the 
complexes after population bottlenecks (a sharp reduction in the size of a population due to 
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environmental events and assumed to play a key role in the maintenance of social traits inmicrobes) 
and frequent recombination seems a likely explanation for this population structure - and this has 
been observed in other E. coli populations (Wirth et al. 2006). Gastrointestinal EAEC complexes were 
not found in the extra-intestinal E. coli phylogeny branch as maintaining the pAA, may not be a 
biological advantage to strains of ExPEC as their pathogenicity is not based on the need to  adhere to 
the gut. 
 
4.2.2 Factors responsible for EAEC evolution 
 
Due to the heterogeneous nature of EAEC, it is likely that several factors are responsible for these 
convergent groups. Distinct populations within a species may emerge because of differential local 
adaptation or genetic drift (Vos & Didelot 2009). This concept may be applied to successful EAEC 
groups which represent clusters of closely related genotypes and can be termed ecotypes (Cohan 
2002). These groups differ in their homologous recombination events because of adaptive evolution 
or environmental constraints  (Vos & Didelot 2009). This is shown by the variable recombination rate 
in different complexes which may have evolved from different environments. The variable 
recombination rate from each country will depend on the complexes found from the sample size 
tested. Although recombination had the lowest impact on the UK EAEC isolates, it is recognised that 
a portion of these had recently travelled outside the UK and would therefore include EAEC from 
many different countries. In summary, there are several factors such as competition with other 
microbes and adaptation to environmental niches responsible for the evolution of these groups 
which has occurred from different ancestral sources, over different time periods and from different 
environments. 
 
Virulent pathotypes have been shown to recombine more than non-pathogens pointing towards the 
theory that that virulence is the driving force for more frequent recombination (Wirth et al. 2006) or 
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that frequent recombination increases pathogenic potential. This is demonstrated with the ST40 
Cplx which was statistically significantly associated with disease (P=0.03) and recombination which 
had the highest impact of on its diversification.  ST10 Cplx, which was also statistically significantly 
associated with disease (P=0.01) in this study and in a previous EAEC study (Okeke et al. 2010) had 
the highest rate of mutation among the groups and the impact of recombination was almost equal 
to mutation (1.2). This indicates that both types of genetic events are important in the pathogenic 
evolution of EAEC. 
 
The EAEC data set showed that the external to internal branch length ratio is significantly higher 
than expected (Table 4.1, Figure 4.1). This means that the inferred genealogy is consistent with 
either an expansion of the population size or acquisition of a fitness advantage early in the history of 
the sample (Didelot & Falush 2006). Therefore, although mutation and recombination are important 
in the evolution of the most pathogenic EAEC groups, other factors have contributed to the 
evolution of the successful established groups. 
 
One fitness advantage could be the acquisition of one (or more) of the plasmids associated with the 
EAEC phenotype harbouring genes that have increase its binding ability giving it the characteristic 
‘stacked bricked’ HEp-2 assay phenotype and more importantly biologically and pathologically 
enabling the EAEC pathotypes to adhere to the host gut mucosa. The ability to adhere to and 
colonise the gut for an extended period of time may confer a selective advantage on this pathotype. 
Independent acquisition of an EAEC plasmid could account for the different rates  of mutation and 
recombination between the groups. Whereas the ancestral ST10 Cplx already had the background 
mutations to be able to acquire and retain the EAEC plasmid, other ST Cplxs such as ST40 might not 
have and therefore needed large recombination events to stably retain the EAEC plasmid.  
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One could argue that this adherence plasmid would not give the organism a particular advantage of 
success as E. coli already have the ability to adhere in the gut via multiple mechanisms (Kaper et al. 
2004), though the efficient binding of EAEC is reflected in persistent diarrhoea. A recent example, 
however, of how acquisition of this EAEC plasmid can increase pathogenicity is the recent ST678 
(0104:H4) STEC German outbreak (Chattaway et al. 2011). This is a VTEC strain that did not have the 
eae gene (attachment and effacement loci for intimate adherence and typically associated with 
severe disease) but did have the aat plasmid and its factors associated with adherence. This strain 
was particularly virulent with high HUS rates despite harbouring the same toxin type as many other 
STEC strains, the difference perhaps being its increased ability to adhere to the host gut mucosa and 
hence expose the host to the toxin for longer. This mechanism of attachment could provide a fitness 
advantage that will enable this relatively new pathotype to become established. 
 
This chapter clearly shows the complexity of the evolution of EAEC, while it is evident that the same 
lineages prevail in multiple global locations indicative of either clonal expansion or convergence, 
there are also lineages ecologically adapted that account for the inconsistent impact rates of 
recombination between different geographical locations. 
 
4.5.  Summary 
 
The work described in this chapter further analyses the MLST data by specifically looking at the 
sequences of the house-keeping genes in the MLST scheme and gives a description of the phylogeny 
of the largest multi-sourced EAEC dataset to date and a unique insight into the evolution of specific 
EAEC designated groups. These groups have evolved independently of each other multiple times in 
multiple locations via a combination of mutation and recombination and converged to the EAEC 
phenotype. With the selection of important EAEC complexes and the understanding how these have 
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evolved, investigation to the assessment of pathogenicity of these groups using phenotypic and 
genotypic models was assessed as discussed in Chapter 5. 
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Chapter 5 - Linking Phenotype and Genotype Models 
5.1 Background 
 
The work described in Chapter 4 suggested there are lineages of EAEC associated with either 
asymptomatic carriage or GI disease. In this chapter the virulence gene profiles and the phenotypic 
properties of these lineages are investigated phenotypically to look for differences between the two 
groups. Specifically the phenotype of strains within a complex was examined by selecting 
representative isolates and investigating the following: the adherence capability by HEp-2 cell assay; 
their pathogenicity using the Caenorhabditis elegans worm model; their metabolic profile using the 
Biolog; and their serotype. In addition, genotypic virulence profiling was assessed for association 
with EAEC complexes. 
5.2 Methods 
5.2.1 Strain Details 
The HEp-2 assay and Caenorhabditis elegans worm model was carried out in the laboratory of Prof. 
Iruka Okeke, Haverford, USA. A representation of prominent and successful ST lineages from strains 
available in Prof. Okeke’s collection was selected. These represented a selection of different ST 
complexes defined in this thesis as being associated with disease or carriage. These included EAEC 
disease associated group (ST394 Cplx), EAEC carriage associated group (ST31 Cplx), one group 
exclusive to EAEC (ST 168 Cplx) and not associated with either disease or carriage and one group 
associated with EAEC and specifically uropathogens (ST38 Cplx). 
For the Biolog metabolic profiling, carried out in the GBRU, a random selection of 97 strains from the 
UK and Bangladesh from cases and controls and including the successful complexes ST10, ST295, 
ST38, ST168 and ST40 Cplxs (all associated with cases, Table 3.3) were used. All UK and Bangladesh 
strains (443 strains) were serotyped. Bangladesh strains were genotyped. 
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5.2.2 Human epithelial (HEp-2) cell assay 
The method originally described by Cravioto et al (Cravioto 1979) was used with modifications 
necessary for delineating aggregative adherence stipulated by Vial et al (Vial et al. 1990). 
5.2.2.1 Preparation of HEp-2 cells 
Gloves were always used and changed regularly throughout this process especially whenever the 
cabinet was entered in order to reduce the high risk of contaminating the tissue cell culture. The 
tissue culture water bath was heated to just below 37oC (over 40oC and the media will become 
inactive) and was monitored throughout. All sterile manipulation work was carried out inside the 
Purifier Class II Biosafety Cabinet [Labconco]. A clean and dirty incubator was used depending on 
whether the flasks were sterile or inoculated with viable material. The area was wiped down with 
70% ethanol regularly. Sterile incubating media was prepared with 50ml of Fetal Bovine Serum 
[Gibco] (to support cell growth), 5ml of 100 µg/ml penicillin/streptomycin [Gibco] (to prevent 
contamination) and 500ml of Dulbecco modified Eagle medium (DMEM) media [Gibco]. A small 
tissue culture flask was filled with 8ml of incubating media and inoculated with HEp-2 cells and 
incubated at 37oC for 48 hours in CO2 (5%) incubator [VWR].  
The flasks were ready to use when the HEp-2 cells formed a 50% confluent growth monolayer. Flasks 
were divided to keep the cells fresh to maintain optimum conditions for testing. After 48 hours 
incubation, an inverted microscope [Zeiss Invertoskop] was used to check if there was a minimum of 
50% confluent growth and whether the cells appeared healthy. Cells were not allowed to grow over 
90% confluent as their physiology would start to change which could affect any testing. If 50% 
confluent growth had not been achieved, the incubating media was replaced with fresh media and 
the flask was incubated and checked every 24 hours. When the HEp-2 monolayers were ready for 
dividing they were washed three times with Dulbecco’s phosphate-buffered saline [Gibco], this 
washed away the antibiotics and the serum that would inhibit the trypsin. Trypsin [Gibco] (0.8mls) 
was added to the monolayer and left for 30-180 seconds. The flask was gently banged to dislodge 
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the cells and the trypsin started to appear cloudy. The cells were continually checked under the 
inverted microscope, when the cells were trypsinized (cell disassociation, round and free floating), 8 
ml of incubating media was added. This inhibited the trypsin to stop the process. If the cells were 
over trypsinized, the physiology of the cells would change or they would die affecting the test. Loose 
cell media was diluted by adding 4 ml of trypsinized cells and 4 ml of fresh incubating media to an 8 
ml tissue culture flask. An 8 chamber well glass slide [Thermo Scientific] was seeded with 0.4 ml of 
diluted cell loose media and was incubated overnight at 37oC with 5% CO2. 
5.2.2.2 Preparation of strains 
Pure strains were grown statically in 2ml Luria broth overnight at 37oC aerobically in a non-shaking 
incubator. It was important to not shake the broths as this would affect the adherence capability. A 
positive control (pathogenic EAEC strain 042) and a negative control (laboratory E. coli control strain 
pir116) were used in each experiment and all strains were tested in duplicate. 
5.2.2.3 Preparation of adherence media 
Sterile adherence media was made by adding 50mls of 10% mannose (0.5g mannose: 50ml milli q 
water) to 500ml of DMEM which made a final concentration of 1% mannose. Mannose is added as E. 
coli have type 1 fimbriae that will bind to mannose receptors on the HEp-2 cells, the additional of 
mannose will prevent type 1 fimbriae binding to the cells so the adherence you see will relate 
specific E. coli pathotype type binding (Figure 5.1) and not non-specific mannose binding. 
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Figure 5.1 Different pathotype binding phenotypes of E. coli 
 
 
 
 
Localised – EPEC                  Stacked Brick – EAEC 
 
 
 
 
Diffuse – DAEC                                         Cells destroyed - Cytotoxic 
 
Figure 5.1: Photos of the difference adherence patterns of E. coli on HEp-2 cells 
5.2.2.4 Adherence assay 
Chamber wells were washed three times with PBS and 0.4ml of adherence media (DMEM with 
mannose) was added to each well in the safety cabinet. On the laboratory bench, 10µl of bacterial 
suspension was added to each well and incubated for 3 hours at 37oC with 5% CO2 in a non-sterile 
incubator. The monolayers were washed three times with PBS and fixed for 20 min with 70% 
methanol. Each well was stained with 0.4ml Giemsa Stain [Gibco] (1ml concentrate: 5ml PBS),  for 20 
min. The chamber and rubber seal was removed and the cells washed very gently with water and 
dried at room temperature.  
5.2.2.5 Analysis of HEp-2 Assay 
Cells were examined at X1000 magnification under oil immersion. They were checked to ensure they 
were consistent across the slide, a minimum of five fields were checked and two representative 
pictures were taken. Semi-quantitative methods were used to assess the Intensity of adherence of 
each strain and was scored as shown and described in table 5.1   
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Table 5.1  Hep-2 Scoring Assignment 
Score Definition Example 
0 = Cytotoxic Destruction of HEp-2 cells, auto agglutination of EAEC is 
usually still present showing stacked bricked adherence. 
 
1 = Very Light Very little binding, ~ 20% of cell sides covered by EAEC. 
 
2 = Light Light binding of EAEC around the cells, <50% of cell sides 
covered by EAEC 
 
3 = Medium Medium binding of EAEC, ~70% of the side of cells 
covered by EAEC, ~10 % cell surface binding 
 
4 = Heavy Heavy binding of EAEC, ~90%  HEp-2 cell sides covered 
by EAEC, >20% cell surface binding 
 
5 = Very Heavy Excessive binding,  100%  cells covered by EAEC on sides 
and >80% cell surface binding,  evidence of dense 
clumping of bacteria 
 
 
Table 5.1: Parameters of score given for the intensity of adherence, evidenced by photos. 
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5.2.3 Caenorhabditis elegans worm model 
5.2.3.1 Preparation of worms and media 
A worm picker was prepared using a glass pipette and thin wire. The wire was inserted into the glass 
pipette and sealed with a Bunsen burner. Aseptic techniques were used throughout and the wire 
was flamed between worm picking. Worms were maintained on nematode growth medium (NGM) 
(Brenner 1974;Lewis and Fleming 1995) on lawns of E. coli (strain OP50) at 15oC. All plates were 
incubated at 37oC for 24 hours and placed at room temperature for 8-12 hours. Test plates were 
prepared by spreading 5µl of overnight bacterial broth culture on 3.5cm diameter plates containing 
NGM and incubated for four hours at 37oC. This was repeated for each selected enteroaggregative E. 
coli strain. A positive control of the virulent prototypical 042 strain and a negative control of the 
laboratory attenuated pir116 strain were used. The standard N2 Bristol worm strain was used for 
assays and the slow-kill assay protocol was adapted from Tan et al (Tan et al. 1999). Worms were 
found in four stages of growth, L1 being the smallest and L4 being the largest (Figure 5.2). A dead 
carcass (containing multiple L1 larvae) was transferred onto a fresh NGM medium agar plate and 
grown overnight in aerobically at 37oC. Stage L2 larvae were selected for the experiments the next 
day. 
5.2.3.2 Slow-kill assay 
For the slow kill assay, ten N2 hermaphrodites at the L2 stage were seeded into each test plate and 
incubated at 22oC for 24 hours. Survival, motility rate and reproducibility were assayed every 24 
hours. Worms were transferred with the worm picker to new inoculated test plates every 24 hours 
to allow the distinction of subsequent generations. Worms were considered dead when they no 
longer responded to touch (Figure 5.2). 
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Figure 5.2 Flow diagram of slow-kill assay procedure 
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Figure 5.2: Flow diagram of the procedure of the slow kill assay with C. elegans worm model  
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5.2.3.3 Analysis of Caenorhabditis elegans worm model 
Data from the assays were analysed using the Kaplan-Meier method (Bland & Altman 1998) and 
STATA was performed on the results. Log Rank test (Bland & Altman 2004) was carried out for 
equality of survivor functions which was a comparison of all complexes against each other. A cox 
regression (Altman & Andersen 1989) analysis was made against the complex strains against the 
control strains. 
5.2.4 Metabolite profiling using the Biolog 
Strains were streaked onto Columbia blood agar plates (5% sheep blood) [PHE Media]  and 
incubated overnight at 37oC. A single colony was picked and inoculated into type A broth 
[Technopath] using a flat end cotton swab. Biolog GEN III well plates which contained a negative 
control and 95 metabolites (Appendix 7.2) were inoculated immediately with 100µl of type A broth 
[Technopath] and placed into the Biolog with an incubation temperature of 37oC. Reading of the 96 
well Biolog GEN III plates for metabolite utilisation was carried out every 15 min for 22 hours. This is 
a routine method used within the GBRU  
5.2.4.1 Analysis of Biolog Data 
A neighbour-joining tree of the Biolog outputs was constructed using Phylogeny Inference Package 
(PHYLIP) and viewed in FigTree version 1.4.  The first two consisted of EAEC strains only and were 
coloured by case/control or by complex. 
 
As a comparison with the metabolic activity of the clinical E. coli population a third neighbour joining 
tree was then constructed with the 97 EAEC strains overlaid with 1479 clinical E. coli strains 
processed in GBRU from 2010 – 2014.   
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5.2.5 Serotyping of isolates from Bangladesh and UK 
Serotyping of the somatic and flagella antigen (Gross and Rowe 1985) was carried out on the heat 
stable lipopolysaccharide (Somatic or O) antigens and the flagellar (H) antigens on the Bangladesh 
and UK strains. Strains that did not express LPS reacted with all antigens and were termed rough and 
those that did not react with any were designated ‘O unidentified’ or ‘H unidentified’. Nigerian 
strains had previously been identified and published (Okeke et al. 2000b), strains were not 
accessible and serological identification was not performed. 
5.2.6 Virulence typing of isolates from Bangladesh 
DNA extraction and PCR was carried on 153 EAEC isolates from Bangladesh (93 cases and 60 
controls) out as described in Chapter 3 (3.2.3.1 – 3.2.3.2) with annealing temperatures varying 
according to the target detected (Table 5.2). Previously published virulence factor genes included 
aat, aaiC, astA, aggR, aafA, aggA, agg3A, agg4A, pic, set1A, irp2, tia and pet. Virulence factor aaf5A 
primers and probes were provided by Julia Mtwale (University College London). Products were 
visualised on a 1.5% agarose gel and 10X tris acetate EDTA buffer standing with ethidium bromide 
[BIORAD Gel Doc 2000]. Multiple controls were used that were positive for one or more virulence 
factors (Table 5.3). 
Pearson Chi-Square test was carried out to ascertain if there was an association with any genes 
being present in EAEC isolates from cases over controls. Pearson Chi-Square test was repeated to 
see if the presence of a virulence gene was associated with a complex. For this test a sample size of 5 
or more was needed, therefore complex included ST10 (n=18), 155 (8), 165 (5), 168 (5), 295 (20), 31 
(11), 38 (21), 394 (7) and 40 (10). 
The mean virulence score (total of virulence genes present) was listed for these complexes. A linear 
regression was used to analyse if these complexes have a higher virulence in comparison to a 
reference group. ST38 complex was chosen as the reference groups as it contained the largest 
sample size and best representation of the data. All statistical analysis was carried out on STATA v 
13. 
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Table 5.2  Table of virulence factor genes used in this study 
Target gene Primer Primer Sequence 
Amplicon 
length (bp) 
Function Reference  
aat 
aat_F CTG GCG AAA GAC TGT ATC AT 
630 
Anti-aggregation protein transporter gene, Part 
of protein transporter system 
(Jenkins et al. 
2006b) aat_R CAA TGT ATA GAA ATC CGC TGT T 
aaiC 
aaiC_F CTC TTA GCA GGG AGT TTG TC 
430 aaiC from 042 pheU island 
(Jenkins et al. 
2006b) aaiC_R GCT TTG TTT ACC GAC TGA AC 
astA 
astA_F CCA TCA ACA CAG TAT ATC CGA 
111 Enteroaggregative heat stable toxin 1 (EAST-1) 
(Jenkins et al. 
2006b) astA_R GGT CGC GAG TGA CGG CTT TGT 
aggR 
aggR_F CTA ATT GTA CAA TCG ATG TA 
308 Transcriptional activator of AAFs 
(Czeczulin et al. 
1999) aggR_R ATG AAG TAA TTC TTG AAT 
aggA 
aggA_F GCT AAC GCT GCG TTA GAA AGA CC 
421 AAF/1 fimbrial type I (Piva et al. 2003) 
aggA_R GGA GTA TCA TTC TAT ATT CGC C 
aafA 
aafA_F GAC AAC CGC AAC GCT GCG CTG 
133 AAF/II fimbrial type II (Piva et al. 2003) 
aafA_R GAT AGC CGG TGT AAT TGA GCC 
agg3A 
agg3A_F GTA TCA TTG CGA GTC TGG TAT TCA G 
462 AAF/III fimbrial type III 
(Bernier et al. 
2002) 
agg3A_R GGGC TGT TAT AGA GTA ACT TCC AG 
    
agg4A 
agg4A_F ATA CTT TAG ATA CCC CTC ACG CAG 
411 AAF/IV fimbrial type IV (Boisen et al. 2009) 
agg4A_R TCC ATT ATG TCA GGC TGC AA 
aaf5A 
aaf5A_F GACTGGATTCTTCAGCTTAAATTAAG 
250 AAF/V fimbrial type V 
Mtwale 
unpublished 
aaf5A_R TTCATTTGATGCTGGATTGA 
aaf5A_P GAGCCCGAGCCTGTACATAGATTTGT 
pic 
Pic_F TTC AGC GGA AAG ACG AA 
500 
Secreted protease (146kDA), 116kDa after 
cleavage, multifunctional protein involved in 
enteric pathogenesis. 
(Piva et al. 2003) 
Pic_R TCT GCG CAT TCA TAC CA 
Set1A 
Set1A_F TCA CGC TAC CAT CAA AGA 
309 Shigella enterotoxin, anti-sense strand of pic (Huang et al. 2007) 
Set1A_R TAT CCC CCT TTG GTG GTA 
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Table 5.2  Table of virulence factor genes used in this study… continued 
Target gene Primer Primer Sequence 
Amplicon 
length (bp) 
Function Reference  
Irp2 
Irp2_F AAG GAT TCG CTG TTA CCG GAC 
280 Yersiniabactin biosynthetic gene (Schubert et al. 1998) 
Irp2_R TCG TCG GGC AGC GTT TCT TCT 
tia 
tia_F AGT GAT AGC GGA GAT GAT TG 
705 putative invasion determinant (Jenkins et al. 2006a) 
tia_R CTC ACC CCG CTA TTT ATA TT 
aap 
aap_F CTTTTCTGGCATCTTGGGT 
232 Dispersin gene (Piva et al. 2003) 
aap_R GTAACAACCCCTTTGGAAGT 
pet 
pet_F CCGCAAATGGAGCTGCAAC 
1132 Plasmid encoded toxin (Sheikh et al. 2002) 
pet_R CGAGTTTTCCGCCGTTTTC 
aaiC 
aaiC_F CATTTCACGCTTTTTCAGGAAT  
160 
Part of the aai gene cluster encoding a type Vi 
secretion system 
(EU Reference 
Laboratory for E.coli 
Department of 
Veterinary Public 
Health and Food 
Safety 2013) 
aaiC_R CCTGATTTAGTTGATTCCCTACG  
aaiC_P CACATACAAGACCTTCTGGAGAA  
Table 5.2: List of primers used for virulence typing 
Table 5.3  Table of controls used in this study 
Control Strains Source aggA 
(AAF/I) 
aafA 
(AAF/II) 
agg3A 
(AAF/III) 
agg4A 
(AAF/IV) 
aaf5A 
(AAF/V) 
aat aggR pic astA set1A aaiC irp2 tia hra1 aap pet 
042 (O44:H18) Nataro  -  +  -  -  -  +  +  +  +  +  +  +  -  -  +  + 
8089 (O7:H4) ICDDR,B  -  -  -  +  -  +  +  -  -  -  -  +  -  -  +  - 
601010 (O15:H23) ICDDR,B  -  +  +  -  -  +  +  +  +  +  +   +  +  -  +  - 
900732 (O?:H7) ICDDR,B  -  -  -  +  -  -  +  -  -  -  -  +  -  +  +  - 
900063(O?:H23) ICDDR,B  +  -  -  -  +  +  +  -  +  +  -  -  -  -  +  - 
E099518 (O104:H4) LGP  -  -  +  -  -  +  + NT NT NT NT NT NT NT NT NT 
Table 5.3: Table of control strains used in this study. E099518 was only used for AAF/III and was not tested (NT) against all virulence factor
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5.3 Results 
5.3.1 HEp-2 Adherence 
Strains showed variation in intensity of adherence to HEp-2 cells (Appendix 7.3) between each ST 
complex. In general, EAEC disease group ST394 Cplx showed heavy to very heavy binding (ST130 and 
ST394 Cplx) whereas the EAEC uropathogenic associated ST38 Cplx (Chattaway et al. 2014a) showed 
very light to medium binding. The EAEC exclusive, ST168 Cplx defined as being associated in equal 
numbers of cases and controls showed the most varied of binding capabilities and the groups 
associated with controls (ST31 Cplx) show a medium to very heavy binding phenotype with several 
cytotoxic strains destroying HEp-2 cells altogether (Table 5.4). There was no association between the 
intensity of individual strain adherence and whether it was associated with case or control. 
 154 
 
Table 5.4  HEp-2 Adherence scores 
Isolate ST ST 
Complex 
HEp2 Case Pathotype Country Year Source Origin 
042 414 None 5 = Very Heavy Case EAEC Peru  1987 EAEC reference strain  Human 
H145-1R 31 ST31 Cplx 4 = Heavy Case EAEC Peru None Okeke Human 
44-1R 31 ST31 Cplx 0 = Cytotoxic, autoaggregative Case EAEC Thailand None Okeke Human 
309-1R 31 ST31 Cplx 5 = Very Heavy Case EAEC Thailand None Okeke Human 
E54H 31 ST31 Cplx 3 = Medium Control EAEC Nigeria 1995 Okeke Human 
E56H 31 ST31 Cplx 4 = Heavy Control EAEC Nigeria 1994 Okeke Human 
G149H 474 ST31 Cplx 0 = Cytotoxic, autoaggregative Control EAEC Nigeria 1994 Okeke Human 
G121aH 474 ST31 Cplx 4 = Heavy Control EAEC Nigeria 1995 Okeke Human 
C16D 512 ST31 Cplx 4 = Heavy Case EAEC Nigeria 1995 Okeke Human 
C20D 130 ST31 Cplx 4 = Heavy Case EAEC Nigeria 1995 Okeke Human 
C60H 130 ST31 Cplx 4 = Heavy Control EAEC Nigeria 1995 Okeke Human 
G116H 130 ST31 Cplx 4 = Heavy Control EAEC Nigeria 1995 Okeke Human 
G23D 38 ST38 Cplx 1 = Very Light Case EAEC Nigeria 1995 Okeke Human 
G29D 38 ST38 Cplx 3 = Medium Case EAEC Nigeria 1995 Okeke Human 
G28D 426 ST38 Cplx 2 = Light Case EAEC Nigeria 1995 Okeke Human 
G59D 394 ST394 Cplx 4 = Heavy Case EAEC Nigeria 1995 Okeke Human 
G10D 394 ST394 Cplx 5 = Very Heavy Case EAEC Nigeria 1995 Okeke Human 
C14D 394 ST394 Cplx 5 = Very Heavy Case EAEC Nigeria 1995 Okeke Human 
G17aD 394 ST394 Cplx 4 = Heavy Case EAEC Nigeria 1995 Okeke Human 
C08D 394 ST394 Cplx 5 = Very Heavy Case EAEC Nigeria 1995 Okeke Human 
E30D 394 ST394 Cplx 4 = Heavy Case EAEC Nigeria 1995 Okeke Human 
G108H 394 ST394 Cplx 5 = Very Heavy Control EAEC Nigeria 1995 Okeke Human 
E64H 394 ST394 Cplx 5 = Very Heavy  Control EAEC Nigeria 1995 Okeke Human 
E33D 484 ST168 Cplx 4 = Heavy Case EAEC Nigeria 1995 Okeke Human 
G30D 484 ST168 Cplx 2 = Light Case EAEC Nigeria 1995 Okeke Human 
G110H 484 ST168 Cplx 0 = Cytotoxic, autoaggregative Control EAEC Nigeria 1995 Okeke Human 
D09D 460 ST168 Cplx 3 = Medium Case EAEC Nigeria 1995 Okeke Human 
 
Table 5.4: Table of results showing HEp-2 scores of EAEC strains representing the main groups defined in this study. See Appendix 7.3 for photos
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5.3.2 Worm model  
The graphs below show the worms fed on the control non-pathogenic strain pir116 to have the 
longest survival time whereas worms fed the EAEC strains from each complex were lethal including 
ST31 (carriage group) and ST394 Cplx (disease group) (Figure 5.3), the EAEC uropathogenic ST38 
complex (Figure 5.4) and EAEC exclusive group ST484 (ST168 Cplx) (Figure 5.5). There was no 
association between the survival time and whether individual EAEC strains were from a case or 
control within a complex.  
 
Figure 5.3 Survival of C. elegans fed with ST31 & ST394 Cplx EAEC strains 
  
Figure 5.3: Survival of C. elegans fed with prototypical 042 EAEC virulent strain, laboratory attenuated pir116 
control strain. Test strains include a case and control EAEC strain from EAEC ST31 Cplx (H145-1R & G116H)  and 
ST394 Cplx (C14D & E64H) respectively.   
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Figure 5.4 Survival of C. elegans fed with ST38 EAEC strains  
  
Figure 5.4: Survival of C. elegans fed with prototypical 042 EAEC virulent strain, laboratory attenuated pir116 
control strain. Test strains include a case strains from the EAEC uropathogenic ST38 group 
 
 
Figure 5.5 Survival of C. elegans fed with ST168 Cplx EAEC strains  
  
Figure 5.5: Survival of C. elegans fed with prototypical 042 EAEC virulent strain, laboratory attenuated pir116 
control strain. Test strains include EAEC case strains from the mixed pathotype ST168 complex 
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The log rank test for equality of survivor functions indicated there was a significant difference 
between the survival of the worms in the different complexes in relation to each other (Chi square, P 
= 0.0170). 
The groups were further analysed by cox regression, this study was limited by the small numbers so 
there would need to be extreme differences to show a significance determined by a hazard ratio of 
<0.5 or >2 and a probability <0.05. 
1) The complex groups were comparable with the case reference strain 042 (chi square, P= 
0.649).  
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
ST168 Cplx  
(n=4) 
1.11025    .3928736      0.30    0.768      .5548997    
2.221403 
ST31 Cplx   
(n=11) 
.880873    .2916214     -0.38    0.702      .4603784    
1.685434 
ST38 Cplx (n=3) 1.097805    .4014096 0.26    0.799      .5361493    
2.247838 
ST394 Cplx   
(n=8) 
.7842502    .2651851     -0.72    0.472       .404232    
1.521523 
 
2) The complex groups were statistically significant with the control reference strain pir116 (Chi 
square, P = 0.276). ST168 Cplx and ST38 Cplx were the most pathogenic with the highest  
Hazard ratio (3.1) 
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
ST168 Cplx  
(n=4) 
3.150686    1.388907      2.60    0.009      1.327922    
7.475456 
ST31 Cplx   
(n=11) 
2.511154    1.058663      2.18    0.029      1.099057    
5.737551 
ST38 Cplx (n=3) 3.109995    1.400264      2.52    0.012      1.286794    
7.516404 
ST394 Cplx   
(n=8) 
2.237626    .9526613 1.89    0.059      .9713851    
5.154464 
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3) Case strains from each complex were comparable with the case reference strain 042 (Chi 
square, P=0.3422).  
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
ST168 Cplx   
Cases (3) 
1.120294    .4094586      0.31    0.756      .5472988    
2.293187 
ST31 Cplx   
Cases (5) 
.7960973 .276724     -0.66    0.512      .4027985    
1.573419 
ST38 Cplx   
Cases (3) 
 1.085061    .3971413 0.22    0.823      .5295509    
2.223315 
ST394 Cplx   
Cases (6) 
.7678135     .264989     -0.77    0.444      .3903802    
1.510163 
 
4) Control strains from each complex were comparable to the control reference strain pir116 
(Chi square, P=0.112), ST31 Cplx control strains did show a difference from pir116. For 
example, Cplx control strains were still more pathogenic than the non-EAEC negative control 
strain. ST 168 Cplx was the most pathogenic with the highest hazard ratio, it was 2.7 times 
more likely to be pathogenic. 
 
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
ST168 Cplx   
Controls (1) 
2.720906    1.416667      1.92    0.055      .9806791    
7.549184 
ST31 Cplx   
Controls (6) 
2.456715    1.066777      2.07    0.038       1.04891     
5.75402 
ST394 Cplx   
Controls (2) 
1.987913    .9506842      1.44    0.151      .7786192     
5.07539 
 
5) Case strains from each complex were statistically different from the control reference strain 
pir116 (Chi square, 0.0250). ST168 was 3.7 times more likely to be pathogenic over the non-
EAEC negative control strain.  
 
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
ST168 Cplx  
(n=4) 
3.364593     1.52294      2.68    0.007      1.385629    
8.169925 
ST31 Cplx   
(n=11) 
2.418352    1.052245      2.03    0.042      1.030753    
5.673935 
ST38 Cplx (n=3) 3.254318    1.470943      2.61    0.009      1.341897    
7.892251 
ST394 Cplx   
(n=8) 
2.331175    1.004852      1.96    0.050      1.001532    
5.426063 
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6) All case strains (irrespective of complex) were statistically different from the control 
reference strain pir116 (Chi square, P=0.0078). 
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
Cases  vs pir116 2.604575    1.089875      2.29    0.022      1.146977    
5.914515 
 
 
7) All control strains (irrespective of complex) were statistically different from the control 
reference strain pir116 (Chi square, P=0.0229). 
 
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
Controls  vs 
pir116 
2.366515    1.011242      2.02    0.044      1.024189    
5.468125 
 
 
8) All case strains (irrespective of complex) were comparable with the case reference strain 042 
(Chi square, P= 0.693) 
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
Cases vs 042 .878149    .2868496     -0.40    0.691      .4629361    
1.665771 
 
 
9) All control strains (irrespective of complex) were comparable with the case reference strain 
042 (Chi square, P= 0.8706) 
_t Haz. Ratio    Std. Err.       z P>|z|      [95% Conf. 
Interval] 
Controls  vs 042 .9464675    .3174477     -0.16    0.870      .4904678    
1.826421 
 
 
The slow-kill indicated that EAEC strains were more lethal for worms than control strain pir116 and 
comparable with virulent 042 EAEC prototypical strain but that there was no significant difference 
between strains from cases and those from controls within the Cplxs. ST168 Cplx was the most 
pathogenic complex with this model. 
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5.3.3 Biolog 
Analysis of the metabolite respiration of 97 EAEC (see Appendix 7.1) clustered into three main 
clades. Strains varied in metabolism irrespective of complex and while some complexes clustered 
together on the dendrogram, they were integrated with other complexes (Figure 5.6). There was no 
clustering of EAEC strains from cases or controls (Figure 5.7). This data showed that Biolog analysis 
of real-time metabolite respiration could not be used to differentiate EAEC complexes or EAEC from 
cases or controls which were distributed across the three clades. 
Overlaying EAEC metabolic respiration in comparison to 1479 E. coli clinical strains (2010-2014) 
showed that EAEC had 5 main clusters (Figure 5.8) indicating that groups of EAEC did resolve 
together metabolically. 
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Figure 5.6 Dendrogram of Biolog of 97 EAEC strains coloured by complex 
 
  
  ST10 Cplx 
  ST38 Cplx 
  ST295 Cplx 
  ST40 Cplx 
  ST168 Pplx 
Clade I 
Clade II 
Clade III 
Figure 5.6: Dendogram of EAEC metabolism of 97 EAEC strains separates into three main clades. Strains are coloured by complex and indicated that Biolog 
cannot be used to resolve EAEC into complexes as they are all metabolically heterogeneous. 
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Figure 5.7 Dendrogram of Biolog of 97 EAEC strains coloured by case or control strain 
 
 
  Case 
  Control 
Clade I 
Clade II 
Clade III 
Figure 5.7: Dendogram of EAEC metabolism of 97 EAEC strains separates into three main clades. Strains are coloured by complex and indicated that Biolog 
cannot be used to resolve EAEC into case and control strains as they are all metabolically heterogeneous. 
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Figure 5.8 Dendrogram of Biolog of 97 EAEC strains (pink) with 1479 E. coli 
 
 
 
0.2
Figure 5.8: Dendogram of EAEC metabolism of 97 EAEC strains with 1479 clinical E. coli isolates processed from 2010-2014. 
Dendogram shows that EAEC fall into 4 main clusters. 
Cluster 1 
Cluster 2 
Cluster 3 
Cluster 4 
Cluster 5 
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5.3.4 Serological Distribution with EAEC clonal structure 
Most EAEC serotypes were heterogeneous with respect to ST and dispersed throughout the 
population structure. Some serotypes were predominantly associated with STs (O104:H4-ST678, 
O125ac:H9-ST295, O111:H21-ST40, O153:H30-ST38, O7:H4-ST484) while others were found in 
multiple STs (O126:H27-ST200 & SLV, ST155, O166:H15-ST349 &SLV/DLV, ST130, ST394, O44:H18-
ST449, ST414, ST30). There were no mutually exclusive ST and serotypes found in the EAEC 
population structure (Figure 5.9). 
 
5.3.5 Virulence profiling in EAEC Groups 
Virulence profiling was heterogeneous irrespective of complex, serotype and whether the isolate 
was from a case or control (Appendix 7.4). The average virulence score (total number of virulence 
genes present) was higher in cases (7.3) than controls (6.2), p-value=0.027. The proportion of 
specific individual genes present was similar in cases and controls was similar for most genes (5% 
difference) with p-values for association >0.196, with the exception of the chromosomal gene ipr2 
which was higher in cases (70%) than controls (58%) and borderline significant (p0.107) (Table 5.5). 
 
The majority of virulence EAEC genes (aggR, aat, aap, AAF1-4, astA, pet,pic, setA, ipr2, aaiC and tia) 
were associated with the main complexes (ST 10, 155, 165, 168, 295, 31, 38,394 & 40 Cplx). EAEC 
fimbriae type 5 was not associated with the EAEC main complexes. 
 
Mean of virulence scores per EAEC complex from Bangladesh indicated ST40 and 295 Cplx being the 
most virulent. A multivariable linear regression model with genes as predictors of virulence score 
indicated that ST40 and 295Cplx were statistically associated with more virulence genes than ST 38 
Cplx (the reference group), whereas ST10 and 155 were the least virulent.  
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Figure 5.9 Minimal Spanning Tree of 443 EAEC serotypes 
 
 
 
 
 
 
 
 
 
 
Key Serogroup 
  O153:H30 (9) 
  O104:H4 (8) 
  O166:H15 (7) 
  O111:H21 (6) 
  O126:H27 (5) 
  O134:H27 (4) 
  O130:H27 (4) 
  O4:H33 (4) 
  O44:H18 (4) 
  O44:H34 (3) 
  O86:H30 (3) 
  O125ac:H9 (3) 
  O3:H2 (3) 
  O18ac:H30 (3) 
  O175:H31 (3) 
  O7:H4 (3) 
  Serotype n=<3 
 
Single Locus Variant 
             Double Locus Variant 
             Triple Locus Variant 
10 
678 
295 
38 
40 
200 
394 
34 
130 
31 
484 
155 
Figure 5.9: Minimal Spanning Tree of 443 EAEC serotyped in this study. Tree is colour coded by serotypes 
containing 4 or more isolates. Complexes shaded in grey consist of single locus variants (SLV). MSTree shows 
that some serotypes are ST specific such whereas others are dispersed across different STs indicated that 
serotyping cannot be used to look at genetic relatedness 
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Table 5.5  Virulence gene content in EAEC from cases and controls 
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Case (93) 
72% 
(67) 
80% 
(74) 
86% 
(80) 
14% 
(13) 
22% 
(20) 
17% 
(16) 
15% 
(14) 
18% 
(17) 
43% 
(40) 
22.% 
(21) 
44% 
(41) 
45% 
(42) 
70% 
(66) 
37% 
(34) 
45% 
(42)) 
Control 
(60) 
67% 
(40) 
83% 
(50) 
83% 
(50) 
17% 
(10) 
22% 
(13) 13% (8) 
17% 
(10) 13% (8) 
47% 
(28) 
23% 
(14) 
48% 
(29) 
40% 
(24) 
58% 
(35) 
37% 
(22) 
56% 
(33) 
Probability 0.479 0.562 0.65 0.65 0.981 0.52 0.811 0.419 0.657 0.914 0.607 0.529 0.107 0.989 0.196 
 
Table 5.5: Table showing the content of each gene in association with cases and controls from 153 EAEC from Bangladesh.  
 
Table 5.6  Virulence gene content in EAEC by association of complex (>5 isolates) 
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Probability 
associated 
with 
complex 
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.001 0.217 0.002 <0.001 <0.001 <0.001 <0.001 0.002 <0.001 
 
Table 5.6: Table showing the Complex included sample sizes of 5 or more including ST10 (n=18), 155 (8), 165 (5), 168 (5), 295 (20), 31 (11), 38 (21), 394 (7) and 40 (10) 
complexes. Majority of virulence EAEC genes were associated with the main complexes, EAEC fimbrie type 5 was not associated of being present with the EAEC main 
complexes. 
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Table 5.7  Mean virulence score of EAEC complexes  
Complex Sample size Mean of virulence score 
10 18 6.8 
155 8 6.8 
165 5 4.6 
168 5 6.8 
295 20 9.2 
31 11 7.7 
38 21 6.3 
394 7 5.6 
40 10 10.4 
 
Table 5.7: Mean of virulence scores per EAEC complex from Bangladesh. ST40 and 295 Cplx are the most virulent  in terms of average virulent gene content. 
Table 5.8  Virulence score of complexes in comparison to reference group ST38 complex via linear regression. 
Complex Coefficient Std. Err. t P>/t/ 95% conf. Interval 
10 0.44 0.85 0.520 0.601 -1.23, 2.12 
155 0.29 1.10 0.270 0.790 -1.88, 2.46 
165 -1.73 1.31 -1.320 0.189 -4.33, 0.87 
168 0.47 1.31 0.360 0.723 -2.13, 3.07 
295 2.87 0.82 3.480 0.001 1.23, 4.50 
31 1.39 0.98 1.420 0.158 -0.55, 3.34 
394 -0.76 1.15 -0.660 0.509 -3.04, 1.52 
40 4.07 1.01 4.020 0.000 2.06, 6.07 
 
Table 5.8: Comparison of virulence of complexes in relation to the reference group ST38 Cplx, ST 40 and 295 Cplx are statistically associated as being more virulent than ST 
38 Cplx. 
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5.4 Discussion 
5.4.1 Different EAEC complex’s show variation in intensity of HEp-2 binding 
There are multiple studies reporting proteins responsible for the aggregative adherence (AA) 
phenotype, notably the dispersin protein encoded by aap, EAEC fimbriae, aggR regulator (Bhargava 
et al. 2009;Boisen et al. 2008;Farfan et al. 2008;Moreira et al. 2003;Nataro et al. 1994;Sheikh et al. 
2002). However, there have been no studies to date to assess if different lineages of EAEC have 
different binding capabilities. In this study EAEC lineages have been defined and their association 
with disease or carriage investigated. For reasons already discussed such as carriage, post infection 
immunity and co-infections, sequence type complexes invariably contain a mixture of EAEC from 
cases and controls; the pathogenicity of the lineage itself was investigated in this chapter.  
 
Adherence varied in each of the ST complexes studied irrespective of whether the complex was 
associated with cases or controls. For example adherence was heavy or very heavy in ST394 Cplx 
(associated with cases) and ST31 Cplx (statistically associated with controls, Table 3.3). Variability 
was also seen looking at individual strains where a control or case strain could be light or heavy. This 
study indicated that intensity of adherence was independent of sequence type and not linked to 
whether the isolate had come from a case or a control. 
 
Adherence capabilities of EAEC lineages based on this small study is not an appropriate method to 
assess phenotype for several reasons: 
 
1) The case/control definition varies in literature and assumption that EAEC isolated from a 
diarrhoeal case is the causative agent maybe flawed. For example; co-infections were found 
in 40% of EAEC cases in some studies (Chattaway et al. 2013) demonstrating that EAEC from 
a case may not be capable of causing disease and incorrectly labelled as a case strain. 
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Conversely, strains isolated from a control may not have caused symptoms in that host, but 
maybe capable of causing symptoms in others. 
 
2) The HEp-2 cell assay is laborious with multiple stages and techniques required, it is 
technically demanding and there are multiple stages where the test can go wrong affecting 
the end result. The final result is also qualitative and down to interpretation leading to 
discrepancies between laboratories.  
 
3) There may have been laboratory discrepancies (such as misinterpretation of the slide) 
historically so it would not be possible to do a fair comparison to with current results. Also, 
technicians only stated an end point of adherence type, there have been no attempts to 
quantify the levels of adherence (light to heavy) and so this information was not available. 
 
4) There was no control over strain selection at the time of this study which was based in 
another laboratory with access to a selection of the Nigerian EAEC strains. The main 
complexes of EAEC were not yet defined and so the strains selected were based on results of 
the Nigerian study (Okeke et al. 2010) which did not represent all of the important groups 
identified in this study, such as ST295 and 40 Cplx. 
 
This study shows a complicated picture of adherence in relation to ST lineages and demonstrates 
further that EAEC pathogenicity is complex and multi-factorial. While ST groups associated with 
disease show heavy binding capabilities, so do control groups. In strains belonging to other lineages 
the binding capabilities were more variable (Table 5.4). What this study does clearly show is that 
strain adherence capability alone is not associated with cases or controls. Other factors such as co-
infections (as discussed in Chapter 2) (Chattaway et al. 2013) or immunity (Nataro et al. 1995) or 
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virulence factors (Jenkins et al. 2007) as discussed in this chapter are all likely to play a role in 
infection. 
5.4.2 EAEC complexes vary in lethality in worms 
The EAEC complexes were statistically significant in reducing the survival time of the worms but due 
to the limitations of the log rank test  (which can only assess data as a whole) it was not possible to 
determine which complex were the most pathogenic. This analysis highlights that the successful 
complexes of EAEC  have evolved independently and in a variety of ways as described in Chapter 4 
(Chattaway et al. 2014b) and therefore show different phenotypic characterisitics and have different 
pathogenicity potential. This is unsurprising since EAEC are heterogeneous in terms of genetic 
background, virulence gene content and plasmid compatibility (Okeke et al. 2010). 
 
Data was further analysed using a Cox regression analysis which indicated that all EAEC within the 
complexes were statistically more lethal to worms than non – EAEC control strain pir116. EAEC have 
been shown to colonize distal to the worm grinder (and hence avoid being destroyed by the grinder) 
and throughout the entire length of the worms intestine whereas colonisation is not seen with non-
EAEC control strains (OP50) (Hwang et al. 2010). It was therefore expected that the EAEC strains 
would be comparable with the pathogenic control EAEC strain 042 (the prototypical EAEC strain 
associated with disease) and this was confirmed in this study. The most pathogenic group in terms of 
colonising and killing the worms was ST168 (P=0.007) followed by ST38 (P=0.009), ST31 (P=0.42) and 
ST394 Cplxs (p=0.050). The results were not comparable with the adherence intensity of the HEp-2 
assay in this study where ST31 and 394 Cplxs had the overall heaviest adherence to HEp-2 cells and 
ST38 and 168 were more variable and lighter in its adherence. This shows that intensity of 
adherence on HEp-2 cells is not linked to colonisation in the worm model. 
 
There was no difference in colonisation (as seen in the worm model) as to whether the EAEC isolate 
was from a ‘case’ or ‘control’. For example a ‘control’ isolate in a complex could have a faster kill 
 171 
 
time than a ‘case’ whereas overall ‘case’ isolates within a complex were statistically different from 
the non-EAEC control strain indicating that phenotypic colonisation varies within a complex. This 
could be evidence of homoplasy where strains within each ST complex have not come from the 
same ancestral source but exhibit similar properties and have converged from different sources to 
the same ST complex and therefore exhibit different phenotypes.  
 
The C. elegans worm model has been shown to be a successful model for assessing EAEC pathogenic 
ability where EAEC colonise the distal C. elegans intestine, whereas non-pathogenic E. coli strains do 
not (Hwang et al. 2010). It is logical therefore that EAEC strains from control sources would also have 
a lethal effect on C. elegans. These data  illustrates that, even on a small subset of EAEC from 
different successful complexes, there was variability  between different complexes with respect to 
their ability to cause disease, that strains within a complex can vary and that there was a slight 
difference in the disease EAEC strains versus the carriage EAEC strains within a complex.  
The EAEC strains were the same set tested with the HEp-2 and therefore too small a sample set to 
make statistically significant conclusions. Larger studies of more EAEC isolates within a complex with 
multiple biological repeats and including additionalcomplexes are required to assess if the difference 
described here are consistent as the dataset expands. The worm model assay is also laborious and 
technically demanding and while it has been shown to be a successful model in linking genes to EAEC 
pathogenicity via mutational studies (Hwang et al. 2010) , in this study there was too much 
variability of the strains within a complex to use this approach to assess the pathogenicity of each 
lineage. 
5.4.3 EAEC metabolism varies with complexes 
 
We know that EAEC strains have not evolved from a recent common ancestor rather there has been 
selection of distinct lineages to create the EAEC group. Strains exposed to the same ecological niche, 
the human GI tract, should be under the same selective pressures and should have evolved to 
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adaptat to their environment in the same way. We therefore hypothesised that metabolic ability 
would be similar within the EAEC groups. This metabolic similarity is observed in other groups of 
pathogenic E. coli such as enteroinvasive E. coli and Shigella sonnei. This study clearly shows that 
metabolism of 95 different carbon sources utilised by EAEC strains do not fully resolve into clusters 
associated with ST complexes. This suggests that EAEC strains within a complex may have adapted 
differently from each other. There are clear clusters of complexes, perhaps indicative of ancestral 
evolution, but there are also mixtures of different complexes clustering together and examples 
where the same complex spread across the dendogram (Figure 5.6). This variable metabolism 
further strengthens the theory that groups of EAEC evolved independently and are converging to 
several distinct successful complexes. There was no resolution of metabolic capabilities according as 
to whether a strain was from a case or control (Figure 5.7). With additional factors such as host 
immunity in which a pathogenic EAEC may not cause disease and co-infections where a carriage 
EAEC strain would be isolated from a case, it is unlikely that the definition of case and control strains 
of EAEC in this study are robust. However,  this analysis does indicate,  that EAEC continue to be a 
highly adaptive organism capable of surviving in a variety of ecological niches and therefore 
variability of phenotypic ability is vital in its survival. 
 
Comparison of EAEC metabolic ability in the content of 1479 clinical E .coli gave distinct clustering of 
EAEC into five main clusters (Figure 5.8). Though these clusters contained a variety of serotypes and 
ST complexes (5.3.4 & Appendix 7.1), and therefore it was not possible to differentiate lineages, it 
was possible to identify EAEC signatures. Further work should involve expanding the EAEC strain 
collection representing all of the main complexes and linking information such as clinical source 
(blood, urine faeces, commensal) and symptoms to ascertain if the which metabolic activity is linked 
to clinical symptoms or specific environmental source. 
 173 
 
5.5.4 Can serotyping be used to identify pathogenic lineages of EAEC? 
In this study we found no correlation between the EAEC complexes and serotype (Figure 5.9). Since 
the development of sequence based typing, such as MLST, the use of traditional typing methods, 
such as serotyping as a means of defining population structure (Hartl and Dykhuizen 1984;Tenaillon 
et al. 2010) have come under close scrutiny. Studies have shown that the same serogroups are found 
in genetically unrelated strains of E. coli indicating possible horizontal gene transfer (Beutin et al. 
2005) of the cassette encoding the serogroup genes. 
This demonstrates that typing bacteria on the basis of a single set of genes clustered at the same 
locus, with a product under diversifying selection can result in the clustering of strains which are not 
related ancestrally. On the other hand genes for MLST, which are spread across the whole genome  
(Figure 1.5) are chosen because they encode housekeeping functions (Table 1.2) and so are under 
stabilising selection and accumulate mutations through genetic drift (Cooper and Feil 2004;Turner 
and Feil 2007). This provides a population framework based on ancestry where identical genotypes 
are closely related. This is important because it enables the identification of high risk clones for 
epidemiology such as STEC ST 11 (O157:H7), ST 21 and 29 (O26:H11) and ST678 (O104:H4) 
(Chattaway et al. 2011). 
 
Although some serotypes were associated with single clonal complexes (Figure 5.9), we conclude 
that serotyping is not a suitable method for determining ancestral relatedness of EAEC and cannot 
be used for the identifying pathogenic lineages within EAEC. This may in part be attributable to the 
high recombination rates in some lineages.  
 
5.5.5 Some EAEC complexes are more virulent than others 
Multiple studies including this one, have shown that EAEC is a heterogeneous group in relation to 
virulence gene content , and importantly, there is no consistent chromosomal marker (Okeke et al. 
2010).  There are no studies  assessing whether EAEC complexes contain more virulence genes than 
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others. This has not been attempted as EAEC complexes have not been previously defined as 
described in Chapter 3. 
 
All EAEC genes with the exception of aaf5A were statistically associated with being present in the 
main complexes (Table 5.6). EAEC fimbriae type 5 is a relatively new fimbriae type (Dallman et al. 
2012) and found in low numbers in this dataset and may explain why this gene is not associated with 
the complexes in this dataset. The statistical association of the other EAEC virulent genes support 
the MLST data that these are successful EAEC complexes able to stably retain the plasmid and 
chromosomal EAEC markers. 
 
The association of genes versus EAEC from cases and control was assessed and compared to 
previous studies (Jenkins et al. 2006a). Results showed that the virulence genes had no statistical 
association with cases over controls. This includes  the aaiC  gene (a chromosomal marker encoding 
a secreted protein of the EAEC pathogenicity island AAI, which is co-ordinately regulated by the aggR 
activator). This aaiC  gene has been suggested in a recent study to be  an important component of 
regulating the EAEC pathogenicity AAI Island and that AAI operon deficient strains may have reduced 
pathogenicity irrespective of other virulence gene content (Dallman et al. 2014). In this study, the 
presence of aaiC was higher in controls (56%) than cases (45%) from Bangladesh EAEC strains (Table 
5.5) conflicting this previous study. However, the Dallman et al study was analysing strains relating 
to a complex multi-strain outbreak of travellers in which the larger numbers of specific ST types did 
have the aaiC gene. The Bangladesh dataset is from an endemic region where ‘control’ patients 
(non-travellers) may have acquired immunity. What this study does highlight is that the EAEC strains 
were not consistently found with the regulator gene aggR, indicating that even regulation of genes 
in EAEC is heterogeneous and that there may be multiple regulation factors involved. 
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Previous studies have mainly shown that there is no pattern of specific makers being related to 
disease, as all of the makers are found in either cases or controls (Jenkins et al. 2006a;Okeke et al. 
2010). There is one exception, where a small study in Brazil found a capsular (kps) marker only found 
in cases, but this was in one community and found in only 50% of case strains (Regua-Mangia et al. 
2009). The dataset in this part of the study comprised the Bangladesh strains only and although it 
represented a large proportion of EAEC complexes it did not take into consideration the global 
variation of the EAEC strains. However, results indicate that characterising EAEC from a small 
population without exposure to travel (and therefore an additional subset of EAEC in the 
community) still results in a very heterogeneous group. Virulence typing continues to produce 
heterogeneous results for characterising EAEC and there is no definite pathogenic EAEC marker. 
 
Diagnostically, if the true burden of EAEC is to be determined then the local hospital and regional 
laboratories need a robust assay targeting an EAEC specific gene or combination of genes.  Although 
this study and recent studies have found aaiC in both cases and controls (Boisen et al. 2012;Lima et 
al. 2013), it is recognised as an important marker for clinically significant EAEC and is now used 
alongside aat to detect EAEC (Boisen et al. 2012;Dutta et al. 2013;Taniuchi et al. 2013). In the United 
Kingdom, aggR is used as the primary target for screening diagnostically as it has found to be more 
consistently present in EAEC than aat (Public Health England, Colindale). AaiC is included in follow-
up characteristic studies. Historically previous studies focused on the virulence genes found on the 
plasmid and genetic background (i.e. EAEC complexes) was not considered as important factor in 
association with EAEC disease. This study showed that it is essential to consider the contribution of 
genetic background to the pathogenic potential of strains of EAEC. It is concluded that there are 
important, successful and prevailing complexes associated with cases that contain multiple EAEC 
virulence factors. 
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ST40 and 295 had the highest virulence score (9.6 & 8.3 respectively) (Table 5.7). This was confirmed 
when comparing the virulence score of the complexes against a reference group ST38 Cplx (Table 
5.8). ST38 Cplx was chosen as a reference group as it contained the largest number of strains and 
therefore was assumed to be representative of strain variation with in complex. The ST31 Cplx was 
statistically associated with being a control group (P=0.005, table 3.3) but its virulence score was 
higher than other disease complexes. This may be attributed to  the low numbers of Bangladesh 
ST31 Cplx strains (11/50 strains, 22%) and so the strains included for analysis may not be 
representative of the virulence content within this complex. This study shows that virulence within 
complexes does vary and that some complexes are more virulent than others. ST40 Cplx had the 
highest virulence profile score (Table 5.7) and was shown to be statistically associated with disease 
(Table 3.3) and was significantly  associated with being an EAEC complex (Table 3.4). ST295 Cplx also 
had a high virulence score and statistically associated as an EAEC complex (Table 3.4) but not 
statistically associated with disease (Table 3.3). When analysing table 3.3, it was seen that the largest 
complexes (i.e. containing the most strains) including ST10, 40 and 31 Cplx are statistically relevant 
and contain over 50 isolates but any groups containing less than 50 isolates are not significant 
indicating that these groups are potentially clinically relevant but that the dataset is too small for 
statistical significance. 
 
Although the functions of many of these genes have been described, a full understanding of the 
functions and how they interact with other genes are not known. While each virulence genes was 
not independently significantly associated with the ability to cause disease, the number and 
combination of virulence genes could be significant. This study illustrates how a combination of 
defined EAEC complexes in association with known virulence gene profiles can contribute to the  
clinical picture and that the genomic background and virulence gene content may relate to disease. 
For example it is known that from previous studies ST11 (O157:H7) with the stx gene is clinically 
important, this study highlights that ST40 EAEC is associated with disease and high virulence 
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potential as shown a recent EAEC/STEC household outbreak (Dallman et al. 2012). ST38 Cplx (Table 
3.5), shown to be associated with extra-intestinal infection had an average high virulence score of 9 
(including extra-intestinal virulence markers) (Chattaway et al. 2014a). ST38 Cplx in the Bangladesh 
set had an average high virulence score of 6 though over 50% of the strains had a higher score 
(Figure 7.4). Other complexes such as ST678 (Chattaway et al. 2011) and 278 Cplx (both of which are 
not represented by the Bangladesh subset) are associated with outbreaks (Figure 3.5) as described in 
Chapter 3 and are also likely to have a high virulence score. 
5.5 Summary 
 
This study demonstrated that the diverse genetic backgrounds of EAEC also have heterogeneous 
phenotypes; there is no obvious link between different phenotypic models of EAEC complexes and 
pathogenesis as defined by belonging to a case or control. There is not one EAEC complex that is 
directly linked to a particular phenotype or disease capability. This  confirms the heterogeneous 
nature of EAEC and provides further evidence of the likelihood of independent evolution, homoplasy 
and convergence of the EAEC phenotype from multiple ancestral lineages. In this work, because of 
the small sample size of the strains selected and the complexity of the the in vitro models of 
pathogenesis, this approach did not help resolve the central question of the thesis.  However, the 
genotypic model of linking virulence genes to defined EAEC complexes showed how certain EAEC 
complexes are more virulent and therefore clinically relevant in public health. 
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Chapter 6 - Discussion 
Prior to this study in 2009, EAEC was defined as the ability of adhere to HEp-2 cells in a stacked 
bricked formation  and/or contain the AA plasmid and was known to cause diarrhoea in developing 
and developed countries (Okeke & Nataro 2001). EAEC was not recognised as an important 
pathogen in the UK as shown by protocols for the detection of gastrointestinal (GI) pathogens at 
frontline hospital laboratories which did not include EAEC. The second intestinal infectious disease 
(IID) study in 2008-2009 was reanalysed in this study to ascertain if the association between EAEC 
carriage and diarrhoea was causal. Taking bacterial load and co-infection of other pathogens into 
account, EAEC accounted for approximately 1% of diarrhoeal disease annually in the UK, equivalent 
to Salmonella, confirming that EAEC was an important pathogen in the UK (Chattaway et al. 2013). 
 
In 2011 awareness of EAEC as a significant pathogen of GI disease was further increased by a large 
outbreak of HUS in Germany caused by an EAEC strain (ST678 and serotype O104:H4) that acquired 
the stx phage from a STEC (Chattaway et al. 2011). In preparation for the London Olympics in 2012, a 
multiplex PCR was developed for the detection of common gastrointestinal pathogens, including 
EAEC.  This assay was subsequently was rolled out to frontline laboratories. Select laboratories 
continue to use this assay in the event of an outbreak which has detected EAEC in samples that 
would have previously been missed. These samples were sent to the Gastrointestinal Bacteria 
Reference Unit (GBRU) for isolation and typing. GBRU introduced routine detection of EAEC in 2012 
and have seen an increase of EAEC for identification in the past two years (Figure 6.1).  EAEC have 
been isolated from routinely screened faeces originally submitted for testing for STEC or Shigella 
indicating that some strains of EAEC can cause severe symptoms and that many clinicians are still not 
aware of EAEC as a potential aetiological agent for IID. 
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Figure 6.1 Number of EAEC detected at GBRU 
 
 
Figure 6.1: Number of EAEC detected  over the past four years at Gastrointestinal Bacteria Reference Unit, 
Public Health England, Colindale. 
 
 
EAEC is independently capable of causing disease even when accounting for co-infections and 
people are 2.5 times more likely to have IID if they have EAEC present in their stool (Chattaway et al. 
2013). Clearly EAEC is an important cause of gastrointestinal disease and accounts for ~ 1% of IID in 
the UK, but it can also be carried asymptomatically (Chattaway et al. 2013) suggesting that there are 
different strains that vary in their ability to cause disease. An investigation of the population 
structure of EAEC using isolates from case control studies and routinely isolated strains was carried 
out to look for lineages associated with disease or carriage. 
 
Within the global EAEC population over the past 30 years, there were multiple successful EAEC 
lineages characterised by the ability to maintain carriage of the EAEC plasmid (Chapter 3). These 
lineages have continued to expand over time and develop single, double and triple locus variants 
particularly the ST10, 31, 40 and 295 Cplxs and were found in multiple countries across the globe 
(Figure 3.2). This study defined successful EAEC lineages associated with disease, the largest (10 
strains or more) being ST 10, 38, 40, 295, 278, 394, 678 and 746 (DLV to ST10) Cplx. When using this 
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population structure approach in the context of other public health concerns it was discovered that 
there is an emerging extra-intestinal ST38 EAEC Cplx with multiple drug resistance (Chattaway et al. 
2014a) and two important groups associated with multiple EAEC outbreaks including ST678 
(Chattaway et al. 2011) and ST278 Cplx (Chapter 3, Figure 3.5). Now that these clinically relevant 
EAEC groups have been defined they can be used when interpreting data. 
 
Further analysing this population structure via ClonalFrame indicated multiple genetic events across 
the MLST loci and that a combination of mutation and recombination events were responsible for 
the evolution of this pathotype (Chapter 4, Figure 4.2) (Chattaway et al. 2014b). Overlaying the EAEC 
population structure with the entire E. coli phylogeny showed that these successful EAEC groups 
were dispersed throughout the E. coli population (Chapter 4) (Chattaway et al. 2014b), again 
indicating independent evolution of EAEC lineages. These lineages were not resolved into distinct 
case and control lineages indicating that other factors such as the bacterial phenotype (for example 
intensity of adherence), the definition of a ‘case’, co-infection or host variation may play a role the 
ability of a given EAEC strain to cause disease.  
 
When looking at pathogenicity models to link genotype to phenotype, results were variable in terms 
of strain variability and reproducibility between models (Chapter 5). EAEC was more lethal in the 
worm model than non-pathogenic E. coli but the rate of killing was variable between strains within a 
complex. The least survival time of the worm model was linked to ST168 Cplx yet the adherence 
assay showed light adherence. The highest level of adherence was seen with ST31 & ST394 Cplx but 
these were the least pathogenic groups in the worm model. The phenotypic HEp-2 assay and worm 
model were inconclusive. A larger more comprehensive study may resolve results, particularly in 
light of the knowledge gained during the cause of this study. 
 
 182 
 
Although there were serotypes exclusively from cases (O3:H2, O44:H18, O104:H4, O111:H21, 
O126:H27and O134:H27) we found no link between a sequence type and a single serotype in this 
study. Although some serotypes were associated with single clonal complexes, they were not 
mutually exclusive and high recombination rates in some lineages meant that a given serotype could 
also be distributed in different complexes (Chapter 5, Figure 5.9). Due to the fact that serotyping did 
not always correlate with genetic relatedness or disease, it cannot be used to infer genetic 
background or pathogenicity. 
 
The metabolic activity, as measured by the Biolog, was variable with all of the complexes with 
different complexes falling into the same clusters (Figure 5.6). These data produced further evidence  
that these organisms did not evolve from one ancestral source expanding into different complexes 
with the same phenotypic abilities. Instead, it seems likely that there were multiple events in 
different lineages and that these groups evolved independently and have converged into the 
successful and established EAEC phenotype. This model of evolution suggests selective pressure is at 
work. 
 
The genotypic model of linking virulence gene content to the defined EAEC complexes in this study 
showed that some complexes were more virulent than others. ST40 Cplx had the highest virulence 
score (Chapter 5, Table 5.34 & 5.3.5), was statistically associated with disease (Table 3.3) and being 
associated as an EAEC complex (Table 3.4) and has been implicated in a recent EAEC/STEC household 
outbreak (Dallman et al. 2012). The approach used in this study has been unique by defining 
successful EAEC complexes associated with disease and then testing these groups to assess clinical 
relevance in the context of public health.  
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6.1 Further work 
 
This work could be taken further by investigating Biolog as a tool to identify EAEC from other E. coli. 
Biolog is currently used as a tool for identification of E. coli at the reference laboratory (Public Health 
England) but this study has highlighted potential clusters of EAEC that separate from the other E. coli 
(Figure 5.8). These clusters are only based on 97 EAEC and a small subset so a larger dataset would 
be required to assess if EAEC do differentiate from other E. coli. It was shown that the clusters are 
not by defined ‘cases’ or complexes but could be for other reasons such as the source of E. coli 
(urine, blood, faeces) and severity of symptoms which could be assessed. 
This project has been based on MLST which is small representation on the core genome, ideally, this 
dataset could be further sequenced by whole genome sequencing and the core and accessory 
genome used for further analysis.  
This would help ascertain: 
1) If the MLST population structure is a true representation of the EAEC phylogeny (using core 
genome) 
2) A base line for variation of the complexes for future outbreak investigation (such as single 
nucleotide polymorphism analysis of the core genome) 
3) A true picture of all virulence genes present rather than a specific selection, other genes 
maybe highlighted as being important. 
4) Redefining what is an EAEC case, currently the definition is an EAEC isolated from a case but 
this does not mean it is pathogenic. 
This study has enabled an understanding of the complexes associated with disease but none of these 
methods such as the HEp-2 assay, virulence typing or population structure define disease. There are 
clearly sub-populations of EAEC that are pathogenic but can still be in asymptomatic controls. This 
highlights the complexity and heterogeneous nature of this organism and that more information is 
needed. A comparison analysis of clinical information and the techniques used throughout this thesis 
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can be used with whole genome sequence data to determine markers and redefine the group as 
pathogenic and not whether it is ‘EAEC’. 
 
6.2 Conclusion 
 
The analysis of the data generated during this study has enabled the original objectives to be met as 
described below: 
i. Methods to assess disease burden using results of a semi-quantitative real-time PCR 
assay to diagnose EAEC aetiology in episodes of IID in the UK were developed (Chapter 
2). This study has shown that EAEC is capable of causing disease independently of other 
co-infections and is responsible for 1% of gastrointestinal infection in the UK (Chattaway 
et al. 2013). 
ii. The population structure of EAEC globally has been defined and divided into 
phylogenetically relevant groups to allow analysis of the association between defined 
groups and disease (Chapter 3). This study has defined clinically relevant EAEC Cplxs and 
the approach has been used in public health investigations (Chattaway et al. 
2011;Chattaway et al. 2014a;Dallman et al. 2012)  
iii. The ancestry of the defined groups has been analysed (Chapter 4). This study has shown 
how these groups have independently evolved via mutation and recombination events 
(Chattaway et al. 2014b). 
iv. The genotype phenotype associations to define characteristics which may be useful for 
diagnosis has been investigated (Chapter 5). This study has shown the phenotypic 
association with disease Cplxs and that genes associated with disease can be useful in 
public health investigation (Dallman et al. 2014). 
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EAEC is an important aetiological agent of gastrointestinal disease and several clinically relevant 
complexes have been defined to facilitate public health investigations. This study showed that many 
groups of E. coli known as EAEC have independently evolved and that the heterogeneous nature has 
enabled EAEC to expand globally and patho-adapt to cause extra-intestinal infections and STEC 
outbreaks. The novel approach in understanding the population structure of EAEC used in this study 
has had a positive impact on public health by facilitating outbreak investigations 
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Chapter 7 - Appendix 
7.1 Characteristics of 564 EAEC strains, isolated from human faeces, used in this study 
Isolate MOLIS No. Country Source Pathogen Year Somatic Flagella ST ST Complex Allelic Profile 
3026 H103320332 Bangladesh GEMS Study Control 2007-2011 O? 27 TLV TLV 6 11 4 8 9 2 7 
1037 H103320336 Bangladesh GEMS Study Case 2007-2011 159 23 1490 None 9 6 204 131 24 8 7 
1038 H103320334 Bangladesh GEMS Study Case 2007-2011 25 H- SLV None 6 11 4 8 0 78 2 
3036 H103320339 Bangladesh GEMS Study Control 2007-2011 113 H- DLV None 0 11 4 8 67 8 2 
7064 H102400217 Bangladesh GEMS Study Control 2007-2011 153 36 157 None 33 57 58 63 37 5 4 
7067 H102340354 Bangladesh GEMS Study Control 2007-2011 86 27 2166 None 6 29 5 16 9 8 44 
7092 H102340349 Bangladesh GEMS Study Control 2007-2011 125ac 8 1295 None 6 4 5 9 9 8 2 
7121 H102340363 Bangladesh GEMS Study Control 2007-2011 77 18 DLV None 35 35 12 52 5 0 4 
900694 H103820323 Bangladesh GEMS Study Case 2007-2011 O? 24 219 None 58 53 53 58 24 1 42 
900693 H103820322 Bangladesh GEMS Study Case 2007-2011 44 H- 720 None 35 3 58 6 5 16 4 
900553 H103800321 Bangladesh GEMS Study Case 2007-2011 51 12 DLV None 8 0 1 8 24 1 42 
900512 H103780407 Bangladesh GEMS Study Case 2007-2011 O? 23 157 None 33 57 58 63 37 5 4 
900063 H103760530 Bangladesh GEMS Study Case 2007-2011 O? 23 720 None 35 3 58 6 5 16 4 
900851 H104080228 Bangladesh GEMS Study Case 2007-2011 125ac 11 SLV None 76 15 13 15 30 14 2 
900794 H104080226 Bangladesh GEMS Study Case 2007-2011 O? 10 SLV None 6 11 4 8 24 8 14 
900753 H104120574 Bangladesh GEMS Study Case 2007-2011 166 15 SLV None 34 36 207 87 67 8 4 
900732 H113860291 Bangladesh GEMS Study Case 2007-2011 O? 7 1891 None 6 4 3 26 7 8 6 
900550 H104080224 Bangladesh GEMS Study Case 2007-2011 128 12 1326 None 6 220 3 26 9 7 7 
900442 H103840253 Bangladesh GEMS Study Case 2007-2011 121 H? SLV  None 8 0 1 8 7 18 6 
900245 H104080225 Bangladesh GEMS Study Case 2007-2011 161 H- TLV None 0 0 4 8 0 8 2 
900770 H104120576 Bangladesh GEMS Study Case 2007-2011 69 4 678 None 6 6 5 136 9 7 7 
900769 H104120575 Bangladesh GEMS Study Case 2007-2011 69 4 1891 None 6 4 3 26 7 8 6 
600961 H104400252 Bangladesh GEMS Study Case 2007-2011 69 38 3107 None 10 11 5 8 7 219 2 
600965 H104400253 Bangladesh GEMS Study Case 2007-2011 126 7 1891 None 6 4 3 26 7 8 2 
600982 H104180063 Bangladesh GEMS Study Control 2007-2011 166 15 DLV None 34 36 2 25 5 16 4 
601062 H104560240 Bangladesh GEMS Study Case 2007-2011 2 42 SLV None 92 4 87 96 70 58 11 
601087 H104580566 & 
H113860293 
Bangladesh GEMS Study Case 2007-2011 O? 45 3051 None 225 274 307 248 24 2 64 
601098 H104320306 Bangladesh GEMS Study Control 2007-2011 O? 45 SLV None 52 54 46 48 0 40 38 
601101 H104500402 & 
H113860294 
Bangladesh GEMS Study Case 2007-2011 O? 23 SLV None 6 4 5 16 11 8 2 
601106 H104320307 Bangladesh GEMS Study Control 2007-2011 O? 23 2186 None 6 4 5 16 11 8 6 
601155 H113860295 Bangladesh GEMS Study Control 2007-2011 O? 30 678 None 6 6 5 136 9 7 7 
601158 H104500404 Bangladesh GEMS Study Case 2007-2011 2 H- 3738 None 92 4 87 96 70 58 7 
601174 H113860297 Bangladesh GEMS Study Control 2007-2011 78 7 1891 None 6 4 3 26 7 8 6 
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601175 H104500405 & 
H113860298 
Bangladesh GEMS Study Case 2007-2011 8 9 720 None 35 3 58 6 5 16 4 
601176 H104500406 Bangladesh GEMS Study Case 2007-2011 O? H- 720 None 35 3 58 6 5 16 4 
601180 H104380396 Bangladesh GEMS Study Control 2007-2011 O? 23 2186 None 6 4 5 16 11 8 6 
900108 H104060670 Bangladesh GEMS Study Case 2007-2011 21 8 1295 None 6 4 5 9 9 8 2 
H103060197 H103060197 UK GBRU Case 2010 O? H? SLV None 76 43 9 36 0 14 10 
H093880675 H093880675 UK GBRU Case 2009 O? H? 504 None 76 43 9 36 17 14 10 
900883 H104120572 Bangladesh GEMS Study Case 2007-2011 44 23 720 None 35 3 58 6 5 16 4 
2506 H101200081 UK IID2 Case 2008 153 2 120 None 49 4 44 9 11 35 7 
G146  - Nigeria Okeke Study Control 1995  -  - 483 None 56 11 4 110 8 83 83 
G125  - Nigeria Okeke Study Control 1995  -  - 499 None 64 7 12 8 78 18 6 
G150a  - Nigeria Okeke Study Control 1995  -  - 499 None 64 7 12 8 78 18 6 
G115  - Nigeria Okeke Study Control 1995  -  - 513 None 56 133 12 1 9 5 7 
D05  - Nigeria Okeke Study Case 1995  -  - 489 None 56 4 15 112 9 2 7 
G112a  - Nigeria Okeke Study Control 1995  -  - 511 None 108 4 33 114 20 12 7 
G80a  - Nigeria Okeke Study Case 1995  -  - 940 None 6 6 22 16 11 1 7 
G05b  - Nigeria Okeke Study Case 1995  -  - 455 None 56 6 22 16 11 1 7 
C66  - Nigeria Okeke Study Control 1995  -  - 455 None 56 6 22 16 11 1 7 
G74  - Nigeria Okeke Study Case 1995  -  - 424 None 6 30 32 16 11 8 7 
G30a  - Nigeria Okeke Study Case 1995  -  - 438 None 40 13 9 13 16 0 9 
G01b  - Nigeria Okeke Study Case 1995  -  - 557 None 56 4 15 18 9 8 6 
D08  - Nigeria Okeke Study Case 1995  -  - 464 None 56 4 3 18 9 8 6 
G01  - Nigeria Okeke Study Case 1995  -  - 435 None 56 4 15 102 9 73 6 
E10  - Nigeria Okeke Study Case 1995  -  - 435 None 56 4 15 102 9 73 6 
D34a  - Nigeria Okeke Study Case 1995  -  - 481 None 56 11 100 1 20 8 2 
D33b  - Nigeria Okeke Study Case 1995  -  - 481 None 56 11 100 1 20 8 2 
G37a  - Nigeria Okeke Study Case 1995  -  - 52 None 6 11 5 1 20 8 2 
G67  - Nigeria Okeke Study Case 1995  -  - 515 None 57 11 1 109 7 8 2 
C78a  - Nigeria Okeke Study Control 1995  -  - 468 None 57 11 1 109 7 81 2 
C05a  - Nigeria Okeke Study Case 1995  -  - 437 None 9 117 99 18 11 8 6 
E66  - Nigeria Okeke Study Control 1995  -  - 470 None 56 4 14 16 24 40 14 
G83  - Nigeria Okeke Study Case 1995  -  - 506 None 20 45 0 105 7 50 80 
G16  - Nigeria Okeke Study Case 1995  -  - 454 None 20 45 56 105 7 50 80 
E59  - Nigeria Okeke Study Control 1995  -  - 456 None 56 11 95 104 8 7 2 
G107  - Nigeria Okeke Study Control 1995  -  - 456 None 56 11 95 104 8 7 2 
G106  - Nigeria Okeke Study Control 1995  -  - 450 None 6 11 95 104 8 7 2 
E16  - Nigeria Okeke Study Case 1995  -  - 434 None 52 116 55 101 35 40 0 
E07  - Nigeria Okeke Study Case 1995  -  - 485 None 52 116 55 101 35 40 38 
G112  - Nigeria Okeke Study Control 1995  -  - 500 None 6 11 15 9 63 18 7 
G122  - Nigeria Okeke Study Control 1995  -  - 502 None 64 7 17 1 8 8 2 
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E54a  - Nigeria Okeke Study Control 1995  -  - 362 None 62 100 17 31 5 5 4 
E72  - Nigeria Okeke Study Control 1995  -  - 362 None 62 100 17 31 5 5 4 
C54a  - Nigeria Okeke Study Control 1995  -  - 459 None 46 4 87 29 77 9 22 
C54b  - Nigeria Okeke Study Control 1995  -  - 459 None 46 4 87 29 77 9 22 
D31b  - Nigeria Okeke Study Case 1995  -  - 144 None 13 43 9 36 30 44 25 
E04  - Nigeria Okeke Study Case 1995  -  - 728 None 64 4 96 1 24 8 6 
C83  - Nigeria Okeke Study Control 1995  -  - 496 None 56 11 103 113 8 1 2 
G110b  - Nigeria Okeke Study Control 1995  -  - 491 None 13 39 19 36 30 14 82 
G04  - Nigeria Okeke Study Case 1995  -  - 425 None 64 196 188 83 24 8 6 
G52  - Nigeria Okeke Study Case 1995  -  - 422 None 56 95 3 18 11 8 14 
C28  - Nigeria Okeke Study Case 1995  -  - 486 None 0 0 101 39 8 8 2 
E100869  - UK IID1 Case 1994 125ab 27 495 None 10 11 4 10 12 8 2 
E105358  - UK IID1 Control 1994 O? H? SLV None 6 29 5 26 8 8 6 
E105835  - UK IID1 Case 1994 125ab H? 495 None 10 11 4 10 12 8 2 
E107532  - UK IID1 Case 1994 O? H? 937 None 6 29 5 26 24 8 6 
E093414  - UK IID1 Control 1993 128ac H? 1326 None 6 220 3 26 9 7 7 
E099534  - UK IID1 Case 1994 86 34 117 None 20 45 41 43 5 32 2 
E89099  - Bangladesh Outbreak  E Case 1998 28ab 18 1657 None 21 35 2 52 5 5 182 
E89104  - Bangladesh Outbreak  E Case 1998 141 49 111 None 6 29 14 16 24 8 2 
E89106  - Bangladesh Outbreak  E Case 1998 R 7 1891 None 6 4 3 26 7 8 6 
H123280788 H123280788 UK GBRU Case 2012 104 4 678 None 6 6 5 136 9 7 7 
H123630425 H123630425 UK GBRU Case 2012 136 54 329 None 64 4 5 83 24 8 6 
H125280573 H125280573 UK GBRU Case 2012 104 4 678 None 6 6 5 136 9 7 7 
H131920216 H131920216 UK Spice Outbreak Case 2013 104 4 678 None 6 6 5 136 9 7 7 
H131920218 H131920218 UK Spice Outbreak Case 2013 104 4 678 None 6 6 5 136 9 7 7 
H131941062 H131941062 UK Spice Outbreak Case 2013 104 4 678 None 6 6 5 136 9 7 7 
H131941063 H131941063 UK Spice Outbreak Case 2013 104 4 678 None 6 6 5 136 9 7 7 
H131941070 H131941070 UK Spice Outbreak Case 2013 104 4 678 None 6 6 5 136 9 7 7 
H112180280 H112180280 UK German 
Outbreak 
Case 2011 104 4 678 None 6 6 5 136 9 7 7 
767 H100720284 UK IID2 Case 2008 59 H- 1136 None 6 212 4 1 9 48 7 
7004 H102340360 Bangladesh GEMS Study Control 2007-2011 O? 26 2067 None 6 95 3 18 11 122 2 
1773 H100280372 UK IID2 Case 2008 O? 30 DLV None 6 196 1 1 8 8 20 
7071 H102420449 Bangladesh GEMS Study Case 2007-2011 130 35 3670 None 6 4 4 16 24 2 14 
7155 H102320115 Bangladesh GEMS Study Case 2007-2011 25 H- SLV None 6 11 4 8 0 78 2 
1024 H103320333 Bangladesh GEMS Study Case 2007-2011 130 27 10 ST10 Cplx 10 11 4 8 8 8 2 
1027 H103320341 Bangladesh GEMS Study Case 2007-2011 O? H- SLV ST10 Cplx 10 0 4 8 8 8 2 
1116 H103320335 Bangladesh GEMS Study Case 2007-2011 O? 33 10 ST10 Cplx 10 11 4 8 8 8 2 
3074 H102400210 Bangladesh GEMS Study Control 2007-2011 56 48 34 ST10 Cplx 10 11 4 1 8 8 2 
900616 H103820324 Bangladesh GEMS Study Case 2007-2011 113 H- SLV ST10 Cplx 0 11 4 8 8 8 2 
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900008 H103780405 Bangladesh GEMS Study Case 2007-2011 O? 10 34 ST10 Cplx 10 11 4 1 8 8 2 
3042 H103760527 Bangladesh GEMS Study Case 2007-2011 3 2 10 ST10 Cplx 10 11 4 8 8 8 2 
900575 H103840255 Bangladesh GEMS Study Case 2007-2011 O? 10 SLV ST10 Cplx 24 11 4 8 8 8 0 
600978 H104460624 Bangladesh GEMS Study Case 2007-2011 O? 11 48 ST10 Cplx 6 11 4 8 8 8 2 
601035 H104300176 Bangladesh GEMS Study Control 2007-2011 117 27 SLV ST10 Cplx 10 11 4 8 8 8 14 
601051 H104300178 Bangladesh GEMS Study Control 2007-2011 154 19 10 ST10 Cplx 10 11 4 8 8 8 2 
601134 H104320310 Bangladesh GEMS Study Control 2007-2011 O? 10 34 ST10 Cplx 10 11 4 1 8 8 2 
601090 H104480138 Bangladesh GEMS Study Case 2007-2011 O? 33 10 ST10 Cplx 10 11 4 8 8 8 2 
601091 H104480139 Bangladesh GEMS Study Case 2007-2011 O? H- 10 ST10 Cplx 10 11 4 8 8 8 2 
601096 H104480140 Bangladesh GEMS Study Case 2007-2011 O? 33 10 ST10 Cplx 10 11 4 8 8 8 2 
601197 H104380400 Bangladesh GEMS Study Control 2007-2011 3 41 10 ST10 Cplx 10 11 4 8 8 8 2 
2278 H101200133 UK IID2 Case 2008 3 2 10 ST10 Cplx 10 11 4 8 8 8 2 
G49  - Nigeria Okeke Study Case 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
C10  - Nigeria Okeke Study Case 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
G04a  - Nigeria Okeke Study Case 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
D25a  - Nigeria Okeke Study Case 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
C14a  - Nigeria Okeke Study Case 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
C17  - Nigeria Okeke Study Case 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
G63  - Nigeria Okeke Study Case 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
C55  - Nigeria Okeke Study Control 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
G133  - Nigeria Okeke Study Control 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
G123  - Nigeria Okeke Study Control 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
G129  - Nigeria Okeke Study Control 1995  -  - 10 ST10 Cplx 10 11 4 8 8 8 2 
G41  - Nigeria Okeke Study Case 1995  -  - 48 ST10 Cplx 6 11 4 8 8 8 2 
G155a  - Nigeria Okeke Study Control 1995  -  - 520 ST10 Cplx 56 11 4 8 8 8 2 
G36  - Nigeria Okeke Study Case 1995  -  - 167 ST10 Cplx 10 11 4 8 8 13 2 
G85  - Nigeria Okeke Study Case 1995  -  - 167 ST10 Cplx 10 11 4 8 8 13 2 
C53  - Nigeria Okeke Study Control 1995  -  - 167 ST10 Cplx 10 11 4 8 8 13 2 
C22  - Nigeria Okeke Study Case 1995  -  - 436 ST10 Cplx 10 11 4 8 8 74 2 
C29  - Nigeria Okeke Study Case 1995  -  - 218 ST10 Cplx 10 11 4 12 8 8 2 
G50  - Nigeria Okeke Study Case 1995  -  - 218 ST10 Cplx 10 11 4 12 8 8 2 
G126  - Nigeria Okeke Study Control 1995  -  - 475 ST10 Cplx 56 11 4 8 8 78 2 
G155  - Nigeria Okeke Study Control 1995  -  - 510 ST10 Cplx 6 11 4 8 8 86 2 
E12  - Nigeria Okeke Study Case 1995  -  - 488 ST10 Cplx 56 11 102 8 8 8 2 
G113  - Nigeria Okeke Study Control 1994  -  - 556 ST10 Cplx 111 11 12 8 8 8 2 
G170  - Nigeria Okeke Study Control 1995  -  - 34 ST10 Cplx 10 11 4 1 8 8 2 
E099963  - UK IID1 Case 1994 18ac 30 10 ST10 Cplx 10 11 4 8 8 8 2 
E099964  - UK IID1 Case 1994 18ac H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E099966  - UK IID1 Case 1994 151 11 48 ST10 Cplx 6 11 4 8 8 8 2 
E099969  - UK IID1 Control 1994 134 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
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E099970  - UK IID1 Case 1994 53 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E099971  - UK IID1 Control 1994 53 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E099973  - UK IID1 Case 1994 151 11 SLV ST10 Cplx 6 11 4 8 0 8 2 
E099974  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E099977  - UK IID1 Case 1994 86 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E100866  - UK IID1 Case 1994 7 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E100868  - UK IID1 Case 1994 4 33 34 ST10 Cplx 10 11 4 1 8 8 2 
E100870  - UK IID1 Case 1994 R H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E100872  - UK IID1 Case 1994 62 30 34 ST10 Cplx 10 11 4 1 8 8 2 
E100875  - UK IID1 Case 1994 7 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E100876  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E101092  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E101093  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E101094  - UK IID1 Case 1994 4 33 34 ST10 Cplx 10 11 4 1 8 8 2 
E101097  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E103597  - UK IID1 Case 1994 R H? 43 ST10 Cplx 24 11 4 8 8 8 2 
E103599  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E103619  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E104927  - UK IID1 Control 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E104942  - UK IID1 Case 1994 162 10 34 ST10 Cplx 10 11 4 1 8 8 2 
E104943  - UK IID1 Control 1994 O? H? 43 ST10 Cplx 24 11 4 8 8 8 2 
E104965  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E104966  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E104968  - UK IID1 Case 1994 131 H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E104972  - UK IID1 Case 1994 62 30 34 ST10 Cplx 10 11 4 1 8 8 2 
E104973  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E105355  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E105389  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E105837  - UK IID1 Control 1994 O? H? 43 ST10 Cplx 24 11 4 8 8 8 2 
E106505  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E106776  - UK IID1 Control 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107241  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E107246  - UK IID1 Control 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107248  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107249  - UK IID1 Case 1994 21 4 10 ST10 Cplx 10 11 4 8 8 8 2 
E107525  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107528  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E107529  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E107530  - UK IID1 Case 1994 O? H? SLV ST10 Cplx 10 11 4 8 8 8 133 
E107533  - UK IID1 Case 1994 O? H? 43 ST10 Cplx 24 11 4 8 8 8 2 
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E107536  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107537  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107541  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107743  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E107755  - UK IID1 Control 1995 21 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E107756  - UK IID1 Case 1995 131 H- DLV ST10 Cplx 10 7 4 8 0 0 2 
E092843  - UK IID1 Case 1993 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E094704  - UK IID1 Case 1993 R H? SLV ST10 Cplx 24 11 4 55 8 8 2 
E094712  - UK IID1 Case 1994 3 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E096612  - UK IID1 Case 1994 R H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E096616  - UK IID1 Control 1994 5 4 10 ST10 Cplx 10 11 4 8 8 8 2 
E097477  - UK IID1 Case 1994 81 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E097480  - UK IID1 Case 1994 6 10 SLV ST10 Cplx 24 11 4 8 8 8 0 
E097494  - UK IID1 Case 1994 81 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E097496  - UK IID1 Case 1994 86 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E097499  - UK IID1 Case 1994 6 10 10 ST10 Cplx 10 11 4 8 8 8 2 
E099535  - UK IID1 Case 1994 R 27 10 ST10 Cplx 10 11 4 8 8 8 2 
E099536  - UK IID1 Case 1994 4 33 34 ST10 Cplx 10 11 4 1 8 8 2 
E099959  - UK IID1 Case 1994 66 25 10 ST10 Cplx 10 11 4 8 8 8 2 
E099960  - UK IID1 Case 1994 18ac 30 10 ST10 Cplx 10 11 4 8 8 8 2 
E099961  - UK IID1 Control 1994 18ac 30 10 ST10 Cplx 10 11 4 8 8 8 2 
E108398  - UK IID1 Case 1994 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E108400  - UK IID1 Case 1994 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E108689  - UK IID1 Control 1995 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E108690  - UK IID1 Case 1995 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E108692  - UK IID1 Control 1995 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E108838  - UK IID1 Case 1995 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E109634  - UK IID1 Control 1995 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E109635  - UK IID1 Case 1995 O? H? 43 ST10 Cplx 24 11 4 8 8 8 2 
E109902  - UK IID1 Control 1995 4 33 34 ST10 Cplx 10 11 4 1 8 8 2 
E109903  - UK IID1 Case 1995 21 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E109906  - UK IID1 Case 1995 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E110715  - UK IID1 Case 1995 6 10 43 ST10 Cplx 24 11 4 8 8 8 2 
E110899  - UK IID1 Case 1995 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
E110910  - UK IID1 Case 1995 118 11 48 ST10 Cplx 6 11 4 8 8 8 2 
E111139  - UK IID1 Case 1995 4 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E111260  - UK IID1 Control 1995 4 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E111262  - UK IID1 Case 1995 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E111268  - UK IID1 Case 1995 O? H? DLV ST10 Cplx 10 11 4 0 8 8 2 
E111294  - UK IID1 Control 1995 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
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E111479  - UK IID1 Control 1995 11 H- 10 ST10 Cplx 10 11 4 8 8 8 2 
E112215  - UK IID1 Case 1995 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
E59905  - UK GBRU Archive  Case 1989 21 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E60725  - UK GBRU Archive  Case 1990 92 33 34 ST10 Cplx 10 11 4 1 8 8 2 
E67643  - UK GBRU Archive  Case 1990 78 10 10 ST10 Cplx 10 11 4 8 8 8 2 
E73339  - UK GBRU Archive  Case 1991 15 H- 34 ST10 Cplx 10 11 4 1 8 8 2 
E89111  - Bangladesh Outbreak  E Case 1998 89 18 10 ST10 Cplx 10 11 4 8 8 8 2 
E92356  - UK GBRU Archive  Case 1994 3 2 10 ST10 Cplx 10 11 4 8 8 8 2 
E96390  - UK Outbreak B Case 1994 O? H- SLV ST10 Cplx 35 11 4 8 8 8 2 
E96483  - UK Outbreak B Case 1994 O? 33 34 ST10 Cplx 10 11 4 1 8 8 2 
E96487  - UK Outbreak B Case 1994 O? H- 34 ST10 Cplx 10 11 4 1 8 8 2 
E97470  - UK Outbreak C Case 1994 86 34 10 ST10 Cplx 10 11 4 8 8 8 2 
E97590  - UK Outbreak B Case 1994 73 13 48 ST10 Cplx 6 11 4 8 8 8 2 
E97820  - UK Outbreak B Case 1994 62 30 34 ST10 Cplx 10 11 4 1 8 8 2 
E97900  - UK Outbreak B Case 1994 O? H- 34 ST10 Cplx 10 11 4 1 8 8 2 
H101360102 H101360102 UK GBRU Case 2010 O? H? SLV ST10 Cplx 24 11 4 8 8 8 0 
H101360104 H101360104 UK GBRU Case 2010 O? H? 34 ST10 Cplx 10 11 4 1 8 8 2 
H104220291 H104220291 UK GBRU Case 2010 O? 10 SLV ST10 Cplx 24 11 4 8 8 8 0 
H113540517 H113540517 UK GBRU Case 2011 O? H- 10 ST10 Cplx 10 11 4 8 8 8 2 
H122780065 H122780065 UK GBRU Case 2012 O? H? SLV ST10 Cplx 24 11 4 8 8 8 0 
H123600287 H123600287 UK GBRU Case 2012 168 4 10 ST10 Cplx 10 11 4 8 8 8 2 
H123600288 H123600288 UK GBRU Case 2012 168 4 10 ST10 Cplx 10 11 4 8 8 8 2 
H123620421 H123620421 UK GBRU Case 2012 99 52 10 ST10 Cplx 10 11 4 8 8 8 2 
H131440284 H131440284 UK GBRU Case 2013 O? H? 10 ST10 Cplx 10 11 4 8 8 8 2 
H131720375 H131720375 UK GBRU Case 2013 99 H? 10 ST10 Cplx 10 11 4 8 8 8 2 
H131720376 H131720376 UK GBRU Case 2013 100 19 10 ST10 Cplx 10 11 4 8 8 8 2 
H131720388 H131720388 UK GBRU Case 2013 101 5 10 ST10 Cplx 10 11 4 8 8 8 2 
H132320086 H132320086 UK GBRU Case 2013 92 H? 34 ST10 Cplx 10 11 4 1 8 8 2 
H132360076 H132360076 UK GBRU Case 2013 175 H? 10 ST10 Cplx 10 11 4 8 8 8 2 
H131920219 H131920219 UK Spice Outbreak Case 2013 131 27 10 ST10 Cplx 10 11 4 8 8 8 2 
H131920220 H131920220 UK Spice Outbreak Case 2013 131 27 10 ST10 Cplx 10 11 4 8 8 8 2 
H131941061 H131941061 UK Spice Outbreak Case 2013 55 19 10 ST10 Cplx 10 11 4 8 8 8 2 
H131941064 H131941064 UK Spice Outbreak Case 2013 O? 21 227 ST10 Cplx 10 11 4 1 8 9 2 
H131941071 H131941071 UK Spice Outbreak Case 2013 131 27 10 ST10 Cplx 10 11 4 8 8 8 2 
H131941072 H131941072 UK Spice Outbreak Case 2013 131 27 10 ST10 Cplx 10 11 4 8 8 8 2 
H131941073 H131941073 UK Spice Outbreak Case 2013 131 27 10 ST10 Cplx 10 11 4 8 8 8 2 
H131941074 H131941074 UK Spice Outbreak Case 2013 131 27 10 ST10 Cplx 10 11 4 8 8 8 2 
2336 H100160089 UK IID2 Case 2008 114 10 10 ST10 Cplx 10 11 4 8 8 8 2 
2451 H100160091 UK IID2 Case 2008 O? 33 34 ST10 Cplx 10 11 4 1 8 8 2 
651 H100700084 UK IID2 Case 2008 151 21 48 ST10 Cplx 6 11 4 8 8 8 2 
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2633 H100200198 UK IID2 Case 2008 O? 1 10 ST10 Cplx 10 11 4 8 8 8 2 
2745 H100160086 UK IID2 Case 2008 114 10 10 ST10 Cplx 10 11 4 8 8 8 2 
2700 H100160087 UK IID2 Case 2008 O? 10 SLV ST10 Cplx 10 0 4 8 8 8 2 
2466 H100200199 UK IID2 Case 2008 92 33 34 ST10 Cplx 10 11 4 1 8 8 2 
7142 H102340359 Bangladesh GEMS Study Control 2007-2011 89 H- SLV ST10 Cplx 6 11 4 8 8 8 0 
7116 H10240211 Bangladesh GEMS Study Control 2007-2011 O? 36 SLV ST10 Cplx 10 55 4 8 8 8 2 
7201 H102400212 Bangladesh GEMS Study Control 2007-2011 58 51 SLV ST10 Cplx 10 55 4 8 8 8 2 
8016 H102340350 Bangladesh GEMS Study Case 2007-2011 O? 10 SLV ST10 Cplx 24 11 15 8 8 8 2 
7040 H102340357 Bangladesh GEMS Study Case 2007-2011 60 22 101 ST101 Cplx 43 41 15 18 11 7 6 
E74  - Nigeria Okeke Study Control 1995  -  - 476 ST12 Cplx 13 13 9 13 16 82 9 
H123340465 H123340465 UK GBRU Case 2012 O? H? SLV ST13 Cplx 0 6 5 9 9 8 2 
H122780069 H122780069 UK GBRU Case 2012 O? H? 152 ST152 Cplx 11 63 7 1 14 7 7 
900157 H104060671 Bangladesh GEMS Study Case 2007-2011 34 11 223 ST155 Cplx 6 4 4 18 24 8 14 
900098 H103900287 Bangladesh GEMS Study Case 2007-2011 126 27 155 ST155 Cplx 6 4 14 16 24 8 14 
600985 H104460625 Bangladesh GEMS Study Case 2007-2011 77 34 SLV ST155 Cplx 6 4 14 16 24 8 156 
601191 H104560236 Bangladesh GEMS Study Case 2007-2011 9 21 155 ST155 Cplx 6 4 14 16 24 8 14 
601307 H104580571 Bangladesh GEMS Study Case 2007-2011 9 21 155 ST155 Cplx 6 4 14 16 24 8 14 
G48  - Nigeria Okeke Study Case 1995  -  - 155 ST155 Cplx 6 4 14 16 24 8 14 
E89095  - Bangladesh Outbreak  E Case 1998 80 27 SLV ST155 Cplx 0 4 4 16 24 8 14 
E89105  - Bangladesh Outbreak  E Case 1998 80 27 58 ST155 Cplx 6 4 4 16 24 8 14 
8192 H102340356 Bangladesh GEMS Study Case 2007-2011 O? 19 58 ST155 Cplx 6 4 4 16 24 8 14 
8225 H102400213 Bangladesh GEMS Study Control 2007-2011 15 34 155 ST155 Cplx 6 4 14 16 24 8 14 
900547 H103800320 Bangladesh GEMS Study Case 2007-2011 O? 19 165 ST165 Cplx 10 27 5 10 12 8 2 
900603 H103840256 Bangladesh GEMS Study Case 2007-2011 O? 19 165 ST165 Cplx 10 27 5 10 12 8 2 
900500 H103840254 Bangladesh GEMS Study Case 2007-2011 128ab 12 SLV ST165 Cplx 10 27 5 10 12 8 7 
900820 H104080227 Bangladesh GEMS Study Case 2007-2011 O? 19 165 ST165 Cplx 10 27 5 10 12 8 2 
7081 H102340351 Bangladesh GEMS Study Control 2007-2011 O? 19 165 ST165 Cplx 10 27 5 10 12 8 2 
E099978  - UK IID1 Case 1994 80 8 SLV ST165 Cplx 10 27 5 10 12 0 2 
E100867  - UK IID1 Case 1994 O? H? 1114 ST165 Cplx 10 27 5 10 12 1 2 
E98527  - UK Outbreak A Case 1994 19 H- 1114 ST165 Cplx 10 27 5 10 12 1 2 
3029 H103320340 Bangladesh GEMS Study Control 2007-2011 12 4 484 ST168 Cplx 6 11 4 10 7 84 6 
900696 H104060673 Bangladesh GEMS Study Case 2007-2011 7 4 484 ST168 Cplx 6 11 4 10 7 84 6 
601235 H104580568 Bangladesh GEMS Study Case 2007-2011 7 4 484 ST168 Cplx 6 11 4 10 7 84 6 
D09  - Nigeria Okeke Study Case 1995  -  - 460 ST168 Cplx 56 11 4 10 7 8 6 
E33  - Nigeria Okeke Study Case 1995  -  - 484 ST168 Cplx 6 11 4 10 7 84 6 
G30  - Nigeria Okeke Study Case 1995  -  - 484 ST168 Cplx 6 11 4 10 7 84 6 
G110  - Nigeria Okeke Study Control 1995  -  - 484 ST168 Cplx 6 11 4 10 7 84 6 
8089 H102340362 Bangladesh GEMS Study Control 2007-2011 7 4 484 ST168 Cplx 6 11 4 10 7 84 6 
7172 H102340361 Bangladesh GEMS Study Control 2007-2011 12 4 484 ST168 Cplx 6 11 4 10 7 84 6 
600983 H104200075 Bangladesh GEMS Study Control 2007-2011 60 H? 206 ST206 Cplx 6 7 5 1 8 18 2 
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G12a  - Nigeria Okeke Study Case 1995  -  - 478 ST206 Cplx 56 7 5 1 8 18 2 
H104480153 H104480153 UK GBRU Case 2010 O? H? 206 ST206 Cplx 6 7 5 1 8 18 2 
8098 H102340358 Bangladesh GEMS Study Control 2007-2011 11 16 206 ST206 Cplx 6 7 5 1 8 18 2 
G35  - Nigeria Okeke Study Case 1995  -  - 226 ST226 Cplx 10 27 5 8 8 7 2 
E53  - Nigeria Okeke Study Control 1995  -  - 226 ST226 Cplx 10 27 5 8 8 7 2 
G159  - Nigeria Okeke Study Control 1995  -  - 477 ST226 Cplx 10 127 5 8 8 7 2 
H131941060 H131941060 UK Spice Outbreak Case 2013 111ac 4 226 ST226 Cplx 10 27 5 8 8 7 2 
7207 H102340353 Bangladesh GEMS Study Case 2007-2011 91 9 226 ST226 Cplx 10 27 5 8 8 7 2 
G137  - Nigeria Okeke Study Control 1995  -  - 461 ST23 Cplx 56 4 12 1 20 13 7 
G26a  - Nigeria Okeke Study Case 1995  -  - 23 ST23 Cplx 6 4 12 1 20 13 7 
C68  - Nigeria Okeke Study Control 1995  -  - 466 ST23 Cplx 56 4 12 1 20 80 7 
G55  - NIgeria Okeke Study Case 1995  -  - 423 ST23 Cplx 6 4 33 1 20 12 7 
D29  - Nigeria Okeke Study Case 1995  -  - 278 ST278 Cplx 9 23 64 18 11 8 6 
E104970  - UK IID1 Case 1994 33 H- 278 ST278 Cplx 9 23 64 18 11 8 6 
E101396  - UK Outbreak D Case 1995 98 H- 278 ST278 Cplx 9 23 64 18 11 8 6 
E101406  - UK Outbreak D Case 1995 98 H- 278 ST278 Cplx 9 23 64 18 11 8 6 
E101621  - UK Outbreak D Case 1994 98 H- 278 ST278 Cplx 9 23 64 18 11 8 6 
E111613  - UK IID1 Control 1995 165 4 278 ST278 Cplx 9 23 64 18 11 8 6 
E89107  - Bangladesh Outbreak  E Case 1998 O? 27 278 ST278 Cplx 9 23 64 18 11 8 6 
E89115  - Bangladesh Outbreak  E Case 1998 162 H- 278 ST278 Cplx 9 23 64 18 11 8 6 
H131920215 H131920215 UK Spice Outbreak Case 2013 20 H? 278 ST278 Cplx 9 23 64 18 11 8 6 
H131920221 H131920221 UK Spice Outbreak Case 2013 20 19 278 ST278 Cplx 9 23 64 18 11 8 6 
8080 H102340364 Bangladesh GEMS Study Case 2007-2011 125ac 9 295 ST295 Cplx 6 4 12 1 9 2 7 
900545 H103800319 Bangladesh GEMS Study Case 2007-2011 181 16 3748 ST295 Cplx 6 133 12 1 9 2 7 
900020 H103780400 Bangladesh GEMS Study Case 2007-2011 O? 7 841 ST295 Cplx 6 4 5 1 9 2 7 
900286 H103900284 Bangladesh GEMS Study Case 2007-2011 O? 27 295 ST295 Cplx 6 4 12 1 9 2 7 
601083 H104300180 Bangladesh GEMS Study Control 2007-2011 O? 28 295 ST295 Cplx 6 4 12 1 9 2 7 
601110 H104500403 Bangladesh GEMS Study Case 2007-2011 25 7 3748 ST295 Cplx 6 133 12 1 9 2 7 
601144 H104380395 Bangladesh GEMS Study Control 2007-2011 125ac 9 295 ST295 Cplx 6 4 12 1 9 2 7 
601188 H104380398 Bangladesh GEMS Study Control 2007-2011 181 3 295 ST295 Cplx 6 4 12 1 9 2 7 
601221 H113860299 Bangladesh GEMS Study Control 2007-2011 84 27 SLV ST295 Cplx 6 4 12 1 9 2 2 
601226 H104580567 Bangladesh GEMS Study Case 2007-2011 O? 27 SLV ST295 Cplx 6 4 12 1 9 2 64 
601251 H104580569 Bangladesh GEMS Study Case 2007-2011 O? 29 295 ST295 Cplx 6 4 12 1 9 2 7 
7089b H102420446 Bangladesh GEMS Study Control 2007-2011 O? 27 3748 ST295 Cplx 6 133 12 1 9 2 7 
G02  - Nigeria Okeke Study Case 1995  -  - 433 ST295 Cplx 56 4 12 1 9 2 7 
G131  - Nigeria Okeke Study Control 1995  -  - 433 ST295 Cplx 56 4 12 1 9 2 7 
E101098  - UK IID1 Case 1994 O? H? 2517 ST295 Cplx 6 4 12 1 11 2 7 
E104974  - UK IID1 Case 1994 O? H? 295 ST295 Cplx 6 4 12 1 9 2 7 
E092836  - UK IID1 Case 1993 O? H? 295 ST295 Cplx 6 4 12 1 9 2 7 
E110912  - UK IID1 Case 1995 86 27 3570 ST295 Cplx 6 4 12 1 9 281 7 
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E111261  - UK IID1 Case 1995 O? H? 3748 ST295 Cplx 6 133 12 1 9 2 7 
E58596  - UK GBRU Archive  Case 1989 51 11 295 ST295 Cplx 6 4 12 1 9 2 7 
E72376  - UK GBRU Archive  Case 1991 33 16 SLV ST295 Cplx 0 4 12 1 9 2 7 
E89112  - Bangladesh Outbreak  E Case 1998 69 11 SLV ST295 Cplx 6 462 12 1 9 2 7 
H131320944 H131320944 UK GBRU Case 2013 65 H? 841 ST295 Cplx 6 4 5 1 9 2 7 
H131740867 H131740867 UK GBRU Case 2013 65 8 841 ST295 Cplx 6 4 5 1 9 2 7 
H131920217 H131920217 UK Spice Outbreak Case 2013 33 16 295 ST295 Cplx 6 4 12 1 9 2 7 
H131941065 H131941065 UK Spice Outbreak Case 2013 63 12 1664 ST295 Cplx 6 4 15 1 9 2 7 
1778 H100200202 UK IID2 Case 2008 125ac 9 295 ST295 Cplx 6 4 12 1 9 2 7 
2866 H100160092 UK IID2 Case 2008 55 4 3570 ST295 Cplx 6 4 12 1 9 281 7 
7058 H102320431 Bangladesh GEMS Study Control 2007-2011 O? 16 295 ST295 Cplx 6 4 12 1 9 2 7 
7078 H102420448 Bangladesh GEMS Study Control 2007-2011 O? 27 295 ST295 Cplx 6 4 12 1 9 2 7 
7079 H102420450 Bangladesh GEMS Study Case 2007-2011 25 H- SLV ST295 Cplx 6 4 5 1 9 8 7 
7089 H102420444 Bangladesh GEMS Study Control 2007-2011 181 16 3748 ST295 Cplx 6 133 12 1 9 2 7 
7096 H102420447 Bangladesh GEMS Study Control 2007-2011 O? 12 295 ST295 Cplx 6 4 12 1 9 2 7 
8002 H102400209 Bangladesh GEMS Study Control 2007-2011 9a 10 295 ST295 Cplx 6 4 12 1 9 2 7 
8120 H102340365 Bangladesh GEMS Study Case 2007-2011 R 16 3748 ST295 Cplx 6 133 12 1 9 2 7 
8129 H102400208 Bangladesh GEMS Study Control 2007-2011 O? 29 295 ST295 Cplx 6 4 12 1 9 2 7 
#042 H132780234 Peru EAEC reference 
strain 
Case 1985 44 18 414 ST30  Cplx 18 22 20 23 5 15 4 
E100877  - UK IID1 Case 1994 O? H? 30 ST30  Cplx 18 22 16 23 5 15 4 
E103267  - UK IID1 Case 1994 O? H? 30 ST30  Cplx 18 22 16 23 5 15 4 
E103621  - UK IID1 Case 1994 73 8 SLV ST30  Cplx 18 22 16 23 5 15 99 
E110716  - UK IID1 Case 1995 106 18 414 ST30  Cplx 18 22 20 23 5 15 4 
E44939  - UK GBRU Archive  Case 1987 44 18 30 ST30  Cplx 18 22 16 23 5 15 4 
E45730  - UK GBRU Archive  Case 1987 44 18 30 ST30  Cplx 18 22 16 23 5 15 4 
E43509  - UK GBRU Archive  Case 1987 44 18 414 ST30  Cplx 18 22 20 23 5 15 4 
900422 H103900286 Bangladesh GEMS Study Case 2007-2011 176 34 130 ST31 Cplx 18 22 20 6 5 5 4 
900268 H103900283 Bangladesh GEMS Study Case 2007-2011 44 34 130 ST31 Cplx 18 22 20 6 5 5 4 
900985 H104140246 Bangladesh GEMS Study Case 2007-2011 O? 23 130 ST31 Cplx 18 22 20 6 5 5 4 
600974 H104460623 Bangladesh GEMS Study Case 2007-2011 15 34 SLV ST31 Cplx 18 22 20 6 5 0 4 
600988 H104460626 Bangladesh GEMS Study Case 2007-2011 166 16 130 ST31 Cplx 18 22 20 6 5 5 4 
601010 H104480137 Bangladesh GEMS Study Case 2007-2011 15 23 SLV ST31 Cplx 18 22 20 6 5 0 4 
601048 H104300177 Bangladesh GEMS Study Control 2007-2011 O? 23 130 ST31 Cplx 18 22 20 6 5 5 4 
601063 H104300179 Bangladesh GEMS Study Control 2007-2011 15 18 449 ST31 Cplx 18 22 94 6 5 5 4 
601120 H104320309 Bangladesh GEMS Study Control 2007-2011 130 27 31 ST31 Cplx 18 22 17 6 5 5 4 
901006 H104180060 Bangladesh GEMS Study Case 2007-2011 44 34 130 ST31 Cplx 18 22 20 6 5 5 4 
1383 H100640645 UK IID2 Case 2008 44 12 130 ST31 Cplx 18 22 20 6 5 5 4 
E54  - Nigeria Okeke Study Control 1995  -  - 31 ST31 Cplx 18 22 17 6 5 5 4 
E56  - Nigeria Okeke Study Control 1994  -  - 31 ST31 Cplx 18 22 17 6 5 5 4 
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C20  - Nigeria Okeke Study Case 1995  -  - 130 ST31 Cplx 18 22 20 6 5 5 4 
G22b  - Nigeria Okeke Study Case 1995  -  - 130 ST31 Cplx 18 22 20 6 5 5 4 
C60  - Nigeria Okeke Study Control 1995  -  - 130 ST31 Cplx 18 22 20 6 5 5 4 
G116  - Nigeria Okeke Study Control 1995  -  - 130 ST31 Cplx 18 22 20 6 5 5 4 
E68  - Nigeria Okeke Study Control 1995  -  - 449 ST31 Cplx 18 22 94 6 5 5 4 
G103  - Nigeria Okeke Study Control 1995  -  - 449 ST31 Cplx 18 22 94 6 5 5 4 
G149  - Nigeria Okeke Study Control 1994  -  - 474 ST31 Cplx 18 22 1 6 5 5 4 
G121a  - Nigeria Okeke Study Control 1995  -  - 474 ST31 Cplx 18 22 1 6 5 5 4 
C16  - Nigeria Okeke Study Case 1995  -  - 512 ST31 Cplx 21 22 2 6 5 5 4 
*H145-1  - Peru Okeke Study Case 1995  -  - 31 ST31 Cplx 22 22 2 6 5 5 4 
*44-1R  - Thailand Okeke Study Case 1995  -  - 32 ST31 Cplx 23 22 2 6 5 5 4 
*309-1R  - Thailand Okeke Study Case 1995  -  - 33 ST31 Cplx 24 22 2 6 5 5 4 
E099975  - UK IID1 Control 1994 15 18 31 ST31 Cplx 18 22 17 6 5 5 4 
E101091  - UK IID1 Case 1994 134 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E101095  - UK IID1 Case 1994 134 2 31 ST31 Cplx 18 22 17 6 5 5 4 
E101096  - UK IID1 Case 1994 134 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E103594  - UK IID1 Case 1994 11 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E103617  - UK IID1 Case 1994 130 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E104931  - UK IID1 Control 1994 O? H? 31 ST31 Cplx 18 22 17 6 5 5 4 
E104940  - UK IID1 Control 1994 130 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E104946  - UK IID1 Case 1994 O? H? 31 ST31 Cplx 18 22 17 6 5 5 4 
E104967  - UK IID1 Case 1994 O? H? 31 ST31 Cplx 18 22 17 6 5 5 4 
E104969  - UK IID1 Control 1994 130 25 31 ST31 Cplx 18 22 17 6 5 5 4 
E104975  - UK IID1 Case 1994 O? H? SLV ST31 Cplx 18 22 15 6 5 5 4 
E105352  - UK IID1 Control 1994 O? H? 130 ST31 Cplx 18 22 20 6 5 5 4 
E107526  - UK IID1 Case 1994 O? H? 31 ST31 Cplx 18 22 17 6 5 5 4 
E107754  - UK IID1 Control 1995 134 25 31 ST31 Cplx 18 22 17 6 5 5 4 
E097478  - UK IID1 Control 1994 130 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E097502  - UK IID1 Case 1994 134 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E108693  - UK IID1 Control 1995 O? H? 449 ST31 Cplx 18 22 94 6 5 5 4 
E108837  - UK IID1 Control 1995 130 H? 31 ST31 Cplx 18 22 17 6 5 5 4 
E108839  - UK IID1 Case 1995 130 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E110852  - UK IID1 Case 1995 O? H? 31 ST31 Cplx 18 22 17 6 5 5 4 
E111136  - UK IID1 Control 1995 1 H- 31 ST31 Cplx 18 22 17 6 5 5 4 
E58583  - UK GBRU Archive  Case 1989 77 18 SLV ST31 Cplx 18 22 12 6 5 5 4 
E71341  - UK GBRU Archive  Case 1991 102 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E89114  - Bangladesh Outbreak  E Case 1998 44 18 449 ST31 Cplx 18 22 94 6 5 5 4 
E96485  - UK Outbreak B Case 1994 134 27 31 ST31 Cplx 18 22 17 6 5 5 4 
E98529  - UK Outbreak A Case 1994 O? 18 31 ST31 Cplx 18 22 17 6 5 5 4 
7028 H102400215 Bangladesh GEMS Study Control 2007-2011 44 34 DLV ST31 Cplx 18 22 20 16 5 0 4 
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3017 H103320338 Bangladesh GEMS Study Control 2007-2011 166 15 349 ST349 Cplx 34 36 39 87 67 16 4 
600950 H104180061 Bangladesh GEMS Study Control 2007-2011 166 15 349 ST349 Cplx 34 36 39 87 67 16 4 
600990 H104460627 Bangladesh GEMS Study Case 2007-2011 166 15 349 ST349 Cplx 34 36 39 87 67 16 4 
E60  - Nigeria Okeke Study Control 1995  -  - 349 ST349 Cplx 34 36 39 87 67 16 4 
7016 H102400214 Bangladesh GEMS Study Control 2007-2011 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
900033 H103760529 Bangladesh GEMS Study Case 2007-2011 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
900516 H103780408 Bangladesh GEMS Study Case 2007-2011 86 30 38 ST38 Cplx 4 26 2 25 5 5 19 
900252 H103760528 Bangladesh GEMS Study Case 2007-2011 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
900002 H103780406 Bangladesh GEMS Study Case 2007-2011 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
900654 H103840252 Bangladesh GEMS Study Case 2007-2011 O? 18 SLV ST38 Cplx 4 26 2 25 5 16 19 
900978 H104140245 Bangladesh GEMS Study Case 2007-2011 O? 30 315 ST38 Cplx 4 26 2 25 5 8 19 
900912 H104140244 Bangladesh GEMS Study Case 2007-2011 O? 30 315 ST38 Cplx 4 26 2 25 5 8 19 
900745 H104120573 Bangladesh GEMS Study Case 2007-2011 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
601000 H104200076 Bangladesh GEMS Study Control 2007-2011 O? 30 38 ST38 Cplx 4 26 2 25 5 5 19 
601029 H104560238 Bangladesh GEMS Study Case 2007-2011 O? 32 38 ST38 Cplx 4 26 2 25 5 5 19 
601070 H104580565 Bangladesh GEMS Study Case 2007-2011 O? 30 38 ST38 Cplx 4 26 2 25 5 5 19 
601108 H104320308 Bangladesh GEMS Study Control 2007-2011 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
601182 H104380397 Bangladesh GEMS Study Control 2007-2011 O? 30 38 ST38 Cplx 4 26 2 25 5 5 19 
601225 H104400250 Bangladesh GEMS Study Control 2007-2011 86 30 38 ST38 Cplx 4 26 2 25 5 5 19 
601264 H104580570 Bangladesh GEMS Study Case 2007-2011 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
G75a  - Nigeria Okeke Study Case 1995  -  - 38 ST38 Cplx 4 26 2 25 5 5 19 
G23  - Nigeria Okeke Study Case 1995  -  - 38 ST38 Cplx 4 26 2 25 5 5 19 
G29  - Nigeria Okeke Study Case 1995  -  - 38 ST38 Cplx 4 26 2 25 5 5 19 
G28  - Nigeria Okeke Study Case 1995  -  - 426 ST38 Cplx 4 26 2 25 5 40 19 
H132760800 H132760800 UK GBRU Case 2013 O? H? 38 ST38 Cplx 4 26 2 25 5 5 19 
669 H100640648 UK IID2 Case 2008 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
1975 H100280375 UK IID2 Case 2008 153 30 38 ST38 Cplx 4 26 2 25 5 5 19 
7060 H102420445 Bangladesh GEMS Study Case 2007-2011 O? 27 38 ST38 Cplx 4 26 2 25 5 5 19 
7123 H102340352 Bangladesh GEMS Study Control 2007-2011 21 10 315 ST38 Cplx 4 26 2 25 5 8 19 
8095 H102320134 Bangladesh GEMS Study Control 2007-2011 86 30 SLV ST38 Cplx 4 26 12 25 5 5 19 
8130 H102340387 Bangladesh GEMS Study Control 2007-2011 O? 34 SLV ST38 Cplx 4 26 2 25 5 5 7 
7002 H102400216 Bangladesh GEMS Study Control 2007-2011 181 36 38 ST38 Cplx 4 26 2 25 5 5 19 
900673 H103800323 Bangladesh GEMS Study Case 2007-2011 O? 18 394 ST394 Cplx 21 35 61 52 5 5 4 
900088 H103760531 Bangladesh GEMS Study Case 2007-2011 44 40 394 ST394 Cplx 21 35 61 52 5 5 4 
900416 H103900285 Bangladesh GEMS Study Case 2007-2011 O? 18 394 ST394 Cplx 21 35 61 52 5 5 4 
600970 H104400254 Bangladesh GEMS Study Case 2007-2011 O? 18 394 ST394 Cplx 21 35 61 52 5 5 4 
601002 H104200077 Bangladesh GEMS Study Control 2007-2011 O? 41 394 ST394 Cplx 21 35 61 52 5 5 4 
601009 H104480136 Bangladesh GEMS Study Case 2007-2011 166 15 394 ST394 Cplx 21 35 61 52 5 5 4 
601230 H104400251 Bangladesh GEMS Study Control 2007-2011 44 18 394 ST394 Cplx 21 35 61 52 5 5 4 
642 H100860460 UK IID2 Case 2008 68 17 1380 ST394 Cplx 35 35 61 52 5 5 4 
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G59  - Nigeria Okeke Study Case 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
G10  - Nigeria Okeke Study Case 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
C14  - Nigeria Okeke Study Case 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
G17a  - Nigeria Okeke Study Case 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
C08  - Nigeria Okeke Study Case 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
E30  - Nigeria Okeke Study Case 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
G67b  - Nigeria Okeke Study Case 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
G108  - Nigeria Okeke Study Control 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
E64  - Nigeria Okeke Study Control 1995  -  - 394 ST394 Cplx 21 35 61 52 5 5 4 
E62  - Nigeria Okeke Study Control 1995  -  - 471 ST394 Cplx 21 125 61 52 5 5 4 
E107757  - UK IID1 Control 1995 O? H? 1380 ST394 Cplx 35 35 61 52 5 5 4 
E105839  - UK IID1 Control 1994 O? H? 1380 ST394 Cplx 35 35 61 52 5 5 4 
E106507  - UK IID1 Case 1994 O? H? 394 ST394 Cplx 21 35 61 52 5 5 4 
E107247  - UK IID1 Case 1994 O? H? 1380 ST394 Cplx 35 35 61 52 5 5 4 
E108829  - UK IID1 Case 1995 O? H? 1380 ST394 Cplx 35 35 61 52 5 5 4 
E89102  - Bangladesh Outbreak  E Case 1998 44 18 394 ST394 Cplx 21 35 61 52 5 5 4 
E96386  - UK Outbreak B Case 1994 73 18 1380 ST394 Cplx 35 35 61 52 5 5 4 
H122980178 H122980178 UK GBRU Case 2012 O? 18 1380 ST394 Cplx 35 35 61 52 5 5 4 
1627 H000200204 UK IID2 Case 2008 68 18 1380 ST394 Cplx 35 35 61 52 5 5 4 
900657 H103800322 Bangladesh GEMS Study Case 2007-2011 175 28 200 ST40 Cplx 6 4 5 26 7 8 14 
900618 H103820325 Bangladesh GEMS Study Case 2007-2011 175 7 200 ST40 Cplx 6 4 5 26 7 8 14 
900114 H104060672 Bangladesh GEMS Study Case 2007-2011 127 11 DLV ST40 Cplx 6 4 5 26 20 16 14 
600955 H104180062 Bangladesh GEMS Study control 2007-2011 175 1 SLV ST40 Cplx 6 4 5 26 7 8 156 
601017 H104200078 Bangladesh GEMS Study Control 2007-2011 175 28 SLV ST40 Cplx 6 4 5 26 7 8 4 
601033 H104200079 Bangladesh GEMS Study Control 2007-2011 175 31 200 ST40 Cplx 6 4 5 26 7 8 14 
601068 H104560241 Bangladesh GEMS Study Case 2007-2011 2 42 SLV ST40 Cplx 6 4 5 26 7 8 156 
601173 H113860296  Bangladesh GEMS Study Control 2007-2011 O175 31 SLV ST40 Cplx 6 4 5 26 7 8 7 
601192 H104560237 Bangladesh GEMS Study Case 2007-2011 175 1 200 ST40 Cplx 6 4 5 26 7 8 14 
601193 H104380399 Bangladesh GEMS Study Control 2007-2011 175 31 200 ST40 Cplx 6 4 5 26 7 8 14 
900987 H104140247 Bangladesh GEMS Study Case 2007-2011 175 31 200 ST40 Cplx 6 4 5 26 7 8 14 
900998 H104140248 Bangladesh GEMS Study Case 2007-2011 175 1 200 ST40 Cplx 6 4 5 26 7 8 14 
E40104 H132780233 UK EAEC Reference 
strain 
Case 2013 126 H? 200 ST40 Cplx 6 4 5 26 7 8 14 
1150 H100720282 UK IID2 Case 2008 111ac 21 40 ST40 Cplx 6 4 5 26 20 8 14 
1171 H101200082 UK IID2 Case 2008 126 27 200 ST40 Cplx 6 4 5 26 7 8 14 
E63  - Nigeria Okeke Study Control 1995  -  - 473 ST40 Cplx 56 4 5 26 20 8 14 
E099967  - UK IID1 Case 1994 R H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E099972  - UK IID1 Case 1994 O? H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E099979  - UK IID1 Case 1994 75 27 200 ST40 Cplx 6 4 5 26 7 8 14 
E100856  - UK IID1 Case 1994 126 27 200 ST40 Cplx 6 4 5 26 7 8 14 
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E101089  - UK IID1 Case 1994 126 2 200 ST40 Cplx 6 4 5 26 7 8 14 
E106506  - UK IID1 Case 1994 O? H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E107100  - UK IID1 Case 1994 119 27 200 ST40 Cplx 6 4 5 26 7 8 14 
E107531  - UK IID1 Case 1994 R H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E107542  - UK IID1 Case 1994 R H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E094706  - UK IID1 Case 1994 111ab H- SLV ST40 Cplx 6 4 5 10 20 8 14 
E097298  - UK IID1 Case 1994 R 27 200 ST40 Cplx 6 4 5 26 7 8 14 
E097501  - UK IID1 Case 1994 O? H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E099520  - UK IID1 Case 1994 8 7 200 ST40 Cplx 6 4 5 26 7 8 14 
E107759  - UK IID1 Control 1995 O? H? 40 ST40 Cplx 6 4 5 26 20 8 14 
E109907  - UK IID1 Control 1995 111ab H- 40 ST40 Cplx 6 4 5 26 20 8 14 
E110717  - UK IID1 Case 1995 O? H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E111140  - UK IID1 Case 1995 O? H? 200 ST40 Cplx 6 4 5 26 7 8 14 
E36182  - UK GBRU Archive  Case 1987 111 21 40 ST40 Cplx 6 4 5 26 20 8 14 
E43923  - UK GBRU Archive  Case 1987 126 27 200 ST40 Cplx 6 4 5 26 7 8 14 
E55060  - UK GBRU Archive  Case 1998 126 27 200 ST40 Cplx 6 4 5 26 7 8 14 
E55280  - UK GBRU Archive  Case 1998 126 27 SLV ST40 Cplx 0 4 5 26 7 8 14 
E57144  - UK GBRU Archive  Case 1989 111 21 SLV ST40 Cplx 6 4 5 26 20 222 14 
H104680397 H104680397 UK GBRU Case 2010 111ab 21 40 ST40 Cplx 6 4 5 26 20 8 14 
H120820356 H120820356 UK GBRU Case 2012 111ab 21 40 ST40 Cplx 6 4 5 26 20 8 14 
H122840058 H122840058 UK GBRU Case 2012 111ab 11 40 ST40 Cplx 6 4 5 26 20 8 14 
H123160613 H123160613 UK GBRU Case 2012 175 28 200 ST40 Cplx 6 4 5 26 7 8 14 
H123520278 H123520278 UK GBRU Case 2012 175 28 200 ST40 Cplx 6 4 5 26 7 8 14 
H123520279 H123520279 UK GBRU Case 2012 175 28 200 ST40 Cplx 6 4 5 26 7 8 14 
H124020363 H124020363 UK GBRU Case 2012 175 31 200 ST40 Cplx 6 4 5 26 7 8 14 
H132360372 H132360372 UK GBRU Case 2013 126 27 200 ST40 Cplx 6 4 5 26 7 8 14 
H120680226 H120680226 UK Ireland 
Household 
Outbreak 
Case 2012 111ab 21 40 ST40 Cplx 6 4 5 26 20 8 14 
657 H100700085 UK IID2 Case 2008 111ac 11 40 ST40 Cplx 6 4 5 26 20 8 14 
1091 H100720282 UK IID2 Case 2008 111ac 11 40 ST40 Cplx 6 4 5 26 20 8 14 
1244 H100760047 UK IID2 Case 2008 111ac 21 40 ST40 Cplx 6 4 5 26 20 8 14 
2266 H100280373 UK IID2 Case 2008 175 27 200 ST40 Cplx 6 4 5 26 7 8 14 
1337 H100640644 UK IID2 Case 2008 111ac 11 40 ST40 Cplx 6 4 5 26 20 8 14 
C61  - Nigeria Okeke Study Control 1995  -  - 444 ST446 Cplx 56 19 3 26 11 8 6 
900644 H103820326 Bangladesh GEMS Study Case 2007-2011 O? 10 448 ST448 Cplx 6 6 5 16 11 8 7 
G57  - Nigeria Okeke Study Case 1995  -  - 46 ST46 Cplx 8 7 1 8 8 8 6 
C70  - Nigeria Okeke Study Control 1995  -  - 467 ST467 Cplx 64 7 4 8 8 18 6 
D34  - Nigeria Okeke Study Case 1995  -  - 480 ST467 Cplx 10 7 4 8 8 18 6 
D32  - Nigeria Okeke Study Control 1995  -  - 480 ST467 Cplx 10 7 4 8 8 18 6 
 216 
 
G143  - Nigeria Okeke Study Control 1995  -  - 467 ST467 Cplx 64 7 4 8 8 18 6 
C77  - Nigeria Okeke Study Control 1995  -  - 469 ST469 Cplx 6 65 5 1 9 13 6 
G144a  - Nigeria Okeke Study Control 1995  -  - 501 ST501 Cplx 35 132 2 27 37 5 4 
C04  - Nigeria Okeke Study Case 1995 86 11 507 ST501 Cplx 35 132 2 27 37 5 83 
E092830  - UK IID1 Case 1993 86 11 501 ST501 Cplx 35 132 2 27 37 5 4 
E097500  - UK IID1 Case 1994 73 1 501 ST501 Cplx 35 132 2 27 37 5 4 
E107527  - UK IID1 Control 1994 6 1 73 ST73 Cplx 36 24 9 13 17 11 25 
C27  - Nigeria Okeke Study Case 1995  -  - 159 ST746 Cplx 59 7 4 8 12 8 2 
E107758  - UK IID1 Case 1995 O? H? 159 ST746 Cplx 59 7 4 8 12 8 2 
E099976  - UK IID1 Case 1994 113 H- 746 ST746 Cplx 10 7 4 8 12 8 2 
E107250  - UK IID1 Case 1994 O? H? SLV ST746 Cplx 10 7 4 0 12 8 2 
E107252  - UK IID1 Control 1994 O? H? 746 ST746 Cplx 10 7 4 8 12 8 2 
E89096  - Bangladesh Outbreak  E Case 1998 113 H- 159 ST746 Cplx 59 7 4 8 12 8 2 
H104400276 H104400276 UK GBRU Case 2010 O? H- SLV ST746 Cplx 0 7 4 8 12 8 2 
H113160257 H113160257 UK GBRU Case 2011 O? H- SLV ST746 Cplx 0 7 4 8 12 8 2 
H123980248 H123980248 UK GBRU Case 2013 181 H? SLV ST746 Cplx 0 7 4 8 12 8 2 
H132100889 H132100889 UK GBRU Case 2013 181 H? 159 ST746 Cplx 59 7 4 8 12 8 2 
H131920214 H131920214 UK Spice Outbreak Case 2013 O? 19 746 ST746 Cplx 10 7 4 8 12 8 2 
E25  - Nigeria Okeke Study Case 1995  -  - 453 ST86 Cplx 99 6 33 33 24 8 7 
E096617  - UK IID1 Case 1994 R 1 SLV ST86 Cplx 0 6 33 33 24 8 7 
 
Appendix 7.1 Table showing characteristics of the EAEC strains used in this study grouped by complex. Key: - denotes N/A (MOLIS number) or unknown (Serotyping), 
SLV (single locus variant), DLV (double locus variant), TLV (triple locus variant), Cplx (complex with consists of SLVs), IID (intestinal infectious disease study 1 or 2), GBRU 
(Gastrointestinal Bacteria Reference Unit), ST (sequence type). 
 
All 564 EAEC strains were included in the population structure and evolutionary analysis. Three additional strains denoted by * were added for the HEp-2 cell assay and 
worm model. Serotyping was carried out on all strains except those from Nigeria. #EAEC prototypical 042 strain was used in all analysis 
Sub-populations of strains were used in further analysis and are colour coded as follows: 
Colour No. of isolates Analysis 
Purple 27 HEp-2 assay and worm model 
Blue 97 Biolog assay 
Green 153 Virulence gene profiling 
Pink 49 Biolog and virulence gene profiling 
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7.2 Biolog metabolite list 
 
Appendix 7.2 Biolog GEN III plate listing the 95 metabolites (plus one negative control) in each well.
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7.3 Photographs of HEp-2 Cell Assay of EAEC strains 
 
Isolate ST ST Cplx HEp-2 Score Case HEp-2 Result 
042 
 
 
414 
 
 
None 
 
 
5 = Very Heavy 
 
 
Case 
 
  
C27D 
Not included in 
analysis 
 
 
159 
 
 
 
None 
 
 
 
0 = Cytotoxic, auto 
aggregative (heavy) 
 
 
 
Case 
 
 
  
H145-1R 
 
 
 
31 
 
 
 
ST31 Cplx 
 
 
 
4 = Heavy 
 
 
 
Case 
 
 
  
44-1R 
 
 
 
31 
 
 
 
ST31 Cplx 
 
 
 
0 = Cytotoxic, auto 
aggregative (heavy) 
 
 
 
Case 
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309-1R 
 
 
 
31 
 
 
 
ST31 Cplx 
 
 
 
5 = Very Heavy 
 
 
 
Case 
 
 
  
E54H 
 
 
 
31 
 
 
 
ST31 Cplx 
 
 
 
3 = Medium 
 
 
 
Control 
 
 
  
E56H 
 
 
 
31 
 
 
 
ST31 Cplx 
 
 
 
4 = Heavy 
 
 
 
Control 
 
 
  
G149H 
 
 
 
474 
 
 
 
ST31 Cplx 
 
 
 
0 = Cytotoxic, 
autoaggregative (light) 
 
 
 
Control 
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G121aH 
 
 
 
474 
 
 
 
ST31 Cplx 
 
 
 
4 = Heavy 
 
 
 
Control 
 
 
  
C16D 
 
 
 
512 
 
 
 
ST31 Cplx 
 
 
 
4 = Heavy 
 
 
 
Case 
 
 
  
C20D 
 
 
 
130 
 
 
 
ST31 Cplx 
 
 
 
4 = Heavy 
 
 
 
Case 
 
 
  
C60H 
 
 
 
130 
 
 
 
ST31 Cplx 
 
 
 
4 = Heavy 
 
 
 
Control 
 
 
  
G116H 
 
 
 
130 
 
 
 
ST31 Cplx 
 
 
 
4 = Heavy 
 
 
 
Control 
 
 
  
 221 
 
G23D 
 
 
 
38 
 
 
 
ST38 Cplx 
 
 
 
1 = Very Light 
 
 
 
Case 
 
 
  
G29D 
 
 
 
38 
 
 
 
ST38 Cplx 
 
 
 
3 = Medium 
 
 
 
Case 
 
 
  
G28D 
 
 
 
426 
 
 
 
ST38 Cplx 
 
 
 
2 = Light 
 
 
 
Case 
 
 
  
G59D 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
4 = Heavy 
 
 
 
Case 
 
 
  
G10D 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
5 = Very Heavy 
 
 
 
Case 
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C14D 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
5 = Very Heavy 
 
 
 
Case 
 
 
  
G17aD 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
4 = Heavy 
 
 
 
Case 
 
 
  
C08D 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
5 = Very Heavy 
 
 
 
Case 
 
 
  
E30D 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
4 = Heavy 
 
 
 
Case 
 
 
  
G108H 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
5 = Very Heavy  
 
 
 
Control 
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E64H 
 
 
 
394 
 
 
 
ST394 Cplx 
 
 
 
5 = Very Heavy  
 
 
 
Control 
 
 
  
E33D 
 
 
 
484 
 
 
 
ST168 Cplx 
 
 
 
4 = Heavy 
 
 
 
Case 
 
 
  
G30D 
 
 
 
484 
 
 
 
ST168 Cplx 
 
 
 
2 = Light 
 
 
 
Case 
 
 
  
G110H 
 
 
 
484 
 
 
 
ST168 Cplx 
 
 
 
0 = Cytotoxic, 
autoaggregative (light) 
 
 
 
Control 
 
 
  
D09D 
 
 
 
460 
 
 
 
ST168 Cplx 
 
 
 
3 = Medium 
 
 
 
Case 
 
 
  
Appendix 7.3 Table showing photos of HEp-2 cell assay as evidence of how the HEp-2 score was derived. 
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7.4 Virulence Gene Profile of Bangladesh Strains 
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1 8 
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1 
  
1 1 1 
 
1 8 
601035 117 27 SLV 10 Control 
 
1 
             
1 
601051 154 19 10 10 Control 
 
1 
      
1 
 
1 1 1 
  
5 
601134 O? 10 34 10 Control 1 1 1 
 
1 
     
1 1 1 
  
7 
601197 3 41 10 10 Control 1 1 1 1 
      
1 1 1 
  
7 
600978 O? 11 48 10 Case 
 
1 
  
1 
       
1 
 
1 4 
601090 O? 33 10 10 Case 
    
1 
     
1 1 1 1 1 6 
601091 O? H- 10 10 Case 
    
1 
     
1 1 1 1 1 6 
601096 O? 33 10 10 Case 
          
1 1 1 1 1 5 
7028 44 34 DLV 31 Control 1 1 1 
  
1 
       
1 
 
5 
900268 44 34 130 31 Case 1 1 1 
   
1 
       
1 5 
900422 176 34 130 31 Case 1 1 1 
  
1 
  
1 
 
1 1 1 1 1 10 
900985 O? 23 130 31 Case 
 
1 1 
   
1 
     
1 
 
1 5 
601048 O? 23 130 31 Control 1 1 1 
  
1 
  
1 
 
1 1 1 1 
 
9 
601063 15 18 449 31 Control 
 
1 1 
    
1 
    
1 
  
4 
601120 130 27 31 31 Control 1 1 1 
     
1 
 
1 
 
1 
  
6 
600974 15 34 New Allele 31 Case 1 1 1 
  
1 
  
1 
 
1 1 1 1 1 10 
600988 166 16 130 31 Case 1 1 1 
  
1 
  
1 
 
1 1 1 
 
1 9 
601010 15 23 New Allele 31 Case 1 1 1 
 
1 1 
  
1 
 
1 1 1 1 1 11 
8095 86 30 SLV 38 Control 1 1 1 1 
           
4 
8130 O? 34 SLV 38 Control 1 1 1 
  
1 
       
1 
 
5 
900654 O? 18 SLV 38 Case 1 1 1 1 
        
1 
 
1 6 
900912 O? 30 315 38 Case 1 1 1 1 
        
1 1 1 7 
7060 O? 27 38 38 Case 
 
1 1 
 
1 
   
1 1 1 1 1 1 1 10 
7002 181 36 38 38 Control 1 1 1 
     
1 1 1 1 1 1 
 
9 
7016 153 30 38 38 Control 1 1 1 1 
         
1 
 
5 
7123 21 10 315 38 Control 
 
1 
             
1 
900002 153 30 38 38 Case 1 1 1 1 
 
1 
       
1 1 7 
900033 153 30 38 38 Case 1 1 1 
    
1 1 
    
1 1 7 
900252 153 30 38 38 Case 1 1 1 
    
1 
      
1 5 
900516 86 30 38 38 Case 1 1 1 1 
        
1 1 1 7 
900745 153 30 38 38 Case 1 1 1 
  
1 
        
1 5 
900978 O? 30 315 38 Case 1 1 1 1 
   
1 
     
1 1 7 
601000 O? 30 38 38 Control 
 
1 1 1 
    
1 
      
4 
601108 153 30 38 38 Control 1 1 1 
          
1 
 
4 
601182 O? 30 38 38 Control 1 1 1 
         
1 1 
 
5 
601225 86 30 38 38 Control 1 1 1 1 
        
1 
  
5 
601029 O? 32 38 38 Case 1 1 1 1 
        
1 1 1 7 
601070 O? 30 38 38 Case 1 1 1 1 
        
1 1 1 7 
601264 153 30 38 38 Case 1 1 1 1 1 
   
1 1 1 1 1 1 1 12 
900618 175 7 200 40 Case 1 1 1 
 
1 
   
1 1 1 1 1 1 1 11 
900657 175 28 200 40 Case 1 1 1 
 
1 
   
1 1 1 1 1 
 
1 10 
900987 175 31 200 40 Case 1 1 1 
 
1 
  
1 1 1 1 
 
1 
 
1 10 
601017 175 28 SLV 40 Control 1 1 1 
 
1 
   
1 1 1 1 1 
  
9 
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601033 175 31 200 40 Control 
 
1 1 
 
1 
   
1 1 1 1 1 
  
8 
601193 175 31 200 40 Control 1 1 1 
 
1 
   
1 1 1 1 1 
  
9 
601192 175 1 200 40 Case 1 1 1 
 
1 
   
1 1 1 1 1 
 
1 10 
601068 2 42 SLV 40 Case 1 1 1 
 
1 
   
1 1 1 1 1 1 1 11 
7040 60 22 101 101 Case 
          
1 1 1 
 
1 4 
7071 130 35 SLV 155 Case 
 
1 
      
1 1 1 1 1 1 1 8 
8192 O? 19 58 155 Case 
 
1 1 
          
1 1 4 
8225 15 34 155 155 Control 1 
 
1 
  
1 
  
1 
 
1 1 1 1 
 
8 
900098 126 27 155 155 Case 1 1 1 
         
1 
 
1 5 
900157 34 11 223 155 Case 
 
1 1 
   
1 
       
1 4 
600985 77 34 SLV 155 Case 
  
1 
 
1 
   
1 
 
1 1 1 
 
1 7 
601191 9 21 155 155 Case 
  
1 
     
1 
 
1 1 1 
 
1 6 
601307 9 21 155 155 Case 
  
1 
     
1 
 
1 1 1 
 
1 6 
900500 128ab 12 SLV 165 Case 1 
 
1 
  
1 
        
1 4 
900820 O? 19 165 165 Case 1 1 1 
  
1 
        
1 5 
900547 O? 19 165 165 Case 1 1 1 
  
1 
        
1 5 
900603 O? 19 165 165 Case 1 1 1 
  
1 
        
1 5 
7172 12 4 484 168 Control 
 
1 1 
     
1 
   
1 
  
4 
8089 7 4 484 168 Control 1 1 1 
   
1 
     
1 
  
5 
3029 12 4 484 168 Control 1 1 1 
   
1 1 
  
1 1 1 
  
8 
900696 7 4 484 168 Case 1 1 1 
   
1 
     
1 
 
1 6 
601235 7 4 484 168 Case 1 1 1 
   
1 
 
1 
 
1 1 1 
 
1 9 
8098 11 16 206 206 Control 
  
1 
            
1 
600983 60 H? 206 206 Control 
          
1 1 1 
  
3 
7207 91 9 226 226 Case 1 1 1 
       
1 1 1 1 1 8 
7079 25 H- SLV 295 Case 
 
1 
            
1 2 
8080 125ac 9 295 295 Case 1 1 1 
       
1 1 1 1 1 8 
8120 R 16 SLV 295 Case 1 1 1 
    
1 
  
1 1 1 1 1 9 
7058 O? 16 295 295 Control 1 1 1 
   
1 
        
4 
7078 O? 27 295 295 Control 1 1 1 
 
1 
 
1 
 
1 
 
1 1 1 1 
 
10 
7089 181 16 SLV 295 Control 1 1 1 
 
1 
   
1 1 1 1 1 1 
 
10 
7089 O? 27 SLV 295 Control 1 
 
1 
 
1 
 
1 
 
1 1 1 1 1 1 
 
10 
7096 O? 12 295 295 Control 1 1 1 
  
1 1 
  
1 1 1 1 
  
9 
8002 9a 10 295 295 Control 1 1 1 
    
1 
  
1 1 1 
  
7 
8129 O? 29 295 295 Control 1 1 1 
     
1 1 1 
 
1 1 
 
8 
900020 O? 7 841 295 Case 1 1 1 
   
1 
   
1 1 1 1 1 9 
900286 O? 27 295 295 Case 1 1 1 
 
1 
   
1 1 1 1 1 1 1 11 
900545 181 16 SLV 295 Case 1 1 1 
  
1 
 
1 1 
  
1 1 
 
1 9 
601083 O? 28 295 295 Control 
 
1 1 
 
1 
   
1 1 1 
 
1 1 
 
8 
601144 125ac 9 295 295 Control 1 1 1 
       
1 1 1 1 
 
7 
601188 181 3 295 295 Control 1 1 1 
  
1 1 
        
5 
601221 84 27 SLV 295 Control 1 1 1 
 
1 
   
1 1 1 1 1 1 
 
10 
601110 25 7 SLV 295 Case 1 1 1 
 
1 
   
1 1 1 1 1 1 1 11 
601226 O? 27 SLV 295 Case 1 1 1 
 
1 
   
1 1 1 1 1 
 
1 10 
601251 O? 29 295 295 Case 1 1 1 
    
1 
  
1 1 1 1 1 9 
3017 166 15 349 349 Control 
       
1 
  
1 
  
1 
 
3 
600950 166 15 349 349 Control 1 1 1 
  
1 
       
1 
 
5 
600990 166 15 349 349 Case 1 1 1 
         
1 
 
1 5 
900088 44 40 394 394 Case 1 1 1 
    
1 
     
1 1 6 
900416 O? 18 394 394 Case 1 1 1 
      
1 
  
1 
 
1 6 
900673 O? 10 394 394 Case 1 1 1 
    
1 
      
1 5 
601002 O? 41 394 394 Control 
 
1 1 1 
    
1 
      
4 
601230 44 18 394 394 Control 1 1 1 
    
1 
       
4 
600970 O? 18 394 394 Case 1 1 1 
   
1 1 
    
1 
 
1 7 
601009 166 15 394 394 Case 
 
1 1 
       
1 1 1 
 
1 6 
900644 O? 10 448 448 Case 1 1 1 
           
1 4 
7004 O? 26 TLV 3LV Control 1 1 1 
 
1 
   
1 1 1 1 1 1 
 
10 
1024 130 27 TLV 3LV Case 
  
1 
     
1 
 
1 1 1 1 1 7 
3026 O? 27 TLV 3LV Control 1 1 1 
 
1 
  
1 1 1 1 1 1 1 
 
11 
900753 166 15 DLV 3 Case 1 1 1 1 
  
1 
 
1 
   
1 
 
1 8 
900998 175 1 200 40 Case 1 1 1 
 
1 
   
1 1 1 1 1 
 
1 10 
901006 44 34 130 31 Case 1 1 1 
           
1 4 
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600955 175 1 SLV 40 Control 1 1 1 
 
1 
   
1 1 1 
 
1 
  
8 
600982 166 15 SLV 0 Control 1 1 1 1 
    
1 
      
5 
7081 O? 19 165 165 Control 1 1 1 
  
1 
         
4 
7121 77 18 New Allele 1 Control 
        
1 
 
1 1 
   
3 
1038 25 H- New Allele 1 Case 
 
1 
            
1 2 
900245 161 H- New Allele 1 Case 1 1 1 
  
1 
 
1 1 1 1 1 1 
 
1 11 
900442 121 H? New Allele 1 Case 1 1 1 
 
1 
   
1 1 1 1 1 
 
1 10 
900553 51 12 New Allele 1 Case 1 1 1 
 
1 
  
1 1 
 
1 
 
1 1 1 10 
601098 O? 45 New Allele 1 Control 
               
0 
7064 153 36 157 0 Control 1 1 1 1 
           
4 
7067 86 27 2166 0 Control 1 1 1 
    
1 
    
1 1 
 
6 
7092 125ac 8 1295 0 Control 1 1 1 
     
1 
    
1 
 
5 
1037 159 23 1490 0 Case 
        
1 
     
1 2 
900063 O? 23 720 0 Case 1 1 1 1 
   
1 1 
     
1 7 
900108 21 8 1295 0 Case 
 
1 1 
     
1 
    
1 1 5 
900512 O? 23 157 0 Case 1 1 1 
         
1 1 1 6 
900550 128 12 1326 0 Case 1 1 1 
   
1 
     
1 
 
1 6 
900693 44 H- 720 0 Case 1 1 1 1 
    
1 
     
1 6 
900694 O? 24 219 0 Case 1 1 1 
    
1 
    
1 1 1 7 
900732 O? 7 1891 0 Case 1 
 
1 
   
1 
     
1 
 
1 5 
900769 69 4 1891 0 Case 1 
 
1 
  
1 
  
1 
 
1 1 1 
 
1 8 
900770 69 4 678 0 Case 1 1 1 
  
1 
  
1 
 
1 1 1 
 
1 9 
900883 44 23 720 0 Case 1 1 1 1 
    
1 
     
1 6 
601155 O? 30 678 0 Control 
  
1 
 
1 
   
1 
      
3 
601180 O? 23 2186 0 Control 1 1 1 1 
  
1 
        
5 
600965 126 7 SLV 0 Case 1 1 1 
   
1 
     
1 
 
1 6 
601176 O? H- 720 0 Case 1 1 1 1 
    
1 
     
1 6 
601174 78 7 1891 0 Control 
 
1 1 
   
1 
     
1 
  
4 
601106 O? 23 2186 0 Control 
 
1 1 
   
1 
        
3 
7155 25 H- SLV 2 Case 
            
1 
 
1 2 
8016 O? 10 SLV 2 Case 
            
1 
 
1 2 
900114 127 11 SLV 2 Case 1 1 1 
    
1 
  
1 1 1 
 
1 8 
900794 O? 10 SLV 2 Case 1 1 1 
  
1 1 
  
1 
  
1 
 
1 8 
900851 125ac 11 SLV 2 Case 
              
1 1 
600961 69 38 SLV 2 Case 
      
1 
     
1 
 
1 3 
601158 2 H- SLV 2 Case 
  
1 
  
1 
  
1 
     
1 4 
601062 2 42 SLV 2 Case 
  
1 
     
1 
    
1 1 4 
042 44 18 414 30 Case 1 1 1  1 
 
  1 
1 1 1 1  
1 10 
 
Table 7.4: Virulence gene profiling of 153 EAEC isolates from Bangladesh. Virulence score denotes 
the number of positive virulence genes in a given strain. 
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7.5 Descriptive methodology of Chi-Square for EAEC group assignment 
 http://wwwn.cdc.gov/epiinfo/  then selected Open Epi  link on left hand side 
 Selected two by two table under counts section on left hand side 
 Select enter new data 
 Put in results in table, example to test 295 group with 4 cases and 8 controls, total 
are 78 and 37 respectively. Put in value and minus the observed from the totals, then 
select calculate 
 
 
 Put in value and minus the observed from the totals, then select calculate 
 
 
 
 
 Fishers exact test is used when the observed number is less than 5 and the 
totals are between 20-40. No appropriate in this case. 
 228 
 
 Eg complex 10 with 138 cases and 35 in controls. Total of dataset is 412 cases 
and 152 controls, need to minus the 10 complex numbers from the total to 
achieve the total of 564 EAEC. 
  
 Calculate 
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For EAEC associated groups, e.g complex 10 is 191 EAEC and 654 other E. coli  
Total is 719 EAEC strains(564 from PhD + 155 from public database) and 5955 
other E. coli 
 (6815 from PhD and public minus 719  EAEC and minus 141 shigella) from a 
total of 5955 E.coli strains) 
e.g ST10 complex being EAEC associated, 191 EAEC in this group out of 719 
and the other e.coli pathotypes have 272 in ST 10 Cplx out of 5955 E. coli. 
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7.6 Published Papers and Conference Presentations Summary 
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July 2011 
Marie Anne Chattaway, Tim Dallman, Iruke N. Okeke and John Wain 
 
Dec 12 Characterisation of a verocytotoxin-producing enteroaggregative Escherichia 
coli serogroup O111:H21 associated with a household outbreak in Northern 
Ireland 
 Journal of Clinical Microbiology. Vol. 50 Issue 12 Page 4116-4119. 
 December 2012 
Tim Dallman, Geoffrey P. Smith, Brendan O’Brien, Marie A. Chattaway, David 
Finlay, Kathie A. Grant, and Claire Jenkins 
 
Sept 13 Comparative Analysis of ESBL-Positive Escherichia coli Isolates from Animals 
and Humans from the UK, The Netherlands and Germany 
PLOS ONE. Vol. 8  Issue 9 Page 1-10. September 2013 
Guanghui Wu, Michaela J. Day, Muriel T. Mafur, Javier Nunez-Garcia, Jackie 
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June 2014 
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June 2014 
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Zandbergen, Anne-Kathrin Schink, Guanghui Wu, John Threlfall, Martin J. 
Woodward, Nick Coldham, Kristina Kadlec, Stefan Schwarz, Cindy Dierikx, 
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Cravatio, Kaiser Ali Talukder, Tim Dallman, Anthony Underwood ,Steve Platt, 
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